carbapenems has been researched along with Acinetobacter Infections in 918 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (0.44) | 18.2507 |
| 2000's | 134 (14.60) | 29.6817 |
| 2010's | 587 (63.94) | 24.3611 |
| 2020's | 193 (21.02) | 2.80 |
| Authors | Studies |
|---|---|
| Alp, E; Dinç, G; Doğanay, M; Eryılmaz-Eren, E; Kontaş, O | 1 |
| Abdollahi, A; Aliramezani, A; Douraghi, M; Ghourchian, S; Norouzi Shadehi, M; Salehi, M | 1 |
| Ababneh, Q; Al Sbei, S; Al-Zoubi, E; Alawneh, D; Aldaken, N; Alhomsi, T; Jaradat, Z; Saadoun, I | 1 |
| Alvi, AA; Ishtiaq, S; Saleem, S; Waheed, A | 1 |
| Bakry, U; Diab, AA; El-Shqanqery, HE; Elanany, M; Elzayat, MG; Hassan, R; Jalal, D; Samir, O; Sayed, AA; Shalaby, L | 1 |
| Chu, M; Jeon, H; Kim, YJ; Lee, IY; Lee, JC; Na, SH; Oh, MH | 1 |
| Choi, J; Jang, A; Kim, Y; Krishnan, M; Yoon, YK | 1 |
| Chandra, P; Cs, S; M, S; Mk, U; V, R | 1 |
| de Lacerda Bonfante, H; Gontijo, AVL; Pereira, SL | 1 |
| Appaneal, HJ; Caffrey, AR; LaPlante, KL; Lopes, VV; O'Neill, E | 1 |
| Ding, J; Huang, Y; Jia, Y; Liu, H; Peng, J; Wu, D; Xiao, J | 1 |
| Choe, PG; Choi, EH; Choi, S; Jung, J; Kang, CK; Kim, E; Kim, NJ; Lee, HY; Lee, J; Lee, S; Oh, M; Park, WB | 1 |
| Bao, CM; Chen, SM; Cui, EB; Jia, TY; Li, BA; Li, X; Wang, H; Zhang, W | 1 |
| Sun, X; Yao, L; Zhang, L; Zhang, Y | 1 |
| Cai, B; Kanakamedala, H; Pogue, JM; Zhou, Y | 1 |
| Alquethamy, SF; Bauer, MJ; Beatson, SA; Blaskovich, MAT; Brouwer, S; Cork, AJ; De Oliveira, DMP; El-Deeb, IM; Forde, BM; Harbison-Price, N; Keller, N; Li, G; McDevitt, CA; McEwan, AG; Paterson, DL; Phan, MD; Roberts, JA; Schembri, MA; Steiner, B; von Itzstein, M; Walker, MJ; Zhang, B; Zuegg, J | 1 |
| Gunawan, C; Hamidian, M; Harmer, CJ; Mann, R; Rafei, R | 1 |
| Boggian, K; Filipovic, M; Flury, D; Haller, S; Kleger, GR; Kohler, P; Nolte, O; Scanferla, G; Schlegel, M; Seiffert, SN; Seneghini, M; Thoma, R; Vuichard Gysin, D | 1 |
| Barreto, S; Charpentier, X; Godeux, AS; Laaberki, MH; Potron, A; Svedholm, E; Venner, S | 1 |
| Bernardo, M; Bitterman, R; Carmeli, Y; Daikos, GL; Daitch, V; Dishon Benattar, Y; Durante-Mangoni, E; Frenk, S; Friberg, LE; Geffen, Y; Gershon, R; Iossa, D; Keren-Paz, A; Leibovici, L; Lurie-Weinberger, MN; Mouton, JW; Nutman, A; Paul, M; Rakovitsky, N; Rov, R; Skiada, A; Temkin, E; Theuretzbacher, U; Wullfhart, L; Yahav, D; Zusman, O | 1 |
| Ambrose, SJ; Evans, BA; Hall, RM | 1 |
| Abouelfetouh, A; Evans, BA; Li, E; Mattock, J; Turner, D | 1 |
| Camacho-Ortiz, A; Flores-Treviño, S; Garza-González, E; Lara-Medrano, R; Martínez-Reséndez, MF; Mendoza-Olazarán, S | 1 |
| Chen, M; Lei, Z; Qu, D; Qu, S; Yan, L; Zhao, F; Zhao, Y; Zhou, XW; Zhu, T | 1 |
| Ballet, S; Breine, A; Elsocht, M; Philippe, C; Quinet, T; Valcek, A; Van der Henst, C; Van Gysel, M; Whiteway, C; Wouters, J | 1 |
| Barcelos Valiatti, T; Cayô, R; da Silva, CC; da Silva, JTP; Dos Santos, LA; Fernandes Santos, F; Ferreira, JA; Gales, AC; Moura, LB; Silva Carvalho, T; Silva Nodari, C | 1 |
| Naknaen, A; Phaonakrop, N; Pomwised, R; Roytrakul, S; Smith, DR; Surachat, K; Voravuthikunchai, SP; Wintachai, P | 1 |
| Avendano, DH; Canavan, K; Eckardt, P; George, E; Guran, R; Himed, K; Kim, M; Miller, N; Ramirez, KHG | 1 |
| Chang, CC; Chang, JC; Chen, DS; Chen, LK; Chen, YT; Chu, HT; Jiang, HL; Li, YZ; Sankhla, D; Teh, SH; Tseng, CC; Wang, LS; Yang, HH | 1 |
| Heil, EL; Hirsch, EB; Karaba, SM | 1 |
| Becerra-Aparicio, F; Fuchs, F; Higgins, PG; Seifert, H; Xanthopoulou, K | 1 |
| Assous, MV; Ben-Chetrit, E; Bnaya, A; Tordgman, D; Wiener-Well, Y; Wolfovitz-Barchad, O; Yinnon, AM | 1 |
| Kurihara, MNL; Mahmoud, FF; Mansano, MCT; Sales, RO; Silva, GD; Silva, KED; Simionatto, S | 1 |
| Ju, YG; Lee, HJ; Lee, MG; Sohn, JW; Yim, HS; Yoon, YK | 1 |
| Perez, F; Stiefel, U | 1 |
| Bang, JH; Cheon, S; Choe, PG; Choi, HJ; Jung, SI; Jung, Y; Kang, YM; Kim, CJ; Kim, ES; Kim, HB; Kim, SE; Kim, YJ; Kwak, YG; Lee, CM; Lee, S; Lee, SH; Park, KH; Park, WB; Song, KH | 1 |
| Ang, BSP; De, PP; Ho, BCH; Khong, WX; Marimuthu, K; Ng, OT; Ong, SWX; Ong, VYF; Rao, P; Sridatta, PSR; Thevasagayam, NM | 1 |
| Bouvier, M; Findlay, J; Nordmann, P; Poirel, L | 1 |
| Eom, YB; Kim, HR | 1 |
| Chen, H; Gao, Y; Li, H; Wang, H; Wang, R; Wang, Z; Zhang, J | 1 |
| Anggraini, D; Hadi, U; Kemal, RA; Kuntaman, K | 1 |
| Fu, Y; Hua, X; Jiang, Y; Lan, P; Li, T; Liu, H; Yan, R; Yang, Y; Yu, Y; Zhou, Z | 1 |
| Erac, B; Temel, A | 1 |
| Cruz-López, F; Garza-González, E; Maldonado-Garza, H; Martínez-Meléndez, A; Morfín-Otero, R; Villarreal-Treviño, L | 1 |
| Capalash, N; Kashyap, S; Sharma, P; Sidhu, H | 1 |
| Fu, Y; Hua, X; Leptihn, S; Liu, H; Yao, Y; Yu, Y; Zhang, L; Zhao, F; Zhou, Z | 1 |
| Al-Madboly, LA | 1 |
| Bae, JY; Bang, JH; Cheon, S; Choe, PG; Choi, HJ; Jung, SI; Jung, Y; Kang, YM; Kim, CJ; Kim, ES; Kim, HB; Kim, SE; Kim, YS; Kwak, YG; Lee, CM; Lee, S; Lee, SH; Lee, SS; Park, KH; Park, WB; Song, JE; Song, KH | 1 |
| Ballard, SA; Basu, I; Blakiston, MR; Roberts, S; Schultz, MB; Williamson, D | 1 |
| Himmel, LE; Kunkle, DE; Maloney, KN; Monteith, AJ; Sheldon, JR; Skaar, EP | 1 |
| Boutiba-Ben Boubaker, I; Ferjani, A; Ferjani, S; Hamzaoui, Z; Kanzari, L; Maamar, E; Rehaiem, A | 1 |
| Brito, BP; Garcia, P; Hamidian, M; Koong, J; Opazo-Capurro, A; To, J; Wozniak, A | 1 |
| Hayashi, C; Kai, D; Kamoshida, G; Kanda, N; Kaya, Y; Morimoto, H; Nakamura, T; Okada, T; Sakaguchi, M; Sawada, T; Takemoto, N; Yahiro, K; Yamada, N; Yamaguchi, D; Yamashita, M | 1 |
| Chen, TL; Cheng, A; Chiang, TT; Huang, TW; Kuo, SC; Lee, YT; Liu, CP; Liu, YM; Sun, JR; Wang, YC; Yang, YS | 1 |
| Alosaimy, S; Andrade, J; Biagi, M; Bouchard, J; Cosimi, R; Davis, SL; Gore, T; Hobbs, ALV; Huang, G; Jones, B; Kang-Birken, SL; King, MA; Lagnf, AM; Molina, KC; Morrisette, T; Perkins, NB; Pierce, M; Pullinger, BM; Rojas, LM; Rybak, MJ; Scipione, MR; Truong, J; Veve, MP; Zhao, JJ | 1 |
| Gao, Z; Guan, J; He, Y; Li, Y; Ma, X; Ni, W; Wang, Y; Zhao, J | 1 |
| Abu-Taleb, R; Alamneh, YA; Bushnell, RV; Czintos, CM; Daly, MJ; Dollery, SJ; Escatte, MG; MacLeod, DA; Meeks, HN; Su, W; Tasker, NJPER; Tobin, GJ; Tobin, JK; Wiggins, TJ; Zurawski, DV | 1 |
| Chen, L; Deng, Y; Huang, X; Yang, Y; Yu, H; Yue, M | 1 |
| Burnham, CD; Calix, JJ; Dantas, G; de Almeida, MCS; Potter, RF; Wallace, MA | 1 |
| Li, W; Li, Y; Shao, X; Tao, Y; Wang, Y; Zhang, X; Zhu, Y | 1 |
| Kim, M; Kim, Y; Krishnan, M; Lee, H; Yoon, YK | 1 |
| Dissaneevate, S; Janjindamai, W; Maneenil, G; Phatigomet, M; Thatrimontrichai, A | 1 |
| Goy, K; Luna, B; Miller, S; She, R; Spellberg, B | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Chan, MC; Chen, CM; Chen, CY; Chou, YC; Feng, JY; Lin, YC; Peng, CK; Sheu, CC; Wang, SH; Yang, KY; Zheng, ZR | 1 |
| Guo, HB; Huang, HL; Li, YY | 1 |
| Choi, MC; Joo, DJ; Kim, DG; Kim, MS; Lee, JG; Min, EK; Yim, SH | 1 |
| Banoub, M; Claeys, KC; Doi, Y; Heil, EL; Iovleva, A; Kline, EG; Luethy, PM; Noval, MM; Rogers, TM; Shields, RK; Squires, KM | 1 |
| Akca, G; Drcelic, M; Goic-Barisic, I; Hrenovic, J; Jakovac, S; Music, MS; Tonkić, M; Tuncbilek, S | 1 |
| Akcam, FZ; Cetin, ES; Gonen, I; Kaya, O; Ozturk, T; Temel, EN; Unal, O | 1 |
| Ma, Y; Pathak, A; Pathania, R; Shadan, A; Singh, RP | 1 |
| Carmeli, Y; Lerner, AO; Schechner, V; Temkin, E | 1 |
| Fahy, S; Lucey, B; O'Connor, JA; Sleator, RD | 1 |
| Bleick, C; Caniff, K; El-Ghali, A; Kunz Coyne, AJ; Rybak, MJ | 1 |
| Çakıral, K; Güran, M; Kandemir, T; Köksal, F; Nagiyev, T; Öcal, MM; Şanlıtürk, G; Teralı, K | 1 |
| Bonomo, RA; Watkins, RR | 1 |
| Altarac, D; Du, B; Isaacs, R; Watkins, RR | 1 |
| Paterson, DL; Shields, RK; Tamma, PD | 1 |
| Bernardo, M; Carmeli, Y; Daikos, GL; Daitch, V; Dickstein, Y; Dishon Benattar, Y; Durante-Mangoni, E; Friberg, LE; Hameir, A; Iossa, D; Kaye, KS; Keren Paz, A; Kon, H; Leibovici, L; Lellouche, J; Mendelsohn, S; Nutman, A; Paul, M; Pollak, D; Schwartz, D; Skiada, A; Temkin, E; Theuretzbacher, U; Weiss, DS; Yahav, D | 1 |
| Arend, LNVS; de Andrade, AP; Dos Santos Oliveira, D; Telles, JP; Tuon, FF; Yamada, CH | 1 |
| Katip, W; Nampuan, T; Oberdorfer, P; Rayanakorn, A; Taruangsri, P | 1 |
| Buonomo, AR; Calò, F; Coppola, N; De Luca, I; Di Caprio, G; Durante-Mangoni, E; Gentile, I; Iuliano, P; Leone, S; Macera, M; Maggi, P; Massa, A; Monari, C; Numis, FG; Onorato, L; Pagliano, P | 1 |
| Ghavidel, M; Ghazvini, K; Khoshbakht, R; Neshani, A; Panahi, S | 1 |
| Actis, LA; Bonomo, RA; Escalante, J; Marin, I; Mezcord, V; Nishimura, B; Pasteran, F; Ramirez, MS; Rao, G; Sharma, R; Subils, T; Tolmasky, ME; Traglia, GM; Tuttobene, MR; Vallé, Q | 1 |
| Bartolini, A; Bartoloni, A; Bernardo, M; Bianco, V; Botta, A; Faragona, A; Giacometti, A; Giani, T; Graziani, L; Lagi, F; Morroni, G; Parrella, R; Piccica, M; Rossolini, GM; Spinicci, M; Tavio, M | 1 |
| Aygen, B; Bolat, D; Dinc, G; Eren, EE; Gönen, ZB; İzci, F; Ture, Z; Ünüvar, GK; Yay, AH; Yıldız, O | 1 |
| Kim, JY; Kim, SB; Lee, WJ; Sohn, JW; Suh, JW; Yoon, YK | 1 |
| Blythe, D; French, I; Harris, AD; Heller, A; Johnson, JK; Klein, L; O'Hara, LM; Perlmutter, R; Pineles, L; Rubin, J; Smith, LL; Thoguru, J; Vaeth, E | 1 |
| Alharbi, N; Kadaikunnan, S | 1 |
| Arowolo, MT; Batholomew, OH; Essiet, UU; Ezeani, OM; Ishola, OD; Lagoke, OA; Ogunrinde, OG; Olaitan, MO; Olumodeji, E; Onishile, AO; Orababa, OQ; Osibeluwo, BV; Soriwei, JD | 1 |
| Batistão, D; Campos, PA; Ferreira, ML; Fuga, B; Gontijo-Filho, PP; Machado, LG; Melo, GN; Resende, DS; Ribas, RM; Rossi, I; Royer, S; Urzedo, JE | 1 |
| Ghalavand, Z; Kadkhoda, H; Kodori, M; Maleki, DT; Mohammadzadeh, M; Salehi, B | 1 |
| Gupta, V; Lawrence, K; Murray, J; Olesky, M; Ye, G; Yu, K | 1 |
| Leung, CH; Liu, CP | 1 |
| Eigenbrod, T; Gross, A; Günther, F; Heeg, K; Kocer, K; Mutters, NT; Nurjadi, D; Reuter, S; Zimmermann, S | 1 |
| Abbas, H; Al-Hamad, A; Alsubikhy, F; Darwish, D; Ghazawi, A; Hejles, H; Leskafi, H; Pal, T; Sonnevend, A | 1 |
| Bahmani, M; Choolandaimy, ZB; Delfani, S; Rezaie, F; Shakib, P | 1 |
| Cen, C; Liu, J; Xiao, X; Yang, M; Yuan, H | 1 |
| Al-Hassan, L; El-Mahallawy, H; Zafer, MM | 1 |
| Hamidian, M; Nigro, SJ | 1 |
| Caccuri, F; Caruso, A; De Francesco, MA; Gargiulo, F; Gurrieri, F; Lorenzin, G; Piccinelli, G; Scaltriti, E | 1 |
| Božić, D; Brkić, S; Ćirković, I; Jovanović, M; Stepanović, M; Stojanović, N; Topalov, D; Vitorović, T | 1 |
| Duan, X; Li, S; Peng, Y; Rui, Y | 1 |
| Bedenić, B; Dekić, S; Godan-Hauptman, A; Hrenović, J; Musić, MŠ; Šijak, D; Siroglavić, M; Slade, M | 1 |
| Arsava, EM; Aytaç, H; Bölek, EÇ; Metan, G; Metin, BC; Otlu, B; Tekin, İ; Ünal, S; Zarakolu, P | 1 |
| Bedenić, B; Grisold, A; Kos, M; Lukić-Grlić, A; Luxner, J; Zarfel, G; Žižek, M | 1 |
| Bonomo, RA; Evans, SR; Jiang, Y; Pan, Q; Perez, F; Wilson, BM | 1 |
| Ahn, JY; Choi, H; Choi, JY; Choi, YH; Jeong, SJ; Kim, JM; Ku, NS; Lee, SH; Lim, YS; Shin, SJ; Song, YG; Yeom, JS; Yong, D | 1 |
| Ardebili, A; Ezadi, F; Heidari, A; Jamali, A; Javid, N | 1 |
| Bo, T; Gao, N; Gu, J; Hu, S; Niu, L; Nong, J; Wang, C; Wang, H; Wu, L; Yan, L; Zhao, F; Zhu, X | 1 |
| Li, X; Lu, C; Sun, S; Wang, D; Wang, Y | 1 |
| Girija, SA; Paramasivam, A; Priyadharsini, JV | 1 |
| Abouelfetouh, A; Aboulmagd, E; Torky, AS | 1 |
| AlAmri, AM; AlNimr, AM; AlQurayan, AM; Sebastian, T | 1 |
| Anandan, S; Bhattacharya, S; Deotale, V; Kanthan, K; Kapil, A; Mathur, P; Ms, DP; Ohri, VC; Ray, P; Sistla, S; Veeraraghavan, B; Vijayabaskar, S; Vijayakumar, S; Walia, K; Wattal, C | 1 |
| Cai, HM; Chen, J; Fang, Y; Jin, YZ; Lv, Y; Wang, C; Wang, H; Wei, QD; Wu, YJ; Xiang, Q; Yu, H; Zeng, B | 1 |
| Castillo-Ramírez, S; Cevallos, MA; Colín-Castro, CA; Evans, BA; Franco-Cendejas, R; Graña-Miraglia, L; Hernández-Durán, M; López-Jácome, LE; Volkow-Fernández, P | 1 |
| Abad, CLR; Li, KL | 1 |
| Ashfaq, UA; Aslam, B; Guo, Q; Khurshid, M; Rasool, MH; Wang, M; Waseem, M; Xu, Q; Zhang, X | 1 |
| Caliskan, E; Copur Cicek, A; Sandalli, C; Say Coskun, US; Turumtay, H | 1 |
| Annambhotla, P; Bardossy, AC; Barros, N; Basavaraju, SV; Epstein, L; Haas, W; Maloney, M; Musser, KA; Nazarian, E; Pepe, D; Pierce, VM; Snavely, EA; Walters, M | 1 |
| Azeem, F; Khurshid, M; Naeem, M; Nisar, MA; Qamar, MU; Rasool, MH; Saqalein, M; Sarfraz, M; Shahzad, A; Siddique, MH; Sohail, M; Taj, Z | 1 |
| Choi, JY; Jeong, H; Kim, MH; Lee, S; Ryu, CM; Sim, YM; Yong, D | 1 |
| Abdallah, S; Azar, E; Badawi, R; Dandachi, I; Daoud, Z; Hamouch, R; Kanaan, E; Khairallah, T; Maliha, P; Matar, GM | 1 |
| Anahtar, MN; Bramante, JT; Hawkins, FR; Herriott, IC; Hooper, DC; Huntley, MH; Kwon, DS; Pangestu, FK; Pierce, VM; Sater, MRA; Shenoy, ES; Suslak, D; West, LR | 1 |
| Adams, MD; Albornoz, E; Bonomo, RA; Corso, A; Fernandez, JS; Gonzalez, LJ; Huang, F; Liu, C; Lopez, C; Martinez, J; Pasteran, F; Ramirez, MS; Traglia, GM; Vila, AJ | 1 |
| Chen, CS; Chen, IH; Chen, YY; Huang, WT; Wang, FD; Wu, PF | 1 |
| Apisarnthanarak, A; Dissaneevate, S; Janjindamai, W; Maneenil, G; Pannaraj, PS; Thatrimontrichai, A | 1 |
| Bertani, AMJ; Bueno, MS; Camargo, CH; Cunha, MPV; de Barcellos, TAF; de Vasconcellos, FM; Ferreira, AM; Gonçalves, CR; Mondelli, AL; Montelli, AC; Sacchi, CT; Sadatsune, T; Sant'Ana, DA; Santos, CA; Tavares, LCB; Tiba-Casas, MR | 1 |
| Gajic, I; Hadnadjev, M; Jovanovic, S; Kekic, D; Mijac, V; Mijovic, G; Opavski, N; Ranin, L; Smitran, A; Travar, M | 1 |
| Ashraf, A; Atrkar Roushan, Z; Khanjani, S; Mojtahedi, A; Sedigh Ebrahim-Saraie, H; Shenagari, M | 1 |
| de Souza, MJ; Genteluci, GL; Gomes, DBC; Neves, MC; Pereira, D; Rangel, K; Villas Bôas, MHS | 1 |
| Badrinath, V; Eram, D; Muddebihalkar, AG; Niranjan, V; Skariyachan, S; Umashankar, B; Uttarkar, A | 1 |
| Almeida, LGP; Cayô, R; Gales, AC; Lincopan, N; Martins, WMBS; Narciso, AC; Ramos, PL; Santos, SV; Vasconcelos, ATR | 1 |
| Liu, X; Lyu, C; Wu, J; Zhang, J; Zhang, Y | 1 |
| Almatroudi, A; Khurshid, M; Rasool, MH; Saqalein, M; Taj, Z | 1 |
| Lakshmi, V; Sritharan, V; Sudhaharan, S; Suguna Ratnakar, K; Swathi, C | 1 |
| Gao, CY; Hou, PF; Pan, Y; Zhu, LJ | 1 |
| Ghazvini, K; Jahangiri, A; Mirhosseini, SA; Neshani, A; Sedighian, H; Zare, H | 1 |
| Karakonstantis, S | 1 |
| Lorton, A; Maboni, G; Sanchez, S; Seguel, M | 1 |
| Carmeli, Y; Nutman, A | 1 |
| Amaral, SC; Conceição, FR; de Freitas, SB; Ferreira, MRA; Hartwig, DD; Moreira, C; Roloff, BC | 1 |
| Katip, W; Oberdorfer, P; Uitrakul, S | 1 |
| Almaeen, AH; Bandy, A | 1 |
| Higgins, PG; Kresken, M; Miller, A; Müller, C; Seifert, H; Stefanik, D | 1 |
| Ascencio, F; Estrada-Garcia, MT; Garciglia Mercado, C; Gaxiola Robles, R; Gomez-Anduro, G; Silva-Sanchez, J | 1 |
| Alon, D; Chowers, M; Mudrik, H; Shitrit, P | 1 |
| Ayobami, O; Eckmanns, T; Markwart, R; Suwono, B; Willrich, N | 1 |
| Cares Network, OBOT; Chen, H; Li, H; Liu, Y; Wang, H; Wang, Q; Zhao, C | 1 |
| Ben David, D; Carmeli, Y; Lellouche, J; Nutman, A; Schwartz, D; Temkin, E | 1 |
| Fournier, C; Nordmann, P; Poirel, L | 1 |
| Bai, H; Bao, H; Guo, T; Hai, Y; Jiao, Y; Li, H; Liu, W; Ren, W; Tian, J; Wang, M; Xing, H; Xu, B; Yang, H; Yang, L; Yang, Y; Zhang, K; Zhang, S; Zhao, Y | 1 |
| Álvarez, E; Barrera, E; Cardoso, B; Cerdeira, L; Cifuentes, S; Esposito, F; Gonzalez-Rocha, G; Lincopan, N; Moura, Q; Opazo-Capurro, A | 1 |
| Bennett, JW; Galac, MR; Hinkle, K; Jones, AR; Julius, M; Kwak, YI; Lebreton, F; Lesho, EP; Maybank, R; Mc Gann, P; Ong, AC; Snesrud, E; Stam, J; Waterman, PE | 1 |
| Ayfan, AK; Mohd Sazlly Lim, S; Naicker, S; Roberts, JA; Sime, FB; Zowawi, H | 1 |
| Devereux, M; Galdino, ACM; McCann, M; Nunes, APF; Santos, ALS; Schuenck, RP; Ventura, RF; Viganor, L | 1 |
| Brito, JCM; da Cruz Nizer, WS; Lima, WG | 1 |
| Cuba, GT; Ramos, JF; Veiga Kiffer, CR | 1 |
| Alaguero, M; Escudero, D; Fernández, J; Quindós, B; Rodicio, MR; Rodríguez-Lucas, C; Vázquez, X | 1 |
| Gikas, A; Karakonstantis, S; Kritsotakis, EI | 1 |
| Cai, L; Gao, S; Huang, W; Kang, Y; Qiao, F; Tao, C; Wei, L; Zhu, S; Zong, Z | 1 |
| Hu, YM; Li, J; Li, YJ; Luo, Y; Peng, JY; Tao, XY; Wang, HC; Yu, T; Zou, MX | 1 |
| Chanawong, A; Charoensri, N; Faksri, K; Lulitanond, A; Lunha, K; Ngudsuntia, A; Tavichakorntrakool, R; Thet, KT; Wonglakorn, L | 1 |
| Ahmad, I; Khalid, F; Saleem, S | 1 |
| Gozen, AG; Guclu, AU | 1 |
| Grosso, F; Ksiezarek, M; Peixe, L; Ramos, H; Rodrigues, C; Silva, L | 1 |
| Al-Azzam, S; Aldeyab, MA; Conlon-Bingham, G; Conway, BR; Gould, I; Hayajneh, WA; Lattyak, EA; Lattyak, WJ; López-Lozano, JM; Yusef, D | 1 |
| Albiger, B; Kohlenberg, A; Lötsch, F; Monnet, DL; Seifert, H; Struelens, MJ | 1 |
| Atrouni, AA; B Halimeh, F; Dabboussi, F; Haenni, M; Hamze, M; Jamal, S; Lupo, A; M Diene, S; Madec, JY; Mallat, H; Moudani, W; Osman, M; Raad, EB; Rafei, R; Rolain, JM; Saras, E; Tom, JE | 1 |
| Gruninger, RJ; Horth, RZ; Nakashima, AK; Oakeson, KF; Rider, L; Rossi, A; Sangster, A; Schuckel, H; Smith, AR; Smith, L; Stewart, J; Vowles, M; Wagner, JM; Young, EL | 1 |
| Açıkgoz, ZC; Aydogan, S; Cakirlar, FK; Durmaz, R; Gozalan, A; Guldemir, D; Kuzucu, C; Unaldı, O | 1 |
| Arias, J; Chew, D; Greeley, R; Innes, GK; Mehr, J; Perez, S; Walters, MS | 1 |
| AlDeesi, ZO; AlSharhan, MA; Ayoub Moubareck, C; Celiloglu, H; Hammoudi Halat, D; Han, A; Karam Sarkis, D; Nabi, A | 1 |
| Bueno, MS; Camargo, CH; Chimara, E; Cunha, MPV; de Barcellos, TAF; de Carvalho, E; Moreno, AM; Moreno, LZ; Nagamori, FO; Takagi, EH; Tiba-Casas, MR | 1 |
| Chen, F; Guo, Y; Hu, F; Li, M; Liu, Y; Ni, Y; Sun, J; Tang, J; Wu, W; Yin, D; Zhang, H; Zhao, H | 1 |
| Belman, D; Ben-Chetrit, E; Benjaminov, O; Dadon, Z; Levin, PD; Taha, L; Wiener-Well, Y | 1 |
| Avery, TM; Boone, RL; Chambers, SA; Damo, SM; Dent, L; Doster, RS; Francis, JD; Gaddy, JA; Guevara, MA; Lu, J; Manning, SD; Marshall, D; Moore, RE; Townsend, SD; Whitehead, B | 1 |
| Ani Caovilla Follador, F; Carolina Lucio, L; Elize Defante Ferreto, L; Fiorentin Vandresen, D; Paula Vieira, A; Pereira Bento Casaril, K; Pitt Benedetti, V; Shigueyasu Yamada, R; Viviane Buzanello Martins, C; Welter Wendt, G | 1 |
| Cheong, HJ; Choi, WS; Jo, YM; Kim, B; Kim, J; Kim, JH; Kim, JY; Kim, YR; Lee, HJ; Lee, S; Moon, C; Pai, H; Park, DW; Park, MN; Seok, H; Sohn, JW; Song, JY | 1 |
| Andini, R; Boccia, F; Corcione, A; De Rosa, R; Durante-Mangoni, E; Gagliardi, M; Karruli, A; Murino, P; Patauner, F; Ruocco, G; Sommese, P; Ursi, MP; Zampino, R | 1 |
| Duan, R; Fan, Y; Huang, Z; Jing, H; Lv, D; Qin, S; Shi, X; Stirling, K; Wang, H; Wang, J; Wang, X; Zhang, L | 1 |
| Ayobami, O; Eckmanns, T; Markwart, R; Noll, I; Said, D; Willrich, N | 1 |
| Chen, H; Huang, W; Jiang, Y; Liu, X; Ma, Y; Tan, X; Zhang, M; Zhao, Y | 1 |
| Awan, F; Jiang, H; Li, F; Lv, W; Zeng, Z; Zhang, X | 1 |
| Banerjee, T; Barman, H; Das, A; Kumar, A; Sharma, S; Yadav, G | 1 |
| Chomnawang, MT; Houngsaitong, J; Kanathum, P; Khuntayaporn, P; Montakantikul, P; Thirapanmethee, K | 1 |
| Adler, A; Andini, R; Antoniadou, A; Babich, T; Ben-Zvi, H; Benattar, YD; Bitterman, R; Carmeli, Y; Cavezza, G; Daikos, GL; Daitch, V; Dickstein, Y; Durante-Mangoni, E; Eliakim-Raz, N; Friberg, LE; Koppel, F; Leibovici, L; Levi, I; Mouton, JW; Nutman, A; Paul, M; Pavleas, I; Skiada, A; Theuretzbacher, U; Turjeman, A; Yahav, D; Zak-Doron, Y; Zampino, R; Zayyad, H; Zusman, O | 1 |
| Chen, JW; Chia, JS; Chuang, YC; Hsu, CC; Huang, TY; Jung, CJ; Kuo, YM; Liao, YD | 1 |
| Bacca, E; Bedini, A; Franceschini, E; Kaleci, S; Menozzi, M; Meschiari, M; Mussini, C; Orlando, G; Puzzolante, C; Santoro, A; Sarti, M; Selmi, S; Vecchi, E; Venturelli, C | 1 |
| Agard, A; Bos, J; Dale, JL; Ditto, G; Epstein, L; Franklin, P; Gasser, C; Glowicz, J; Hahn, R; Halpin, AL; Ham, DC; McAllister, GA; McKinsey, DS; McKinsey, JP; Poiry, M; Poteete, C; Turabelidze, G; Vagnone, PS; Vlachos, N; Zellmer, B | 1 |
| Joshi, SG; Nguyen, M | 1 |
| Brito, JCM; Cardoso, VN; de Assis, DCS; de Lima, ME; de Paiva, MC; Fernandes, SOA; Lima, WG; Pizarro, ACST; Vianna, MAMM | 1 |
| Bernardo, M; Carmeli, Y; Daikos, G; Dishon, Y; Durante-Mangoni, E; Eliakim, N; Friberg, LE; Hameir, A; Iossa, D; Leibovici, L; Lellouche, J; Nutman, A; Paul, M; Pavleas, I; Petersiel, N; Rakovitsky, N; Temkin, E; Theuretzbacher, U; Yahav, D | 1 |
| Buchan, BW; Graham, MB; Ledeboer, NA; Munoz-Price, LS; Reeme, A; Rivera, F; Valley, AM | 1 |
| Hwang, HR; Jun, SH; Kim, HJ; Kim, N; Kim, YK; Lee, DE; Lee, JC; Lee, YC | 1 |
| Aboalheja, W; Alon, T; Dickstein, Y; Eluk, O; Firan, I; Hussein, K; Putler, RKB; Warman, S | 1 |
| Abou Fayad, AG; Haraoui, LP; Higgins, PG; Jaafar, M; Matar, GM; Sleiman, A; Zorgani, A | 1 |
| Bouzari, S; Ehsani, P; Heravi, FS; Japoni-Nejad, A; Mood, EH; Sardari, S; Shahrokhi, N | 1 |
| Elkholy, YS; Hassan, RM; Hassan, SIM; Hegab, AS; Salem, ST | 1 |
| Lodise, TP; O'Donnell, JN; Putra, V | 1 |
| Ahn, SH; Cho, HK; Choi, HK; Choi, WS; Jeon, JH; Jung, JH; Kim, SH; Park, DW; Seo, M; Seok, H; Sung, SA | 1 |
| Chen, HY; Chou, YC; Chuang, CC; Hsu, WJ; Lin, IC; Sun, JR | 1 |
| Dale, GE; Gitzinger, M; Kemmer, C; Lociuro, S; Trebosc, V | 1 |
| Bian, X; Feng, M; Li, X; Liu, X; Song, S; Zhang, J; Zhang, X; Zheng, H | 1 |
| Chen, T; Fu, Y; Hua, X; Jiang, Y; Lan, P; Xu, Q; Yu, Y; Zhou, Z | 1 |
| Carniel, E; Dalpiaz, G; Dias, CG; Narvaez, GA; Perez, LRR; Vetter, M | 1 |
| Peters, AT; Pickens, CI; Postelnick, MJ; Qi, C; Wunderink, RG; Zembower, TR | 1 |
| Bacca, E; Busani, S; Di Pilato, V; Franceschini, E; Gimenez-Esparza, C; Girardis, M; Grottola, A; Gyssens, IC; Lòpez-Lozano, JM; Meschiari, M; Monnet, DL; Mussini, C; Orlando, G; Pecorari, M; Rossolini, GM; Sarti, M; Serio, L; Vecchi, E; Venturelli, C | 1 |
| Howard-Anderson, J; van Duin, D | 1 |
| Livermore, DM; Mushtaq, S; Vickers, A; Woodford, N | 1 |
| Bulitta, JB; Forrest, A; Garonzik, SM; Kaye, KS; Lenhard, JR; Li, J; Nation, RL; Silveira, FP; Soo Shin, B; Tao, X; Thamlikitkul, V; Tsuji, BT | 1 |
| Achour, W; Ben Hassen, A; Botelho, J; Grosso, F; Mabrouk, A; Peixe, L | 1 |
| Baker, S; Campbell, JI; Edwards, DJ; Fournier-Level, A; Hall, RM; Hawkey, J; Holt, KE; Ingle, DJ; Kenyon, JJ; Pham Thanh, D; Phu Huong Lan, N; Schultz, MB; Thi Khanh Nhu, N; Thwaites, G; Tran Do Hoan, N; Wick, RR | 1 |
| Bastos, AN; Bastos, RV; Da Silva, VL; De Andrade Bastos, LQ; De Andrade Bastos, VQ; Dias, VC; Diniz, CG; Resende, JA | 1 |
| Bosch, T; Chamuleau, MED; de Vries, J; Haarman, EG; Schade, RP; Schouls, L; Sieswerda, E; van Dijk, K | 1 |
| Hall, RM; Hamidian, M; Nigro, SJ | 1 |
| Azar, E; Dahdouh, EA; Daoud, Z; Sarkis, DK; Soudeiha, MAH | 1 |
| Afshan, N; Hamid, M; Nawaz, B | 1 |
| Antachopoulos, C; Karampatakis, T; Roilides, E; Tsakris, A | 1 |
| Dafopoulou, K; Pournaras, S; Tsakris, A; Vourli, S; Vrioni, G | 1 |
| Bonomo, RA; Cadnum, JL; Domitrovic, TN; Donskey, CJ; Fuldauer, P; Kanwar, A; Koganti, S | 1 |
| Horvath, A; Ostorhazi, E; Otvos, L; Szabo, D | 1 |
| Andrews, B; Bifulco, N; Carter, NM; Chen, B; Comita-Prevoir, J; de Jonge, B; Durand-Réville, TF; Ehmann, DE; Gao, N; Giacobbe, RA; Guler, S; Huynh, H; Lahiri, S; McLaughlin, R; McLeod, SM; Miller, AA; Moussa, SH; Mueller, JP; Newman, JV; O'Donnell, J; Olivier, NB; Palmer, T; Shapiro, AB; Thresher, J; Tommasi, RA; Velez-Vega, C | 1 |
| Chen, CT; Chen, TL; Kuo, SC; Lee, YT; Liu, CP; Liu, YM; Wang, YC; Yang, YS | 1 |
| Cha, MK; Cho, SY; Chung, DR; Ha, YE; Kang, CI; Kim, JY; Lee, JH; Lee, NY; Park, GE; Peck, KR; Seok, H; Song, JH | 1 |
| Chang, HT; Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Sheng, WH; Sun, HY; Yang, CJ; Yang, JL | 1 |
| Patel, V; Tiwari, D; Tiwari, M; Tiwari, V | 1 |
| Bai, C; Huang, Y; Li, P; Liu, H; Liu, Y; Niu, W; Yin, X; Yu, L; Yuan, J; Yuan, X; Zheng, J; Zou, D | 1 |
| Hou, CJ; Hu, YF; Kuo, CF; Leung, CH; Liu, CP; Wang, NY; Wu, AY; Yeh, HI | 1 |
| Antunes, NT; Maltz, L; Smith, CA; Stewart, NK; Toth, M; Vakulenko, SB | 1 |
| El Bannah, AMS; Hassan, RMM; Nawar, NN; Salem, STB | 1 |
| Alcántar-Curiel, MD; Fernández-Vázquez, JL; Gayosso-Vázquez, C; Jarillo-Quijada, MD; Rivera-Benítez, C; Rosales-Reyes, R; Santos-Preciado, JI | 1 |
| Chen, Y; Dong, H; Dong, P; Gu, S; Hu, X; Sheng, YY; Zhen, X | 1 |
| Cheng, MH; Chuang, SS; Hsieh, YC; Huang, CT; Huang, PY; Lin, SP; Liu, TP; Shie, SS; Wu, TL; Wu, TS; Ye, JJ | 1 |
| Abdollahi, A; Feizabadi, MM; Jafari, S; Sabokbar, A; Zafari, M | 1 |
| Kousouli, E; Polimeri, K; Politi, L; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Vrioni, G; Zarkotou, O | 1 |
| Baffoe-Bonnie, AW; Brima, JK; Childress, JC; Fernandez-Cotarelo, MJ; Grgurich, D; Kerkering, TM; Mitkos, MC; Mukhopadhyay, B; Pearce, SN; Rao, J; Susanti, D | 1 |
| Batista da Cruz, J; Cayô, R; Gales, AC; Martins, WMBS; Narciso, AC; Pereira de Matos, A; Ramos, PL; Santos, SV | 1 |
| Bux, A; Durrani, MA; Indhar, F; Sohail, M | 1 |
| Hall, RM; Nigro, SJ | 3 |
| Lewis, S; Opene, BNA; Simner, PJ; Tamma, PD; Wang, R | 1 |
| Amat, T; Cisneros, JM; Garnacho-Montero, J; Gracia-Ahufinger, I; Gutiérrez-Pizarraya, A; Machuca, I; Pérez-Nadales, E; Torre-Cisneros, J; Torre-Giménez, Á | 1 |
| Ashfaq, UA; Aslam, B; Khurshid, M; Rasool, MH; Waseem, M | 1 |
| Cao, J; Hu, Y; Huang, JJ; Jin, Z; Que, CL; Wang, GF; Wang, X; Zhang, H; Zhang, W | 1 |
| Grosso, F; Mourão, J; Peixe, L; Silva, L | 1 |
| Park, W; Shin, B | 1 |
| Jeong, SH; Kim, HS; Kim, JO; Lee, H; Lee, K; Lee, KJ; Yang, JW; Yoon, EJ | 1 |
| Bampi, JVB; Casagrande, JC; Cayô, R; Croda, J; da Silva, KE; de Almeida de Souza, GH; de Sales, RO; Gales, AC; Limiere, LC; Maciel, WG; Ramos, AC; Simionatto, S | 1 |
| Chang, HL; Chen, HC; Liang, CA; Lin, YC; Lu, PL; Sheu, CC | 1 |
| Ewers, C; Jacobmeyer, L; Klotz, P; Leidner, U; Semmler, T; Stamm, I | 1 |
| Bias, TE; Ehrlich, GD; Emery, CL; Joshi, SG; Law, N; Raible, KM; Sen, B | 1 |
| Bae, IG; Baek, EH; Bak, MH; Cho, OH; Hong, J; Hong, SI; Jang, OJ; Park, KH | 1 |
| Hiraki, Y; Kawano, F; Matsui, M; Shibayama, K; Suzuki, M; Suzuki, S; Tsutsui, A; Watahiki, M; Yatsuyanagi, J | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Pattharachayakul, S; Sakarunchai, I; Santimaleeworagun, W; Singkhamanan, K | 1 |
| Chen, Z; Kang, M; Li, M; Liu, M; Song, Q; Wu, L; Xie, Y | 1 |
| Caio, C; Gona, F; Maugeri, G; Mezzatesta, ML; Stefani, S; Zingali, T | 1 |
| Aditianingsih, D; Goessens, WHF; Karuniawati, A; Klaassen, CHW; Saharman, YR; Sedono, R; Severin, JA; Sudarmono, P; Verbrugh, HA | 1 |
| Britto, XB; Gautam, V; Kaur, R; Kumar, SM; Ray, P; Sharma, M; Singhal, L; Verma, S | 1 |
| Chatsuwan, T; Singkham-In, U | 2 |
| Katsiari, M; Mavroidi, A; Nikolaou, C; Platsouka, ED | 1 |
| Álvarez Montes, L; Bustamante, Z; Cerezales, M; Díaz Ríos, C; Gallego, L; Higgins, PG; Martínez-Martínez, L; Ocampo-Sosa, AA; Santos, J | 1 |
| Dekic, S; Goic-Barisic, I; Hrenovic, J; Kovacic, A; Novak, A; Rubic, Z; Seruga Music, M; Tonkic, M | 1 |
| Bamberg, W; Beldavs, Z; Bower, C; Bulens, SN; Cassidy, PM; Concannon, C; Dumyati, G; Hancock, EB; Jacob, JT; Janelle, SJ; Kainer, M; Kallen, AJ; Kenslow, N; Lynfield, R; Mounsey, J; Muleta, D; Phipps, EC; Reno, J; Shaw, K; Vaeth, E; Vagnone, PS; Walters, MS; Wilson, L; Yi, SH | 1 |
| Alavi-Moghaddam, M; Ghalavand, Z; Goudarzi, H; Houri, H; Nikmanesh, B; Salehi, B | 1 |
| Diene, SM; Hadjadj, L; Rolain, JM; Shoja, S | 1 |
| Gandra, S; Laxminarayan, R; Logan, LK; Trett, A; Weinstein, RA | 1 |
| Kronenberg, A; Ramette, A | 1 |
| Jitwasinkul, T; Kerdsin, A; Preechachuawong, P; Samret, W; Santimaleeworagun, W | 1 |
| Cayô, R; de Paula Luz, A; Dijkshoorn, L; Gales, AC; Matos, AP; Nodari, CS; Pignatari, ACC; Streling, AP | 1 |
| Li, XX; Liu, WS; Wu, HG; Zhu, M | 1 |
| Ang, B; De, PP; Khong, WX; Lee, JJ; Marimuthu, K; Ng, DHL; Ng, OT; Poh, BF; Raj, MDR; Rao, P; Zhang, W | 1 |
| Agoba, EE; Essack, SY; Govinden, U; Osei Sekyere, J; Peer, AKC | 1 |
| Seliem, WA; Sultan, AM | 1 |
| Chen, HY; Chiueh, TS; Chou, YC; Hsu, WJ; Huang, LS; Sun, JR; Wang, YC; Yang, YS | 1 |
| Andini, R; Antoniadou, A; Carmeli, Y; Cavezza, G; Daikos, GL; Dishon Benattar, Y; Durante-Mangoni, E; Eliakim-Raz, N; Leibovici, L; Nutman, A; Paul, M; Pfeffer, I; Skiada, A; Yahav, D; Zak-Doron, Y | 1 |
| Choi, HJ; Choi, JY; Kim, DG; Kim, SI; Kim, YJ; Lee, YD; Yoon, SK; You, YK | 1 |
| Alvarez-Uria, G; Midde, M | 1 |
| Araújo Pirez, L; Bado, I; Cordeiro, NF; Delgado-Blas, JF; García-Fulgueiras, V; Gaudio, M; Gonzalez-Zorn, B; Gutiérrez, C; Medina, JC; Papa-Ezdra, R; Rieppi, G; Seija, V; Vignoli, R | 1 |
| Strehl, E | 1 |
| Del Valle-Mendoza, J; Levy-Blitchtein, S; Moreno-Morales, J; Muñoz, L; Plasencia-Rebata, S; Pons, MJ; Roca, I; Velásquez-Pomar, J; Vicente-Taboada, W; Vila, J | 1 |
| Charpentier, X; Godeux, AS; Guette-Marquet, S; Haenni, M; Laaberki, MH; Lupo, A; Wilharm, G | 1 |
| Watkins, RR | 1 |
| Bai, J; Gong, M; Li, X; Yang, J; Yang, R; Ye, L; Yu, J; Zhang, H | 1 |
| Choi, CW; Chung, C; Kim, GH; Kim, SI; Lee, H; Lee, JC; Lee, SY; Moon, JY; Oh, MH; Park, EC; Shin, J; Song, HS; Yi, YS; Yun, SH | 1 |
| Alexandrova, I; Danilov, G; Ershova, K; Ershova, O; Fursova, N; Kurdyumova, N; Savin, I; Shifrin, M; Sokolova, E; Wong, D; Zelman, V | 1 |
| Cooper, VS; Doi, Y; Ernst, RK; Li, B; Marshall, CW; McElheny, CL; Mettus, RT; Mustapha, MM; Pacey, MP | 1 |
| Brasiliense, DM; de Oliveira Souza, C; Dutra, LMG; Lima, KVB; Mamizuka, EM; McCulloch, JA; Pérez-Chaparro, PJ | 1 |
| Bamberg, WM; Croyle, C; Janelle, SJ; Knepper, BC; Kurtz, J; Miller, A; Reese, SM; Schutz, K; Young, HL | 1 |
| Haghi, F; Kashefieh, M; Shirmohammadlou, N; Zeighami, H | 1 |
| Bakour, S; Hadjadj, L; Rolain, JM | 1 |
| Abdollahi, A; Beigmohammadi, MT; Doomanlou, M; Khalili, H; Mohammadi, M; Shojaei, L | 1 |
| Feng, J; Jia, R; Ju, Y; Li, J; Tang, N; Tian, J; Zhang, G | 1 |
| Chen, F; Chen, Y; Grundmann, H; Han, L; Han, X; Li, H; Liu, L; Qiu, G; Sun, J; Tian, S; Yang, Y; Zhao, J | 1 |
| Amaratunga, K; Boyd, DA; Bryce, E; Embree, J; Katz, K; Kibsey, P; Langley, JM; Lavallee, C; Mataseje, LF; Mitchell, R; Mulvey, MR; Pelude, L; Roscoe, D; Simor, AE; Taylor, G; Turgeon, N | 1 |
| Bonomo, RA; Doi, Y; Isler, B; Paterson, DL | 1 |
| Cho, EB; Choi, SH; Chung, JW; Lee, MK | 1 |
| Goossens, H; Kostyanev, T; Lammens, C; Timbermont, L; Van't Veen, A; Vilken, T | 1 |
| Gutierrez-Bedmar, M; Lopez-Gigosos, RM; Mariscal, A; Mariscal-López, E; Real, M | 1 |
| Barth, AL; Martins, AF; Niada, M; Nunes, LS; Pagano, M | 1 |
| Choo, EJ; Jeon, MH; Kim, T; Kim, TH; Lee, EJ; Lee, MS; Lee, YM; Park, KH; Park, SY; Yu, SN | 1 |
| Dimov, S; Mitov, I; Savov, E; Sirakov, I; Stoeva, T; Stratev, A; Strateva, T | 1 |
| Hefzy, EM; Khalil, MAF; Moawad, SS | 1 |
| Guo, Z; Tang, X; Wang, L; Wang, Q; Xiao, S; Zhou, K; Zhuo, C | 1 |
| Hu, F; Li, Y; Su, J; Wang, M; Xu, S; Xu, X; Zhu, D | 1 |
| Ai, J; Jiang, L; Liang, Y; Wang, X; Yao, W; Zhao, Z | 1 |
| Liu, CP; Lu, HP; Luor, T | 1 |
| Andini, R; Antoniadou, A; Ben Dalak Amar, M; Bitterman, R; Carmeli, Y; Daikos, GL; Daitch, V; Dickstein, Y; Dishon Benattar, Y; Durante-Mangoni, E; Friberg, LE; Leibovici, L; Lellouche, J; Mouton, JW; Neuberger, A; Nutman, A; Paul, M; Schwartz, D; Skiada, A; Yahav, D; Zampino, R | 1 |
| Assous, MV; Ben-Chetrit, E; Benenson, S; Bier, L; Broyer, C; Cohen, MJ; Kopuit, P; Lesho, E; Levin, PD; McGann, PT; Snesrud, E; Wiener-Well, Y | 1 |
| Malecki, M; Mattner, F; Otchwemah, R; Sakka, SG; Tellez-Castillo, CJ; Wendel, AF | 1 |
| de Azevedo, FKSF; de Sousa, ATHI; Dutra, V; Hahn, RC; Mello, CM; Nakazato, L; Pepato, MA; Souto, FJD; Takahara, DT | 1 |
| Antonini, M; D'Arezzo, S; Di Caro, A; Gruber, CEM; Lanini, S; Marani, A; Nisii, C; Puro, V; Selleri, M; Venditti, C; Vulcano, A | 1 |
| Abdelgani, S; Amir-Ronen, R; Geffen, Y; Liron, Y; Ohanyan, A; Paul, M; Raz-Pasteur, A | 1 |
| Gaind, R; Jain, M; Rani, V; Sen, MK; Sharma, A; Suri, JC | 1 |
| Dona', D; Ellis, S; Heath, P; Sharland, M; Standing, JF; Thomas, R; Velaphi, S; Walker, AS | 1 |
| Antachopoulos, C; Diamantopoulou, G; Iosifidis, E; Karampatakis, T; Karyoti, A; Mouloudi, E; Politi, L; Roilides, E; Tsakris, A; Tsergouli, K | 1 |
| Ibrahim, ME | 1 |
| Aboklaish, AF; Böttger, EC; Cao, S; Crich, D; Ercan, O; Hobbie, SN; Hughes, D; Huseby, DL; Juhas, M; Petersson, A; Polikanov, YS; Rominski, A; Teo, J; Tyrrell, JM; Walsh, TR; Widlake, E | 1 |
| Dekic, S; Durn, G; Hrenovic, J; Hunjak, B; Kisic, I; Seruga Music, M | 1 |
| Antonelli, A; Bogaerts, P; Evrard, S; Giani, T; Glupczynski, Y; Riccobono, E; Rossolini, GM | 1 |
| Ardebili, A; Ghaemi, EA; Hashemi, A; Javid, N; Najari, E; Yazdansetad, S | 1 |
| Dawoud, MEE; Eweis, M; Ghaith, D; Hassan, R; Metwally, R; Zafer, M | 1 |
| Adukauskienė, D; Čiginskienė, A; Dambrauskienė, A; Rello, J | 1 |
| Andrianirina, ZZ; Andrianoelina, VH; Collard, JM; Enouf, V; Kowalewicz, C; Rabenandrasana, MAN; Rakotondrasoa, A; Randrianirina, F; Ratsima, EH; Simo Tchuinte, PL | 1 |
| Arshadi, M; Bigverdi, R; Dabiri, H; Fardsanei, F; Feizabadi, MM; Goudarzi, H; Hajikhani, B; Nasiri, MJ; Tabarsi, P; Zamani, S | 1 |
| De Angelis, M; Garzoli, S; Marzuillo, C; Mastroianni, CM; Oliva, A; Ragno, R; Vullo, V | 1 |
| Brunst, S; Djahanschiri, B; Ebersberger, I; Gonzaga, A; Göttig, S; Higgins, PG; Kramer, JS; Nübel, U; Pos, KM; Proschak, E; Riedel-Christ, S; Steglich, M; Tietgen, M; Weidensdorfer, M; Wohra, S | 1 |
| Alves, SR; De Barros, PP; de Cassia Bernardes, R; Figueiredo-Godoi, LMA; Jorge, AOC; Junqueira, JC; Marcolan De Mello, M; Prado, ACC; Ramanzini, NP | 1 |
| Amini, Y; Meshkat, Z; Sadeghian, H; Salimizand, H | 1 |
| Daikos, GL; Miriagou, V; Piperaki, ET; Tzouvelekis, LS | 1 |
| Fu, Y; Ren, D; Yang, Q; Yao, Y; Yu, Y; Zhou, H; Zhou, J; Zhu, B | 1 |
| Jeon, J; Park, JH; Yong, D | 1 |
| Chen, S; Deng, K; Du, X; Feng, G; Shen, Z; Xu, X; Yang, L; Yao, J | 1 |
| Chusri, S; Doi, Y; Kositpantawong, N; Panthuwong, S; Singkhamanan, K; Suphasynth, Y; Wanitsuwan, W | 1 |
| Cuhadar, T; Demirbas Gulmez, Z; Dizbay, M; Guzel Tunccan, O; Kalkanci, A; Ozger, HS; Simsek, H; Unaldi, O; Yildiz, SS | 1 |
| Bello-Toledo, H; Cerdeira, L; Domínguez-Yévenes, M; Esposito, F; González-Rocha, G; Lima, CA; Lincopan, N; Morales-León, F; Opazo-Capurro, A; Quezada-Aguiluz, M; San Martín, I | 1 |
| Charernmak, B; Chongsuvivatwong, V; Chusri, S; Doi, Y; Hortiwakul, T; Silpapojakul, K; Singkhamanan, K | 1 |
| Bhattacharya, S; Chandy, M; Das, S; Goel, G; Mukherjee, S; Roy, S; Walia, K | 1 |
| Babaie, Z; Delfani, S; Mahdian, S; Norolahi, F; Rezaei, F; Shakib, P | 1 |
| Fan, X; Guo, Y; Hu, K; Mensah, SD; Wang, Y; Zhang, J; Zhang, X; Zhao, Y | 1 |
| Amadori, F; Bartoletti, M; Bassetti, M; Carannante, N; Ceccarelli, G; Corcione, S; De Rosa, FG; Del Bono, V; Di Caprio, G; Giacobbe, DR; Giannella, M; Granata, G; Losito, AR; Menichetti, F; Mussini, C; Peghin, M; Petrosillo, N; Russo, A; Santoro, A; Segala, FV; Tascini, C; Tumbarello, M; Vena, A; Venditti, M; Viale, P; Viscoli, C | 1 |
| Lai, RW; Leung, EC; Leung, PH | 1 |
| Cusack, TP; Dance, DAB; Duangmala, K; Hopkins, KL; Phan, HTT; Phimolsarnnousith, V; Phoumin, P; Shetty, N; Stoesser, N; Turton, J; Woodford, N | 1 |
| Beigverdi, R; Emaneini, M; Jabalameli, F; Sattari-Maraji, A | 1 |
| Alawi, M; Almasaudi, SB; Azhar, EI; El-Hossary, D; Farman, M; Jiman-Fatani, AA; Shah, MW; Yasir, M | 1 |
| Anandan, S; Das, BK; Gautam, V; Kapil, A; Mathur, P; Ohri, VC; Parija, SC; Ramya, I; Ray, P; Sistla, S; Subramani, K; Veeraraghavan, B; Vijayakumar, S; Walia, K | 1 |
| Dong, Z; Shi, L; Yang, L; Ye, G; Ye, L; Zhou, J | 1 |
| Kalkan, G; Kara, SS; Polat, M; Simsek, H; Tapisiz, A; Tezer, H | 1 |
| Akeda, Y; Chaihongsa, N; Chiaranaicharoen, S; Hagiya, H; Hamada, S; Hamaguchi, S; Kerdsin, A; Malathum, K; Oishi, K; Okada, K; Santanirand, P; Sirichot, S; Tomono, K; Yamamoto, K; Yamamoto, N; Yoshida, H | 1 |
| Bello-López, E; Castañeda-Lucio, M; Castro-Jaimes, S; Cevallos, MÁ; Gutiérrez-Cazares, Z; Lozano-Zarain, P; Martínez-Laguna, Y; Rocha-Gracia, RDC; Sáenz, Y; Torres, C | 1 |
| Aprameya, IV; Chakravortty, D; Chandra, N; Datey, A; Kulkarni, O; Nagarajan, D; Nanajkar, N; Ravichandran, S; Roy, N; Sarma, SP; T, S; Thakur, C | 1 |
| Akova, M; Chen, T; Hua, X; Ji, S; Leptihn, S; Pi, B; Xu, Q; Yan, B; Yang, Y; Yu, Y; Zhang, L; Zhou, Z | 1 |
| Gautam, V; Kumar, S; Patil, PB; Patil, PP; Ray, P; Singhal, L | 1 |
| Germ, J; Kisek, TC; Nordmann, P; Pirs, M; Poirel, L; Premru, MM; Seme, K; Spik, VC; Zupanc, TL | 1 |
| Carmeli, Y; Fallach, N; Lerner, A; Nutman, A; Schwartz, D | 1 |
| Chang, KC; Kuo, HY; Liou, ML; Liu, CC; Lu, CW; Tang, CY | 1 |
| Bou, G; Fernández, A; Higgins, PG; Pérez-Llarena, FJ; Seifert, H; Zander, E | 1 |
| Chen, L; Liu, S; Lu, Z; Schwarz, S; Si, W; Wang, XM; Yu, S; Zhang, RM; Zhang, WJ | 1 |
| Huang, L; Sun, L; Yan, Y | 1 |
| Al-Dughaym, AM; Al-Taher, AY; Al-Thawadi, SI; Alsultan, AA; Amyes, SGB; Elsayed, EA; Evans, BA; Hamouda, A | 1 |
| Chen, JH; He, YQ; Liu, S; Wan, YF; Xu, CQ; Ye, ML; Zheng, YL; Zhou, LY | 1 |
| Barber, KE; Kaye, KS; Mann, T; Pogue, JM | 1 |
| Abbott, I; Bhuiyan, S; Cerqueira, GM; Peleg, AY | 1 |
| Alba, L; Clock, SA; Kubin, CJ; Saiman, L; Tabibi, S; Whittier, S | 1 |
| Kim, BN; Kim, ES; Kwak, YG; Lee, CS; Moon, C | 1 |
| Ko, WC; Lee, JC; Lee, NY; Li, CW; Li, MC | 1 |
| Chen, T; Lü, X; Wang, X; Yu, R; Zong, Z | 1 |
| Bordi, E; Capone, A; D'Arezzo, S; Di Caro, A; Mazzarelli, A; Petrosillo, N; Principe, L | 1 |
| Alvis, N; Amado, C; Cañon, O; Castañeda, C; de la Hoz, FP; Einarson, TR; Kawai, K; Lemos, EV; Leon, Y; Quevedo, E | 1 |
| Bonnin, RA; Cuzon, G; Nordmann, P; Poirel, L | 1 |
| Hagihara, M; Housman, ST; Kuti, JL; Nicolau, DP | 1 |
| Chang, SC; Chen, YC; Chuang, YC; Lauderdale, TL; Li, SY; Sheng, WH; Wang, JT | 1 |
| Aghazadeh, M; Hojabri, Z; Mahdian, R; Nahaei, MR; Pajand, O; Rezaee, MA; Soroush, MH; Tabrizi, MS | 1 |
| Barin, J; Barth, AL; Hermes, DM; Martins, AF; Pitt, CP; Teixeira, AB | 1 |
| Bonnin, RA; Nordmann, P; Poirel, L | 2 |
| Chung, EK; Jang, HC; Jang, MO; Jung, SI; Kang, SJ; Kim, SH; Ko, KS; Lee, SY; Park, KH; Shin, JH | 1 |
| Costa, SF; Levin, AS; Oliveira, MS; Pedri, Ed; van der Heijden, I | 1 |
| Arheart, KL; Cleary, T; DePascale, D; Doi, Y; Fajardo-Aquino, Y; Munoz-Price, LS; Namias, N; O'Hara, JA; Pizano, L; Rivera, JI | 1 |
| Davies, TA; He, W; Lynch, AS; Queenan, AM | 1 |
| Hiraki, Y; Inoue, D; Kamimura, H; Karube, Y; Kawano, F; Masuda, Y; Takaki, K; Tsuji, Y; Yoshida, M | 1 |
| Chang, FY; Chen, TL; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Sun, JR; Tsai, WC; Yang, CH; Yang, YS | 1 |
| Thamlikitkul, V; Tiengrim, S | 1 |
| Cho, IH; Choi, SW; Chung, SY; Gurung, M; Heo, JY; Jang, CW; Jee, HS; Kim, HS; Lee, JC; Lee, JH; Lee, YC; Moon, SY; Rho, JS; Yu, BH | 1 |
| Lü, XJ; Wang, XH; Zong, ZY | 1 |
| Bogan, C; Marchaim, D | 1 |
| Anais, L; Bonnin, RA; Decousser, JW; Emirian, A; Jansen, C; Merle, JC; Nordmann, P; Poirel, L | 1 |
| Buntaran, L; Carlos, CC; Choi, JY; Chung, DR; Hsu, LY; Hsueh, PR; Kim, DH; Kim, HW; Kim, SH; Ko, KS; Lalitha, MK; Peck, KR; So, TM; Song, JH; Thamlikitkul, V; Yasin, RM | 1 |
| Bou, G; Cisneros, JM; Fernández-Cuenca, F; Gato, E; López, M; Martínez-Martínez, L; Pachón, J; Pascual, A; Rodríguez-Baño, J; Ruiz de Alegría, C; Rumbo, C; Tomás, M; Vila, J | 1 |
| Fukuchi, K; Kugawa, S; Tateishi, Y; Ugajin, K; Yasuhara, T; Yoshida, K | 1 |
| Anders, A; Gatermann, SG; Geis, G; Kaase, M; Lang, U; Pfennigwerth, N; Pranada, AB; Rößler, S; Szabados, F | 1 |
| Hiraki, Y; Kamimura, H; Karube, Y; Kawano, F; Masuda, Y; Matsui, M; Shibayama, K; Takaki, K; Tsuji, Y; Yoshida, M | 1 |
| Alvarez, R; Arheart, K; Boulanger, AE; Cleary, T; Kett, DH; Munoz-Price, LS; Namias, N; Nordmann, P; Pizano, L; Poirel, L | 1 |
| Chen, Y; Fu, Y; Jiang, Y; Ruan, Z; Wang, H; Wang, Y; Yu, Y; Zhou, H; Zhou, Z | 1 |
| Bozkurt, F; Dal, T; Dayan, S; Deveci, Ö; Tekin, A; Tekin, R | 1 |
| Basso, M; Costa, SF; DalBen, MF; Garcia, CP; Jarvis, WR; Levin, AS; Lobo, RD; Oliveira, MS; Toscano, CM | 1 |
| Chen, TL; Fung, CP; Ku, WW; Kung, CH; Kuo, SC; Lee, CH; Lee, YT; Tseng, CP; Wang, FD; Wu, PF | 1 |
| Hasan, B; Olsen, B; Perveen, K; Zahra, R | 1 |
| Ahmed, H; Awali, RA; Chaudary, K; Chopra, T; Hothi, J; Johnson, P; Kaye, KS; Krishna, A; Lephart, P; Marchaim, D; Pogue, JM; Slim, J; Tansek, R; Zhao, JJ | 1 |
| Apisarnthanarak, A; Jitpokasem, S; Mundy, LM | 1 |
| Dalla-Costa, L; Martins, N; Moreira, BM; Riley, LW; Uehara, AA | 1 |
| Castañeda, C; de la Hoz, FP; Einarson, TR; Kawai, K; Lemos, EV; McGhan, WF; Quevedo, E | 1 |
| Gao, Y; Qiao, F; Wang, X; Yu, R; Zong, Z | 1 |
| Crandon, JL; Macvane, SH; Nicolau, DP | 1 |
| Cipriano, R; Fonseca, EL; Freitas, FS; Scheidegger, E; Vicente, AC | 1 |
| Bedenić, B; Bošnjak, Z; Frančula-Zaninović, S; Ištok, M; Ladavac, R; Minandri, F; Visca, P; Vranić-Ladavac, M | 1 |
| Aşık, G; Atasoy, AR; Ayyildiz, A; Berktaş, M; Ciftci, IH; Gül, M; Gültepe, B; Karakeçe, E; Koçoğlu, E; Köksal Çakırlar, F; Kurtoğlu, MG; Oksüz, L; Ozdemir, M; Sesli Çetin, E; Seyrek, A; Yağcı, S | 1 |
| Deb, M; Gaind, R; Maurya, V; Mohanty, S | 1 |
| Clancy, CJ; Doi, Y; Nguyen, MH; O'Hara, JA; Oleksiuk, LM; Press, EG; Shields, RK; Updike, CL | 1 |
| Bosnak, VK; Karaoglan, I; Mete, AO; Namiduru, M; Zer, Y | 1 |
| Couto, N; Endimiani, A; Perreten, V; Pomba, C; Rossano, A; Saial, D | 1 |
| Barba, MJ; Bou, G; Merino, M; Poza, M; Roca, I; Sousa, MD; Vila, J | 1 |
| Apisarnthanarak, A; Lye, DC; Ng, TM; Teng, CB | 1 |
| Amaya-Villar, R; Artero-González, ML; Bautista-Paloma, J; Corcia-Palomo, Y; Espejo-Gutiérrez de Tena, E; Garnacho-Montero, J; Gutiérrez-Pizarraya, A | 1 |
| Chen, Y; Fu, Y; Ji, J; Ji, S; Ruan, Z; Wang, H; Yu, Y | 1 |
| Guclu, E; Karabay, O; Ogutlu, A; Tuna, N; Utku, AC; Yahyaoglu, M | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F; Metan, G | 1 |
| Abdalhamid, B; Hassan, H; Itbaileh, A; Shorman, M | 1 |
| Agalar, C; Akalin, S; Alici, O; Alp, E; Altay, FA; Altin, N; Arslan, F; Aslan, T; Balkan, II; Batirel, A; Bekiroglu, N; Celik, AD; Cesur, S; Dogan, M; Durdu, B; Duygu, F; Engin, A; Engin, DO; Gonen, I; Guclu, E; Guven, T; Hatipoglu, CA; Hosoglu, S; Karabay, O; Karahocagil, MK; Kilic, AU; Ormen, B; Ozdemir, D; Ozer, S; Oztoprak, N; Sezak, N; Turhan, V; Turker, N; Yilmaz, H | 1 |
| Dabboussi, F; Eveillard, M; Hamze, M; Joly-Guillou, ML; Kempf, M; Lemarié, C; Mallat, H; Rafei, R; Rolain, JM | 1 |
| Arakawa, Y; Konda, T; Matsui, M; Shibayama, K; Suzuki, M; Suzuki, S; Yamane, K | 1 |
| Arheart, KL; Cleary, T; Depascale, D; Fajardo-Aquino, Y; Kett, DH; Munoz-Price, LS; Namias, N; Pizano, L; Rosa, R | 1 |
| Al-Agamy, MH; El Kholy, A; Khalaf, NG; Shibl, AM; Tawfick, MM | 1 |
| Apisarnthanarak, A; Khawcharoenporn, T; Mundy, LM; Pruetpongpun, N; Rutchanawech, S; Tiamsak, P | 1 |
| Anh, ND; Chan, WM; Garcia, J; Harijanto, E; Lee, C; Loo, CM; Mustafa, M; Van Kinh, N | 1 |
| Chang, SC; Chuang, YC; Huang, YS; Sheng, WH; Wang, JT | 1 |
| Agodi, A; Barchitta, M; Bellocchi, P; Castiglione, G; Giaquinta, L; Poulou, A; Quattrocchi, A; Romeo, MA; Santangelo, C; Tsakris, A; Voulgari, E; Vrioni, G | 1 |
| Chang, PC; Chen, YY; Lai, CC; Liu, WL; Tan, CK; Tang, HJ | 1 |
| Chen, H; Liu, DW; Long, Y; Wang, XT; Zhang, HM | 1 |
| Al-Hazmi, SS; El-Ageery, SM | 1 |
| Arheart, K; Carling, P; Cleary, T; DePascale, D; Fajardo-Aquino, Y; Hughes, M; Jimenez, A; Kett, DH; Munoz-Price, LS; Namias, N; Pizano, L | 1 |
| Arslan, U; Kus, H; Tuncer, I; Turk Dagi, H | 1 |
| Alfandari, S; Blondiaux, N; Boussekey, N; Chiche, A; Delannoy, PY; Georges, H; Gois, J; Leroy, O; Melliez, H; Meybeck, A; Patoz, P; Senneville, E | 1 |
| Adler, A; Carmeli, Y; Moran-Gilad, J; Navon-Venezia, S; Schwartz, D | 1 |
| Asensi, MD; Carvalho, KR; Carvalho-Assef, AP; Chagas, TP; de Oliveira Santos, IC | 1 |
| Bou, G; Calvo, J; Cano, ME; Cayô, R; Martínez-Martínez, L; Merino, M; Ruiz Del Castillo, B | 1 |
| Hall, RM; Hamidian, M; Holt, KE; Kenyon, JJ; Pickard, D | 1 |
| Kim, HJ; Kim, MJ; Lee, SE; Sohn, JW; Yang, KS; Yoon, YK | 1 |
| Cox, HL; Enfield, KB; Gosseling, MF; Hazen, KC; Huq, NN; Kundzins, JR; Lewis, JD; Low, DJ; Mathers, AJ; Sifri, CD; Slitt, G; Toney, DM; Zapata, HJ | 1 |
| Braun, T; Carmeli, Y; Edgar, R; Glick, R; Hoshen, M; Nutman, A; Temkin, E | 1 |
| Lye, DC; Ng, TM; Nikolaou, M; Tam, VH; Tan, MW | 1 |
| Sirijatuphat, R; Thamlikitkul, V | 1 |
| Antachopoulos, C; Dimou, V; Drossou-Agakidou, V; Iosifidis, Ε; Karampatakis, T; Katragkou, A; Orfanou, A; Roilides, E; Sarafidis, K; Tsakris, A; Tsiatsiou, O | 1 |
| Wu, H; Xie, W; Ye, Z; Zhang, W; Zhao, C | 1 |
| Baker, S; Campbell, JI; Chau, NVV; Dung, LT; Hien, TT; Hoang, NVM; Lan, NPH; Le, VM; Loan, HT; Nga, NTT; Nga, TVT; Nghia, HDT; Nhu, NTK; Nhu, TDH; Parry, CM; Tam, PTT; Thompson, C; Thuy, CT; Thwaites, G; Thwaites, L; Tuyen, HT; Van Hao, N; Van Minh, P; Yen, LM; Yen, NTT | 1 |
| Doi, Y; Nguyen, MH; Viehman, JA | 1 |
| Aboulmagd, E; Alsultan, AA; Amyes, SGB; Evans, BA | 1 |
| Kumar, A; Nirupam, N; Rai, Y; Randhawa, VS; Saili, A | 1 |
| Arakawa, Y; Hori, M; Inayoshi, M; Jin, W; Kimura, K; Kitanaka, H; Sasano, MA; Suzuki, M; Wachino, J; Yamada, K; Yokoyama, S | 1 |
| Leonard, DA; Mitchell, JM | 1 |
| Guzmán-Blanco, M; Labarca, JA; Salles, MJ; Seas, C | 1 |
| Bae, IG; Baek, EH; Bak, MH; Cho, OH; Kim, S; Park, KH | 1 |
| Bou, G; Cano, ME; Fernández-Cuenca, F; Garnacho-Montero, J; Gato, E; Martínez-Martínez, L; Miguel Cisneros, J; Pascual, A; Rodríguez-Baño, J; Ruíz de Alegría, C; Tomás, M; Vila, J; Villar, M | 1 |
| Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X | 1 |
| Gong, WT; Li, X; Liu, W; Wang, L; Xu, B; Yang, Y; Zhang, XJ; Zhu, YQ | 1 |
| Cantón, R; García-Fernández, S; Marco, F; Morosini, MI; Mosqueda, N; Roca, I; Vergara, A; Vila, J; Zboromyrska, Y | 1 |
| Bonnin, RA; Dijkshoorn, L; Lescat, M; Nordmann, P; Poirel, L; van der Reijden, TJ | 1 |
| Ebrahimi, F; Gorácz, O; Kardos, G; Miszti, C; Mózes, J | 1 |
| Dawson, A; Gärtner, BC; Gatermann, S; Halfmann, A; Herrmann, M; Jungmann, S; Kaase, M; von Müller, L | 1 |
| Couzigou, C; Lambert, T; Le Monnier, A; Mizrahi, A; Nguyen Van, JC; Vidal, B | 1 |
| Arheart, K; Laowansiri, P; Latibeaudiere, R; Munoz-Price, LS; Namias, N; Rosa, R | 1 |
| Kollef, MH; Micek, ST; Shorr, AF; Zilberberg, MD | 1 |
| Hong, MK; Jeon, JH; Jo, JY; Kang, LW; Karim, AM; Kim, JH; Ko, KS; Lee, JH; Lee, JJ; Lee, SH; Park, KS | 1 |
| Alfizah, H; Biglari, S; Rahman, MM; Ramliza, R | 1 |
| Egea, P; Fernández-Cuenca, F; Galán-Sánchez, F; Guerrero-Lozano, I; Pascual, Á; Rodríguez-Iglesias, M | 1 |
| Li, J; Mukhopadhyay, A; Tambyah, PA; Vasudevan, A; Yuen, EG | 1 |
| Hall, RM; Holt, KE; Nigro, SJ; Pickard, D | 1 |
| Alcántar-Curiel, MD; Fernández-Vázquez, JL; García-Torres, LF; Gayosso-Vázquez, C; Giono-Cerezo, S; González-Chávez, MI; Jarillo-Quijada, MD; Morfín-Otero, R; Rodríguez-Noriega, E; Santos-Preciado, JI | 1 |
| Chongsuvivatwong, V; Chusri, S; McNeil, E; Silpapojakul, K; Singkhamanan, K | 1 |
| Chang, CC; Chen, CM; Ke, SC; Li, CR | 1 |
| Andersson, R; Berge, J; Vandepitte, WP | 1 |
| Brisse, S; Coignard, B; Courvalin, P; Diancourt, L; Jeannot, K; Ribeiro, A; Thouverez, M; Vaux, S | 1 |
| Dabboussi, F; Eveillard, M; Gaultier, MP; Hamze, M; Husni-Samaha, R; Joly-Guillou, ML; Kempf, M; Lemarié, C; Mallat, H; Moghnieh, R; Rafei, R | 1 |
| Alp, E; Cevahir, F; Kaynar, L; Metan, G; Pala, Ç | 1 |
| Aşik, G; Ayyildiz, A; Berktaş, M; Çiftci, İH; Gül, M; Koçoğlu, ME; Kurtoğlu, MG; Öksüz, L; Özdemir, M; Sesli Çetin, E; Seyrek, A; Yağci, S | 1 |
| Ding, B; Guo, Q; Hu, F; Huang, J; Wang, M; Yang, Y | 1 |
| Chen, TL; Chow, SF; Liu, CP; Shih, SC; Sun, FJ; Wang, NY; Wu, AY; Yan, TR | 1 |
| Al Johani, SM; Al Salman, J; Al-Jardani, A; Alfaresi, M; AlJindan, RY; Balkhy, HH; Dashti, AA; Ibrahim, E; Johani, K; Paterson, DL; Sartor, AL; Sidjabat, HE; Walsh, TR; Zowawi, HM | 1 |
| Almasri, M; Assiri, A; Gatermann, SG; Hathout, H; Kaase, M; Memish, ZA; Roshdy, H; Yezli, S | 1 |
| Beader, N; Bedenić, B; Godič-Torkar, K; Grisold, AJ; Luxner, J; Veir, Z; Vranić-Ladavac, M; Zarfel, G | 1 |
| Hu, Y; Wang, M; Wu, X; Yang, X; Yang, Z; Zhang, X; Zhou, Y | 1 |
| Doi, Y; Ernst, RK; Hittle, LE; O'Hara, JA; Pasculle, AW; Qureshi, ZA; Rivera, JI; Shields, RK; Syed, A | 1 |
| Cohen, DA; Marchaim, D; Pogue, JM | 1 |
| Dong, D; Huang, L; Huang, S; Huang, Y; Li, H; Liu, W; Tong, Y; Wang, X; Wei, X; Yan, X; Yang, Z; Yuan, J; Zhao, X; Zou, D | 1 |
| Boyce, JD; Bulitta, JB; Landersdorfer, CB; Nation, RL; Yadav, R | 1 |
| Kazi, M; Nikam, C; Rodrigues, C; Shetty, A | 1 |
| Abdalhamid, B; Aljindan, R; Alomar, A; Bukharie, H | 1 |
| Augustine, JJ; Bonomo, RA; Hujer, AM; Jacobs, GH; Jacobs, MR; Patel, G; Perez, F; Rudin, SD | 1 |
| Chong, Y; Chung, HS; Jeong, SH; Kim, CK; Lee, K; Lee, Y; Yong, D | 1 |
| Chang, FY; Chen, TL; Chiu, CH; Fung, CP; Kuo, SC; Lee, YT; Lin, JC; Sun, JR; Wang, YC; Yang, YS; Yin, T | 1 |
| Ahmed, SS; Alp, E; Demiraslan, H; Dinc, G; Doganay, M; Elmali, F | 1 |
| Cheng, CW; Hsu, PC; Huang, CT; Lee, MH; Leu, HS; Lin, HS; Ye, JJ | 1 |
| Barin, J; Martins, AF; Pagano, M; Zavascki, AP | 1 |
| Hulst, AG; Jansen, HJ; Majchrzykiewicz-Koehorst, JA; Mende, K; Murray, CK; Paauw, A; Sedee, NJ; Trip, H | 1 |
| Chang, SC; Chen, YC; Cheng, A; Chuang, YC; Hsueh, PR; Hung, CC; Liao, CH; Shen, NJ; Sheng, WH; Sun, HY; Wang, JT; Yang, CJ; Yang, JL | 1 |
| Andersen, PS; Hammerum, AM; Hansen, F; Holm, A; Jakobsen, L; Justesen, US; Skov, MN; Stegger, M | 1 |
| Abdallah, M; Charles, C; Cortes, C; Landman, D; Olafisoye, O; Quale, J; Urban, C | 1 |
| Amaya-Villar, R; Díaz-Martín, A; Ferrándiz-Millón, C; Garnacho-Montero, J; Gutiérrez-Pizarraya, A; López-Sánchez, JM | 1 |
| Chen, JC; Chen, JY; Chen, TL; Hui, CF; Pan, CY; Wu, JL | 1 |
| Jin, X; Liu, Y; Lu, J; Lu, Y; Wu, J; Wu, S; Wu, W | 1 |
| Bonomo, RA; Spellberg, B | 1 |
| Acikgoz, ZC; Guner, R; Guven, T; Izdes, S; Kocak Tufan, Z; Tasyaran, MA; Yilmaz, GR | 1 |
| Dafopoulou, K; Dimitroulia, E; Gennimata, V; Hadjichristodoulou, C; Pournaras, S; Tsakris, A; Zarkotou, O | 1 |
| Chaiwarith, R; Inchai, J; Khositsakulchai, W; Liwsrisakun, C; Pothirat, C; Theerakittikul, T | 1 |
| Chang, YJ; Chen, CH; Lin, LC; Liu, CE; Soon, MS | 1 |
| Hawari, FI; Le, J; Nazer, LH; Rihani, S | 1 |
| Belmonte, O; Cuziat, J; Eveillard, M; Joly-Guillou, ML; Kempf, M; Lemarié, C; Pailhoriès, H; Quinqueneau, C; Ramont, C | 1 |
| Hu, D; Li, H; Li, Q; Li, Z; Qu, Y; Xing, J | 1 |
| Botziori, C; Kakasi, E; Koteli, A; Meletis, G; Oustas, E | 1 |
| Aksu, N; Alaçam, S; Baran, I; Kurşun, Ş; Mumcuoğlu, İ; Sarı, B | 1 |
| Balicer, RD; Berlin, A; German, L; Gluzman, I; Henig, O; Hoshen, MB; Neuberger, A; Paul, M; Shapira, C; Weber, G | 1 |
| Akeda, Y; Bonomo, RA; Hamaguchi, S; Ishii, Y; Kerdsin, A; Malathum, K; Oishi, K; Paveenkittiporn, W; Santanirand, P; Seki, M; Tomono, K; Yamamoto, N | 1 |
| Chung, YK; Kang, BS; Kang, HJ; Kim, HS; Kim, JS; Lee, HJ; Lee, JA; Lee, SS; Park, EY; Shin, KS | 1 |
| Cakirlar, FK; Ciftci, IH; Gonullu, N | 1 |
| Luís Barth, A; Reus Rodrigues Perez, L | 1 |
| Heo, ST; Jeon, H; Lee, JC; Lee, YC; Nicholas, A; Selasi, GN; Yoo, JR | 1 |
| Kollef, MH; Shorr, AF; Zilberberg, MD | 1 |
| Castro, J; Latibeaudiere, R; Munoz-Price, LS; Namias, N; Rosa, R | 1 |
| Barišić, Z; Goic-Barisic, I; Hrenović, J; Kaliterna, M; Kaliterna, V; Tonkić, M | 1 |
| Bassetti, M; Poulakou, G; Tsiodras, S | 1 |
| Cao, JG; Liu, YX; Xu, YP; Yan, ZQ; Zhang, H | 1 |
| Barbara, CS; Caresta, E; Ceccarelli, G; D'Abramo, A; d'Ettorre, G; Mascellino, MT; Moretti, C; Oliva, A; Papoff, P; Venditti, M; Visca, P; Vullo, V | 1 |
| Grosso, F; Peixe, L; Quinteira, S; Ramos, H; Silva, L; Sousa, C | 1 |
| Ansari, M; Gilani, M; Hafeez, A; Latif, M; Munir, T; Najeeb, S; Rehman, S; Saad, N | 1 |
| Antonelli, M; De Pascale, G | 1 |
| Corona, A | 1 |
| Dalekos, GN; Georgiadou, S; Mantzarlis, K; Oikonomou, O; Papagiannitsis, CC; Petinaki, E; Sarrou, S; Zakynthinos, E | 1 |
| Abdala, E; Bonazzi, PR; Costa, SF; D'Albuquerque, LA; Freire, MP; Machado, AS; Oliveira, LM; Oshiro, IC; Pierrotti, LC; Rossi, F; Van Der Heijden, IM | 1 |
| Endo, S; Kamoshida, G; Kikuchi, H; Kikuchi-Ueda, T; Mu, X; Nakano, A; Nakano, R; Ono, Y; Tansho-Nagakawa, S; Ubagai, T; Yano, H | 1 |
| Joshi, SG; Sen, B | 1 |
| Choi, IS; Choi, JA; Jang, SJ; Jeong, SH; Kang, SH; Kim, CM; Moon, DS; Park, G; Park, GC | 1 |
| Seenama, C; Thamlikitkul, V; Tiengrim, S | 1 |
| Higgins, PG; Hornei, B; Kasper, G; Kröschel, P; Mandraka, F; Molter, G; Öhler, M; Reuter, S; Schwimmbeck, P; Seifert, H; Weidmann, B | 1 |
| Brahmi, S; Cadière, A; Djahmi, N; Dunyach-Remy, C; Lavigne, JP; Pantel, A; Sotto, A; Touati, A | 1 |
| Cardoso, CL; Menegucci, TC; Moreira, RR; Tognim, MC; Viana, GF; Zago, MC; Zarpellon, MN | 1 |
| Dwibedi, CK; Edquist, P; Johansson, A; Karah, N; Sjöström, K; Uhlin, BE; Wai, SN | 1 |
| Camargo, CH; Garcia, Dde O; Romero, EC; Saes, MR; Santos, LF; Tiba, MR; Vasconcellos, FM | 1 |
| Barrios, H; Cevallos, MA; Garza-Ramos, U; Gonzalez-Villoria, AM; Rodríguez-Medina, N; Sanchez-Pérez, A; Silva-Sanchez, J; Tamayo-Legorreta, E; Uribe-Aviña, N | 1 |
| Cayô, R; Dijkshoorn, L; Gales, AC; Godoy Carvalhaes, C; Pereira Matos, A; Rodrigues-Costa, F | 1 |
| Cheon, S; Kim, MJ; Kim, YS; Moon, JY; Yun, SJ | 1 |
| Amrami, N; Avivi, D; Dadon, M; Katz, DE; Kaye, KS; Lazarovitch, T; Marchaim, D; Ravid, D; Tal-Jasper, R; Zaidenstein, R | 1 |
| Carroll, KC; Gniadek, TJ; Simner, PJ | 1 |
| Pereira, MR; Uhlemann, AC | 1 |
| Bressan, R; Cian, F; Deiana, ML; Dolzani, L; Furlanis, L; Knezevich, A; Lagatolla, C; Luzzati, R; Milan, A; Tonin, E | 1 |
| Livermore, DM; Mushtaq, S; Warner, M; Woodford, N | 1 |
| Berbel Caban, A; Bueno, MX; Cleary, T; dePascale, D; Doi, Y; Kett, DH; Masuda, E; Munoz-Price, LS; Namias, N; Sfeir, M; Shimose, LA; Spychala, CN | 1 |
| Higgins, PG; Seifert, H; Stefanik, D; Tomaschek, F; Wisplinghoff, H | 1 |
| Çöl, A; Dedeić-Ljubović, A; Hukic, M; Salimović-Bešić, I | 1 |
| Frontzek, A; Pfeifer, Y; Rieber, H | 1 |
| Chan, FHW; Chan, TC; Chen, JHK; Cheng, VCC; Chow, DMK; Ho, PL; Law, TC; Ng, WC; So, SYC; Wong, JYH; Wong, SCY; Yuen, KY | 1 |
| D'Souza, R; Lee, K; Lee, Y; Yong, D | 1 |
| Castro, JG; Laowansiri, P; Latibeaudiere, R; Munoz-Price, LS; Namias, N; Rosa, R; Tarima, S | 1 |
| Abdollahi, A; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghalavand, Z; Ghourchian, S; Mohammadzadeh, M; Nateghi Rostami, M; Rahbar, M; Zeraati, H | 1 |
| Al-Agamy, MH; Al-Qahtani, AA; El-Mahdy, TS; Shibl, AM | 1 |
| Chang, FY; Chen, TL; Chiu, CH; Chuang, MF; Kuo, SC; Lee, YT; Lin, JC; Wang, YC; Yang, YS | 1 |
| Kim, S; Koo, SH; Kwon, GC; Sung, JY | 1 |
| Dissaneevate, S; Janjindamai, W; Kritsaneepaiboon, S; Maneenil, G; Tanaanantarak, P; Techato, C; Thatrimontrichai, A | 1 |
| Cho, SG; Choe, YM; Hong, KC; Jeon, YS; Park, KM; Shin, WY; Song, JH | 1 |
| Bertrand, X; Couppie, P; Demar, M; Djossou, F; Hommel, D; Kallel, H; Mahamat, A; Moreau, B; Nacher, M; Simonnet, C | 1 |
| Fransén, J; Hanberger, H; Huss, FR; Nilsson, LE; Rydell, U; Sjöberg, F | 1 |
| Chen, CH; Chen, JY; Hsu, PJ; Kuo, HY; Liao, PC; Liou, ML; Lu, CW | 1 |
| Ada, B; Ahmed, SS; Aktas, Z; Alp, E; Bagirova, F; Baran, I; Dinc, G; Ersoy, Y; Esen, S; Guven, TG; Hopman, J; Hosoglu, S; Koksal, F; Melchers, W; Parlak, E; Ulu-Kilic, A; Voss, A; Yalcin, AN; Yilmaz, G | 1 |
| Bowler, SL; Doi, Y; McElheny, CL; Mettus, RT; Spychala, CN | 1 |
| Caro-Vega, JM; García-Quintanilla, M; McConnell, MJ; Moreno-Martínez, P; Pachón, J; Pulido, MR | 1 |
| Nowak, P; Paluchowska, P | 1 |
| Al-Bayssari, C; Bakour, S; Bentakouk, MC; Boutefnouchet, N; Djahoudi, A; Mellouk, FZ; Meradji, S; Rolain, JM; Zouyed, F | 1 |
| Ayora, M; Famiglietti, Á; García, S; Nastro, M; Rodriguez, CH; Vay, C | 1 |
| Anetai, M; Endo, K; Hatakeyama, Y; Ishifuji, K; Kurota, M; Narita, K; Sawase, K; Suwabe, A; Yamada, Y | 1 |
| Alaei, N; Aziemzadeh, M; Bahador, A | 1 |
| Brunner, M; Gergova, I; Pfeifer, Y; Pietsch, M; Savov, E; Todorova, I; Trifonova, A; Werner, G; Wilharm, G | 1 |
| Hong, DJ; Jeong, SH; Kim, JO; Lee, H; Lee, K; Yong, D; Yoon, EJ | 1 |
| Huang, CT; Huang, PY; Lee, MH; Lin, HS; Wu, YM; Yang, CC; Ye, JJ; Yeh, CF | 1 |
| Balderrama Yarhui, N; Bastyas, N; Bruni, G; Burger, N; Castro Cañarte, G; Famiglietti, A; Magne Ventura, R; Mota, MI; Nastro, M; Nuñez Quezada, T; Ortellado-Canese, J; Pandolfo, C; Roach, F; Rodríguez, CH; Ugarte Cuba, T; Valenzuela, N; Velázquez Aguayo, G | 1 |
| Altunçekiç Yıldırım, A; Çalgın, MK; Çetinkol, Y; Telli, M | 1 |
| Kraniotaki, E; Nepka, M; Perivolioti, E; Politi, L; Pournaras, S; Tsakris, A | 1 |
| Bayindir, Y; Ersoy, Y; Kayabas, U; Kizilkaya, C; Kuzucu, C; Otlu, B; Togal, T; Yakupogullari, Y | 1 |
| Anandan, S; Nabarro, LEB; Shankar, C; Veeraraghavan, B | 1 |
| Cheng, X; Ge, M; Ruan, L; Wan, G; Yang, T; Yin, Y | 1 |
| Martínez, JA | 1 |
| Heo, ST; Jeon, H; Kim, YJ; Kwon, HI; Lee, JC; Na, SH; Nicholas, A; Oh, MH; Selasi, GN | 1 |
| Adibhesami, H; Aliramezani, A; Boroumand, MA; Douraghi, M; Ghourchian, S; Jasemi, S; Mohammadzadeh, M; Rahbar, M; Zeraati, H | 1 |
| Bowler, SL; Doi, Y; Guo, Y; Kantz, SF; McElheny, CL; Mettus, RT; Wang, P | 1 |
| Chen, TL; Chiang, MC; Kuo, SC; Lee, IH; Lee, YT; Wang, YC; Yang, YS | 1 |
| Al Atrouni, A; Eveillard, M; Hamze, M; Jisr, T; Joly-Guillou, ML; Kempf, M; Lemarié, C | 1 |
| Bian, X; Chen, Y; Li, Y; Liu, X; Shi, J; Zhang, J; Zhao, M | 1 |
| Dang, DA; Loan, CT; Matsui, M; Nga, LT; Pham, TD; Shibayama, K; Suzuki, M; Suzuki, S; Tran, DN; Tran, HH; Trinh, HS; van Doorn, HR; Van Phuong, TT; Wertheim, HF | 1 |
| Katsiari, M; Likousi, S; Mavroidi, A; Nikolaou, C; Palla, E; Platsouka, ED; Roussou, Z | 1 |
| Barreiro, FF; d'Avila, DO; Kroth, LV; Poli-de-Figueiredo, CE; Saitovitch, D; Traesel, MA | 1 |
| Dendrinos, J; Georgiadis, G; Pitiriga, V; Politi, L; Poulou, A; Tsakris, A; Voulgari, E | 1 |
| Apisarnthanarak, A; Ghafur, A; Hsu, LY; Khan, E; Suwantarat, N; Tambyah, PA | 1 |
| Aleandri, M; Ambrosi, C; Conte, MP; Giordano, A; Marazzato, M; Palamara, AT; Scribano, D; Zagaglia, C | 1 |
| Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM | 1 |
| Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R | 1 |
| Jung, SI; Kim, DH; Ko, KS; Kwon, KT | 1 |
| Dahdouh, E; Daoud, Z; Hajjar, M; Suarez, M | 1 |
| Baggiani, A; Barnini, S; Casini, B; Costa, AL; Cristina, ML; Privitera, G; Selvi, C; Tagliaferri, E; Totaro, M; Valentini, P | 1 |
| Bianco, A; Focà, A; Giordano, M; Liberto, MC; Marano, V; Pavia, M; Quirino, A; Rizzo, C | 1 |
| Chen, LK; Chen, YT; Ho, GJ; Ho, YH; Lin, TY; Tseng, CC; Wang, LS; Wang, LY | 1 |
| Camargo, CH; Casas, MRT; Garcia, DO; Tavares, LCB; Vasconcellos, FM | 1 |
| Bao, CM; Chen, FH; Chen, SM; Cui, EB; Huang, J; Li, T; Liu, X; Ning, NZ; Qu, F; Wang, H; Zhang, JL | 1 |
| Altun, B; Altun, Ş; Demiröz, AP; Kınıklı, S; Koçak Tufan, Z; Önde, U | 1 |
| Ardebili, A; Mardaneh, J; Razavi Nikoo, H | 1 |
| Bhattacharjee, A; Garg, A; Paul, D | 1 |
| Kwon, DH; Lee, S; Razqan, GS | 1 |
| Fang, Y; Li, H; Wakefield, MR; Ye, Y; Zhao, L; Zhu, Z | 1 |
| Baker, S; Duong, HHT; Nga, TVT; Tuan Anh, N; Tuan, HM; Tuan, NS; Vinh Chau, NV; Y, DM | 1 |
| Ewers, C; Göttig, S; Klotz, P; Leidner, U; Scheufen, S; Semmler, T | 1 |
| Albano, RM; Asensi, MD; Chagas, TPG; D'Alincourt Carvalho-Assef, AP; Tavares E Oliveira, TR | 1 |
| An, JH; Jang, HC; Jeong, JH; Jung, SI; Kang, SJ; Kim, SH; Kim, YH; Moon, JE; Park, KH | 1 |
| Choi, J; Chong, Y; D'Souza, R; Higgins, PG; Hwang, I; Lee, K; Pinto, NA; Yong, D | 1 |
| Li, P; Wang, W; Wang, X; Zhao, X | 1 |
| Choi, CH; Heo, ST; Jeong, YG; Jin, JS; Kim, JW; Kim, SJ; Lee, JC; Lee, YC | 1 |
| Bojkova, K; Higgins, PG; Seifert, H; Stoeva, T | 1 |
| Petersen, K; Riddle, MS; Sebeny, PJ | 1 |
| Cheong, HJ; Heo, JY; Hwang, IS; Kim, WJ; Lee, J; Noh, JY; Song, JY | 1 |
| Anupurba, S; Garg, A; Gaur, A; Mohapatra, TM; Prakash, P | 1 |
| Huang, L; Sun, L; Xia, T; Xu, G | 1 |
| Brown, NM; Burnstein, RM; Enoch, DA; Enoch, LM; Gillham, MI; Matta, B; Moore, L; Sule, O; Summers, C; Thaxter, R | 1 |
| Bauraing, C; Bogaerts, P; Cuzon, G; Deplano, A; Glupczynski, Y; Lissoir, B; Naas, T; Nordmann, P | 1 |
| Cao, JR; Luo, YP; Shen, DX; Wei, X; Yan, ZQ | 1 |
| Baumann, F; Falcot, V; Lacassin, F; Le Hello, S; Naas, T; Nordmann, P | 1 |
| Cheong, HJ; Kim, WJ; Lee, J; Song, JY; Sung, AK | 1 |
| Mugnier, P; Nordmann, P; Pitout, M; Poirel, L | 1 |
| Alba, V; Marti, S; Sánchez-Céspedes, J; Vila, J | 1 |
| Castanheira, M; Deshpande, LM; Gur, D; Korten, V; Unal, S | 1 |
| Bettaieb, D; Bouallegue, O; Boujaafar, N; Mansour, W; Nordmann, P; Poirel, L | 1 |
| Boo, TW; Crowley, B; Walsh, F | 1 |
| Chen, TP; Doumith, M; Livermore, DM; Lu, PL; Woodford, N | 1 |
| Agodi, A; Daoud, Z; Giannouli, M; Tomasone, F; Triassi, M; Tsakris, A; Vahaboglu, H; Zarrilli, R | 1 |
| Bindayna, KM; Mugnier, PD; Nordmann, P; Poirel, L | 1 |
| Chen, CM; Ke, SC; Liu, PY; Wu, HJ; Wu, LT | 1 |
| Boonkerd, N; Niumsup, PR; Tansawai, U; Tiloklurs, M | 1 |
| Chen, YL; Chen, YS; Hsiao, YS; Hsu, NS; Lin, HH; Wu, CH | 1 |
| Boo, TW; Crowley, B | 1 |
| Al Hashem, G; Dehrab, N; Jamal, W; Rotimi, VO; Salama, M; Shahin, M | 1 |
| Botelho Garcia, L; Bronharo Tognim, MC; Cardoso, CL; Dias Siqueira, VL; dos Santos Saalfeld, SM; Fukita Viana, G | 1 |
| Costa, SF; Levin, AS; Mostachio, AK; Rossi, F; van der Heidjen, I | 1 |
| DeCorby, M; Fuller, J; Hoban, DJ; Loo, V; McCracken, M; Mulvey, MR; Zhanel, GG | 1 |
| Brümmer, S; de Grahl, C; Halle, E; Higgins, PG; Kohlenberg, A; Piening, BC; Rüden, H; Seifert, H; Sohr, D | 1 |
| Chen, CC; Chen, CH; Chiang, SR; Chou, CH; Chuang, YC; Ko, WC; Lee, NY; Tang, HJ | 1 |
| Chang, HH; Cheong, HS; Choi, JY; Chung, DR; Heo, ST; Jung, DS; Jung, SI; Kim, SW; Ko, KS; Lee, H; Park, KH; Park, YK; Peck, KR; Song, JH | 1 |
| Malczynski, M; Qi, C; Scheetz, MH | 1 |
| Bedenic, B; Goic-Barisic, I; Kalenic, S; Katic, S; Novak, A; Punda-Polic, V; Tonkic, M; Towner, KJ | 1 |
| Anbazhagan, D; Mansor, MB; Ong, SY; Sekaran, SD; Wong, EW; Yusof, MY | 1 |
| Costa, SF; Dalben, MF; Garcia, CP; Levin, AS; Lobo, RD; Oliveira, MS; Toscano, CM | 1 |
| Baker, TA; Ison, MG; Reddy, P; Stosor, V; Zembower, TR | 1 |
| Giannouli, M; Tomasone, F; Triassi, M; Tsakris, A; Zarrilli, R | 1 |
| Barth, AL; Boff, R; Kuchenbecker, R; Lutz, L; Machado, AB; Martins, AF; Reiter, KC; Sukiennik, T | 1 |
| Ergin, A; Eser, OK; Hasçelik, G | 1 |
| Gogou, V; Ikonomidis, A; Neou, E; Pournaras, S; Tsakris, A; Vrioni, G | 1 |
| Bahram, F; Emaneini, M; Fatolahzadeh, B; Feizabadi, MM; Mehdi, FM; Mohammad, E; Morovat, T; Setareh, S; Soroush, S; Taherikalani, M | 1 |
| Koulourida, V; Papa, A; Souliou, E | 1 |
| Hsu, LY; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Tan, TT; Tan, TY | 1 |
| Chen, LA; Cui, JC; Liu, YN | 1 |
| Chang, SC; Chen, YC; Hsia, KC; Li, SY; Lin, YC; Sheng, WH | 1 |
| Carignano, E; Dalla Costa, LM; Gales, AC; Luiz, SO; Nascimento, AJ; Paganini, MC; Scheffer, MC; Schimith Bier, KE | 1 |
| Fu, Y; Li, L; Wei, Z; Yang, Q; Yu, Y; Zhou, H; Zhou, J | 1 |
| Doherty, JA; Khan, J; Kollef, MH; Micek, ST; Pervez, M; Reichley, RM; Welch, EC | 1 |
| Allworth, AM; Doidge, M; George, N; Goh, HM; Lipman, J; Marshall, P; Nimmo, GR; O'Brien, K; Paterson, DL; Schembri, MA; Terry, M; Woods, M | 1 |
| Bencini, S; Bosi, A; Casalone, E; Cecconi, D; Donnarumma, F; Fanci, R; Indorato, C; Mannino, R; Mastromei, G; Monnanni, R; Nicoletti, P; Pecile, P; Sergi, S | 1 |
| Chang, WJ; Chang, YH; Juan, CW; Shiau, MY; Tsai, YS; Yang, SC; Yang, TP | 1 |
| Chang, SC; Chen, YC; Hsia, KC; Li, SY; Liao, MH; Lin, YC; Sheng, WH | 1 |
| Sekar, U; Shanthi, M | 1 |
| Giamarellou, H; Markaki, V; Nanas, S; Paniara, O; Platsouka, E; Pratikaki, M; Roussos, C; Routsi, C; Sotiropoulou, C; Vrettou, C | 1 |
| Diraphat, P; Phumisantiphong, U; Siripanichgon, K; Uaratanawong, S; Utrarachkij, F | 1 |
| Amornnopparattanakul, S; Dhiraputra, C; Fungwithaya, S; Leelarasamee, A; Nannha, P; Panapakdee, S; Pongpech, P | 1 |
| Mariano, N; Rahal, JJ; Urban, C | 1 |
| Chiang, PC; Chiu, CH; Huang, CT; Huang, PY; Leu, HS; Shie, SS; Su, LH; Ye, JJ | 1 |
| Brás, Nde J; Clemente, WT; Coutinho, RL; Jesus, LA; Lima, SS; Moreira, RL; Neves, FA; Rezende, EM; Romanelli, RM | 1 |
| Alp, E; Aygen, B; Metan, G; Percin, D; Sumerkan, B; Yildiz, O | 1 |
| Akers, KS; Barsoumian, A; Beckius, ML; Mende, K; Murray, CK | 1 |
| Aktas, E; Celebi, G; Comert, F; Kulah, C; Mooij, MJ; Ozlu, N; Rijnsburger, MC; Savelkoul, PH | 1 |
| Cantarelli, VV; Lopes, FS; Martins, AF; Prates, CG; Ramos, F; Superti, SV; Zavascki, AP | 1 |
| Adams, MD; Bajaksouzian, S; Bonomo, RA; Decker, BK; Dul, MJ; Ecker, DJ; Endimiani, A; Hujer, KM; Jacobs, MR; Perez, F; Ray, AJ; Salata, RA; Toltzis, P; Wallace, CJ; Windau, A | 1 |
| Otük, G; Ozbek, B | 1 |
| Canteras, M; Fernández-Rufete, A; García-Vázquez, E; Gómez, J; Hernández-Torres, A; Herreroa, JA; Ruiz, J; Yagüe, G | 1 |
| Apisarnthanarak, A; Kaewdaeng, S; Kiratisin, P | 1 |
| Hasan, R; Khan, E; Shakoor, S; Zafar, A | 1 |
| Andaluz, D; Bobillo, F; Domínguez-Gil, M; Eiros, JM; Ortiz de Lejarazu, R; Rodríguez-Molins, E; Tenorio-Abreu, A | 1 |
| Fujita, M; Ishikura, H; Kitamura, T; Matsumoto, T; Toyoshima, H; Watanabe, K; Yoshimura, C | 1 |
| Baumann, F; Falcot, V; Lacassin, F; Le Hello, S; Mikulski, M | 1 |
| Bethel, CR; Binas, A; Bonomo, RA; Cassone, M; Nolte, O; Ostorhazi, E; Otvos, L; Rozgonyi, F; Szabo, D; Wade, JD | 1 |
| Dhiraputra, C; Srifuengfung, S; Thapa, B; Tribuddharat, C | 1 |
| Chan, JD; Choudhuri, J; Dellit, TH; Evans, HL; Fulton, C; Gulati, RK; Lynch, JB | 1 |
| Baba Ahmed, Z; Drissi, M; Mugnier, PD; Nordmann, P; Poirel, L | 1 |
| Dhiraputra, C; Rugdeekha, S; Srifuengfung, S; Techachaiwiwat, W; Thapa, B; Tribuddharat, C | 1 |
| Chang, SC; Chen, YS; Hsu, LY; Hsu, MS; Ko, WC; Lau, YJ; Lauderdale, TL; Liao, CH; Lin, SY; Liu, JW; Liu, KS; Sheng, WH; Tsai, TY; Wang, LH | 1 |
| Batista, G; Da Silva, GJ; Duarte, A; Mendonça, N | 1 |
| Chan, MC; Chang, TY; Chiueh, TS; Sun, JR; Wang, WY | 1 |
| Amrine-Madsen, H; Mera, RM; Miller, LA; Sahm, DF | 1 |
| Baig, M; Lavin, MA; Mohapatra, S; Munoz-Price, LS; Penugonda, S; Quinn, JP; Schreckenberger, P; Vais, D; Weinstein, RA; Welbel, S; Zembower, T | 1 |
| Basu, S; Das, P; Roy, S; Singh, A; Viswanathan, R | 1 |
| Cantón, R; García, A; Gimeno, C; Gobernado, M | 1 |
| De Waele, JJ; Deja, M; Diaz, E; Guven, M; Koulenti, D; Lisboa, T; Mañez, R; Martin-Loeches, I; Putensen, C; Rello, J; Ulldemolins, M | 1 |
| Barbosa, PI; Barth, AL; Carneiro, M; Carrilho, CM; Martins, AF; Perugini, M; Possuelo, LG; Renner, JD; Saridakis, HO; Tanita, MT; Tognin, MC; Valim, AR; Vespero, EC | 1 |
| Hamprecht, A; Higgins, PG; Schneiders, T; Seifert, H | 1 |
| Bonomo, RA; Patel, G; Perez, F | 1 |
| Liu, KZ; Zhang, W | 1 |
| Bae, IK; Jeong, SH; Lee, J; Lee, K; Lee, Y | 1 |
| Cöloğlu, D; Dolapçı, I; Karahan, ZC; Mumcuoğlu, I; Tekeli, A; Ulusoy, M; Us, E | 1 |
| Akşit, F; Aybey, AD; Kiremitçi, A; Nayman Alpat, S; Ozgüneş, I; Usluer, G | 1 |
| Abdel-Haq, N; Asmar, BI; Chopra, T; Kaye, KS; Koo, W; McGrath, EJ; Preney, K | 1 |
| Limansky, AS; Mussi, MA; Ravasi, P; Rodriguez, RE; Viale, AM | 1 |
| Averhoff, B; Bingold, T; Brandt, C; Göttig, S; Kempf, VA; Pfeifer, Y; Wichelhaus, TA; Zacharowski, K | 1 |
| Khan, AU; Shakil, S | 1 |
| Cheong, HJ; Choi, WS; Heo, JY; Kim, WJ; Noh, JY; Song, JY | 1 |
| Corção, G; De Oliveira, LM; Ferreira, AE; Fuentefria, DB; Gusatti, CS; Marchetti, DP | 1 |
| Arend, LN; Levin, AS; Penteado-Filho, SR; Pilonetto, M; Rymsza, AM; Tuon, FF | 1 |
| Abbasi, L; Farajnia, S; Hasani, A; Mirsalehian, A; Nahaei, MR; Peymani, A; Sohrabi, N | 1 |
| Aswapokee, N; Dejsirilert, S; Malathum, K; Sawanpanyalert, P; Tiengrim, S | 1 |
| Goic-Barisic, I; Kovacic, A; Novak, A; Punda-Polic, V; Sisko-Kraljevic, K; Tonkic, M; Towner, KJ | 1 |
| Adams-Haduch, JM; Clancy, CJ; Crespo, M; Doi, Y; Kwak, EJ; Nguyen, MH; Pasculle, AW; Pilewski, JM; Potoski, BA; Shields, RK; Silviera, FP; Toyoda, Y | 1 |
| Afzal, O; Haider, S; Hasan, R; Irfan, S; Mehraj, J; Memon, B; Siddiqui, SZ; Turton, JF; Zafar, A | 1 |
| Apisarnthanarak, A; Apisarnthanarak, P; Kiratisin, P; Mundy, LM | 1 |
| He, B; Liu, ZY; Yao, B; Zhang, J; Zhou, QT | 1 |
| Atalay, H; Biyik, Z; Genc, N; Solak, Y; Turkmen, K; Yeksan, M | 1 |
| Aksit, F; Aybey, AD; Durmaz, G; Kiremitci, A; Oz, Y | 1 |
| Hong, KW; Jeong, H; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ; Wie, SH | 1 |
| Barbarini, D; Brisse, S; Carretto, E; Dijkshoorn, L; Farina, C; Passet, V; van der Reijden, TJ | 1 |
| Chang, SC; Chen, YC; Cheng, A; Li, SY; Lin, YC; Sheng, WH; Wang, JT | 1 |
| Chen, P; Chen, Y; Hu, Z; Liu, D; Shi, Y; Wang, H; Wang, Z; Zhao, X | 1 |
| Göttig, S; Higgins, PG; Hunfeld, KP; Pfeifer, Y; Seifert, H; Wichelhaus, TA; Wilharm, G; Witte, W; Zander, E | 1 |
| Cristina, ML; Orlando, P; Ottria, G; Perdelli, F; Sartini, M; Spagnolo, AM | 1 |
| Anunnatsiri, S; Tonsawan, P | 1 |
| Cardoso, CL; dos Santos Saalfeld, SM; Garcia, LB; Pelisson, M; Tognim, MC; Viana, GF | 1 |
| D'Andrea, MM; Fugazza, G; Giani, T; Gona, F; Mezzatesta, ML; Migliavacca, R; Nucleo, E; Pagani, L; Rossolini, GM; Stefani, S | 1 |
| Dijkshoorn, L; Hsu, LY; Khoo, CT; Koh, TH; Ng, SY; Ooi, EE; Tan, TT; Tan, TY; Van Der Reijden, TJ | 1 |
| Chayakul, P; Garey, KW; Pattharachayakul, S; Santimaleeworagun, W; Tansakul, P; Wongpoowarak, P | 1 |
| Cavalcante, AC; Furtado, GH; Gales, AC; Girardelo, R; Medeiros, EA; Oliveira, VG | 1 |
| Chong, Y; Hong, HL; Jeong, SH; Kang, JO; Kim, JS; Kim, MN; Lee, K; Park, YJ; Shin, JH; Yong, D | 1 |
| Guner, R; Hasanoglu, I; Kalem, AK; Keske, S; Tasyaran, MA | 1 |
| Bedenić, B; Budimir, A; Franolić-Kukina, I; Herljević, Z; Higgins, PG; Vraneš, J | 1 |
| Akers, KS; Beckius, ML; Calvano, T; Hospenthal, DR; Markelz, AE; Mende, K; Murray, CK; Yu, X; Zera, WC | 1 |
| Ansaldi, F; Bassetti, M; Canepa, P; Durando, P; Ginocchio, F; Icardi, G; Molinari, MP; Mussap, M; Orengo, G; Talamini, A; Viscoli, C; Zancolli, M | 1 |
| Esterly, JS; Griffith, M; Malczynski, M; Postelnick, MJ; Qi, C; Scheetz, MH | 1 |
| Giske, CG; Karah, N; Samuelsen, Ø; Sundsfjord, A | 1 |
| Choi, JY; Jung, SI; Kim, DH; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Ichiyama, S; Ito, Y; Matsumura, Y; Matsushima, A; Nagao, M; Takakura, S; Yamamoto, M | 1 |
| Ben, RJ; Chien, ST; Hsueh, JC; Shiang, JC; Yang, MC | 1 |
| Hall, RM; Hamidian, M | 1 |
| Bustamante, Z; Fernández, E; Gallego, L; Rosales, I; Sevillano, E; Umaran, A; Zabalaga, S | 1 |
| Bonnin, RA; Licker, M; Nordmann, P; Poirel, L | 1 |
| Adams-Haduch, JM; Bogdanovich, T; Doi, Y; Halstead, DC; Marschall, J; Onuoha, EO; Pasculle, AW; Rhee, D; Spellberg, BJ; Tian, GB; Urban, CM | 1 |
| Giannouli, M; Gogou, V; Piperaki, ET; Pournaras, S; Tsakris, A; Voulgari, E; Zarrilli, R | 1 |
| Caballero-Moyano, FJ; Docobo-Pérez, F; Domínguez-Herrera, J; Fernández-Cuenca, F; Gómez-Sánchez, MC; Pachón, J; Pascual, A; Smani, Y | 1 |
| Ayala, JA; Cayô, R; Espinal, P; Fernández-Cuenca, F; Martínez-Martínez, L; Ocampo-Sosa, AA; Pascual, A; Rodríguez, MC; Vila, J | 1 |
| de Alba, PD; Fernández-Cuenca, F; Gómez-Sánchez, MA; Infante-Martínez, V; Pascual, A; Rodríguez-Martínez, JM | 1 |
| Jung, SI; Kim, SH; Ko, KS; Park, KH; Park, YK | 1 |
| Chang, KC; Kuo, HY; Kuo, JW; Liou, ML; Yueh, HW | 1 |
| Carmeli, Y; Moran-Gilad, J; Navon-Venezia, S; Schwartz, D | 1 |
| Chen, CP; Chen, TL; Chiang, MC; Fung, CP; Kuo, SC; Lee, YT; Yang, SP | 1 |
| Dong, L; Li, HY; Wang, ZY; Zhang, TQ | 1 |
| Chen, CC; Chen, CH; Chiang, SR; Chuang, YC; Ko, WC; Lee, NY; Shieh, JM; Tang, HJ | 1 |
| Canteras, M; García-Vázquez, E; Gómez, J; Hernández-Torres, A; Ruiz, J; Yagüe, G | 1 |
| Kempf, M; Rolain, JM | 1 |
| Bonnin, RA; Duranteau, J; Figueiredo, S; Nordmann, P; Poirel, L | 1 |
| Bonnin, RA; Boulanger, A; Kaase, M; Nordmann, P; Poirel, L; Schrenzel, J | 1 |
| Boasquevisque, CH; Costa, LD; de Freitas, WV; de Matos, JA; de Souza, TC; Dias, RC; Girão, VB; Magalhães, AC; Martins, IS; Martins, N; Moreira, BM; Nouér, SA; Pellegrino, FL; Riley, LW; Santoro-Lopes, G | 1 |
| B Hamadeh, M; Bonnin, RA; Ghazawi, A; Hashmey, R; Nordmann, P; Pál, T; Poirel, L; Rizvi, TA; Sonnevend, A | 1 |
| Akduman, D; Aktas, E; Aydemir, H; Celebi, G; Keskin, AS; Oztoprak, N; Piskin, N; Sumbuloglu, V | 1 |
| Al Najjar, M; Hamzeh, AR; Mahfoud, M | 1 |
| Bheemreddy, S; Blunden, C; Bonomo, RA; Campbell, ML; Chopra, T; Dhar, S; Hayakawa, K; Hujer, AM; Kaye, KS; Lee, J; Lephart, PR; Manickam, P; Marchaim, D; Martin, ET; Patel, D; Perez, F; Pogue, JM; Rudin, S; Shango, M; Varkey, J | 1 |
| Harada, S; Ishii, Y; Kouyama, Y; Saga, T; Tateda, K; Yamaguchi, K; Yoshizumi, A | 1 |
| Al-Hubail, M; Al-Sweih, NA; Rotimi, VO | 1 |
| Akhi, MT; Amiri, Z; Farajnia, S; Naghili, B; Nahaei, MR; Peymani, A; Rezaee, MA; Saeedi, N; Sohrabi, N | 1 |
| Aoyagi, T; Arai, K; Endo, S; Gu, Y; Hatta, M; Hirakata, Y; Kaku, M; Kitagawa, M; Kunishima, H; Ogawa, M; Sasano, M; Shimojima, M; Tokuda, K; Yamada, M; Yano, H | 1 |
| Bakour, S; Berrazeg, M; Brunel, JM; Drissi, M; Flaudrops, C; Kempf, M; Mesli, E; Rolain, JM; Touati, A | 1 |
| Abreu-Lanfranco, O; Bhargava, A; Bheemreddy, S; Campbell, M; Chopra, T; Dhar, S; Hayakawa, K; Kaye, KS; Khandker, N; Ku, K; Lephart, PR; Marchaim, D; Martin, ET; Moshos, J; Pogue, JM; Wang, Y | 1 |
| Baño, JR; Bou, G; Caballero-Moyano, FJ; Fernández Cuenca, F; Martínez-Martínez, L; Pascual, A; Sánchez, Mdel C; Vila, J | 1 |
| Aoyagi, T; Arai, K; Endo, S; Hatta, M; Hirakata, Y; Ishibashi, N; Kaku, M; Kanamori, H; Kitagawa, M; Kunishima, H; Ogawa, M; Shimojima, M; Tokuda, K; Yamada, M; Yano, H | 1 |
| Costa, SF; Levin, AS; Mostachio, AK; Rizek, C; Rossi, F; Zerbini, J | 1 |
| Amyes, SG; Bello, H; Domínguez, M; González-Rocha, G; Opazo, A | 1 |
| Farajnia, S; Higgins, PG; Nahaei, MR; Peymani, A; Seifert, H | 1 |
| Cheng, A; Hsueh, PR; Huang, YT; Lee, YC; Liao, CH; Liu, CY; Tsai, HY | 1 |
| Hong, KW; Kang, MW; Kim, SI; Kim, YJ; Kim, YR; Park, YJ | 1 |
| Chen, TL; Chiang, MC; Chiang, TH; Fung, CP; Huang, ST; Kuo, SC; Lee, YT; Yang, SP | 1 |
| Kapil, A; Moganty, RR; Tiwari, V | 1 |
| Ait Ameur, A; Bakour, S; Haouchine, D; Kempf, M; Rolain, JM; Sahli, F; Touati, A | 1 |
| Chang, FY; Chang, SC; Chi, CL; Chien, LJ; Hsiung, CA; Su, CH; Wang, JT; Yu, HT | 1 |
| Dou, Q; Li, J; Liang, W; Liu, W; Wu, G; Wu, J; Zou, M | 1 |
| Kim, DH; Ko, KS; Park, YK | 1 |
| Choi, JY; Jung, SI; Kim, DH; Ko, KS; Song, JH; Thamlikitkul, V | 1 |
| Catania, MR; Del Pezzo, M; Lambiase, A; Piazza, O; Rossano, F; Tufano, R | 1 |
| Barin, J; Barth, AL; Machado, AB; Martins, AF; Pagano, M | 1 |
| Bulanda, M; Chmielarczyk, A; Gosiewski, T; Heczko, P; Higgins, PG; Romaniszyn, D; Seifert, H; Synowiec, E; Wojkowska-Mach, J; Zander, E | 1 |
| Kapil, A; Moganty, RR; Tiwari, V; Vashistt, J | 1 |
| Chang, HH; Chung, DR; Heo, ST; Joung, MK; Jung, SI; Kang, CI; Kim, SW; Lee, JA; Moon, C; Moon, SY; Peck, KR; Ryu, SY; Shin, SY; Son, JS; Song, JH | 1 |
| Gu, HT; Huang, YF; Lu, XX; Pang, J; Sui, WJ; Wang, HL; Wang, JR; Wang, M | 1 |
| Bou, G; Fernández-Cuenca, F; Gómez-Sánchez, M; Martínez-Martínez, L; Pascual, A; Rodríguez-Baño, J; Vila, J | 1 |
| Aleo, A; Bonura, C; Calà, C; Cracchiolo, AN; Fasciana, T; Mammina, C; Palma, DM; Saporito, MA; Sodano, C; Tetamo, R; Verde, MS | 1 |
| Karah, N; Samuelsen, Ø; Sundsfjord, A; Towner, K | 1 |
| Huang, WF; Jiang, W; Liu, H; Xiao, DW; Yang, YC; Zhong, M | 1 |
| Chang, J; Chung, KS; Jung, JY; Kang, YA; Kim, EY; Kim, SK; Kim, SY; Kim, YS; Lee, SK; Lim, JE; Park, BH; Park, MS; Park, SC | 1 |
| Caniça, M; Ferreira, E; Jones-Dias, D; Louro, D; Manageiro, V | 1 |
| Amyes, SG; Evans, BA; Hamouda, A | 1 |
| Nithitamsakun, N; Punpanich, W; Suntarattiwong, P; Treeratweeraphong, V | 1 |
| Bi, S; Fan, W; Huang, Y; Ji, Z; Li, L; Wiradharma, N; Xu, K; Yang, YY | 1 |
| Hukić, M; Siširak, M | 1 |
| Altouvas, G; Mamali, V; Pitiriga, V; Pournaras, S; Themeli-Digalaki, K; Tsakris, A; Tziraki, M; Zarkotou, O | 1 |
| Bou, G; Fernández, JL; Fernández, Mdel C; Gosálvez, J; Otero, FM; Santiso, R; Tamayo, M; Tomás, M | 1 |
| Apisarnthanarak, A; Chanvitan, P; Dissaneevate, S; Janjindamai, W; Maneenil, G; Thatrimontrichai, A | 1 |
| Akduman, D; Aydemir, H; Celebi, G; Comert, F; Horuz, E; Kokturk, F; Ornek, T; Piskin, N; Terzi, A | 1 |
| Asghari, B; Azimi, L; Gholami, A; Lari, AR; Owlia, P | 1 |
| Chmielarczyk, A; Heczko, P; Higgins, PG; Seifert, H; Zander, E | 1 |
| Azza, S; Colson, P; Diene, S; Dubourg, G; Fournier, PE; Joly-Guillou, ML; Kempf, M; Papazian, L; Raoult, D; Ribeiro, A; Richet, H; Rolain, JM | 1 |
| Gan, HM; Lean, SS; Suhaili, Z; Thong, KL; Yeo, CC | 1 |
| Bou, G; Espinal, P; Fernández-Cuenca, F; Gato, E; Macià, MD; Oliver, A; Roca, I; Rodríguez-Baño, J; Ruíz, E; Tomás, M; Vila, J | 1 |
| Diene, SM; Fall, B; Fenollar, F; Kempf, M; Niang, B; Raoult, D; Rolain, JM; Sow, K; Wade, B | 1 |
| Al Hubail, M; Al Sweih, N; Bonnin, RA; Gasiorowski, E; Nordmann, P; Poirel, L; Rotimi, VO | 1 |
| Cerniauskiene, K; Dambrauskiene, A; Rimdeika, R; Sakalauskas, R; Vitkauskiene, A | 1 |
| Higgins, PG; Seifert, H; Zander, E | 1 |
| Cao, J; Dai, W; Huang, S; Sun, S; Zhang, L | 1 |
| Apisarnthanarak, A; Warren, DK | 1 |
| Chung, GT; Kim, HS; Lee, KM; Lee, YS; Park, S; Yoo, JI; Yoo, JS | 1 |
| Balode, A; Dumpis, U; Karah, N; Karlsone, A; Miklasevics, E; Samuelsen, Ø; Saule, M; Sundsfjord, A | 1 |
| Caprioli, RM; Chazin, WJ; Hood, MI; Kehl-Fie, TE; Moore, JL; Mortensen, BL; Skaar, EP; Sugitani, N; Zhang, Y | 1 |
| Basto, ST; de Gouvêa, EF; Ferreira, AL; Gonçalves, RT; Halpern, M; Martins, IS; Moreira, BM; Santoro-Lopes, G | 1 |
| Daikos, G; Katerelos, P; Kontopidou, F; Maltezou, HC; Roilides, E; Theodoridou, M | 1 |
| Suwabe, A; Yamada, Y | 1 |
| Cacci, LC; Coelho-Souza, T; Costa-Lourenço, AP; Dalla-Costa, L; de Figueiredo, MP; de Freitas, WV; de Matos, JA; Dias, RC; Ferreira, AL; Girão, VB; Maralhães, AC; Martins, IS; Martins, N; Moreira, BM; Nouér, SA; Riley, LW; Santoro-Lopes, G | 1 |
| Ichise, Y; Kodama, N; Kosuge, Y; Matsui, M; Shibayama, K; Sugita, A; Suzuki, M; Suzuki, S | 1 |
| Coelho-Souza, T; Dias, RC; Martins, IS; Martins, N; Menezes, AO; Moreira, BM; Reis, JN; Reis, MG; Riley, LW; Silva, NO | 1 |
| Kim, JD; Kwon, NY; Pai, HJ | 1 |
| Gallego, L; Livermore, DM; Lopez-Otsoa, F; Towner, KJ; Tysall, L; Woodford, N | 1 |
| Henwood, CJ; James, D; Livermore, DM; Spence, RP; Towner, KJ; Woodford, N | 1 |
| Aygün, G; Demirkiran, O; Dikmen, Y; Mete, B; Oztürk, R; Urkmez, S; Utku, T; Yaşar, H; Yilmaz, M | 1 |
| Barbolla, RE; Catalano, M; Centrón, D; Di Martino, A; Famiglietti, A; Maimone, S; Salgueira, C; Vay, C | 1 |
| Farrag, N; Holliman, R; Manuel, RJ; Shin, GY | 1 |
| Bragagnolo, KL; Castro, ME; Coelho, JM; Dalla-Costa, LM; Livermore, DM; Penteado-Filho, SR; Rea-Neto, A; Souza, HA; Stier, CJ; Woodford, N | 1 |
| Greenhalgh, JM; Turner, PJ | 1 |
| Bratu, S; Heddurshetti, R; Landman, D; Quale, J | 1 |
| Maniatis, AN; Polyzos, S; Pournaras, S; Sofianou, D; Tsakris, A; Tsioni, C | 1 |
| Bagattini, M; Barretta, E; Crispino, M; Di Popolo, A; Triassi, M; Villari, P; Zarrilli, R | 1 |
| Kong, HS; Xu, GY; Xu, XW; Yang, Q; Yu, YS; Zhong, BY | 1 |
| Oliver, A | 1 |
| Calvo, F; Canduela, MJ; Gallego, L; Martín, G; Pujana, I; Sevillano, E; Umaran, A | 1 |
| Andrade, SS; Gales, AC; Jones, RN; Sader, HS; Silbert, S; Tognim, MC | 1 |
| Ariza, J; Ayats, J; Borraz, C; Cabellos, C; Corbella, X; Doménech, A; Gudiol, F; Montero, A; Tubau, F | 1 |
| Dubouix, A; Héritier, C; Marty, N; Nordmann, P; Poirel, L | 1 |
| Castanheira, M; Jones, RN; Mendes, RE; Sader, HS; Toleman, M; Walsh, TR | 1 |
| Amyes, SG; Brown, S; Young, HK | 1 |
| Boldur, I; Carmeli, Y; Lazarovitch, T; Ostfeld, I; Paul, M; Pitlik, S; Rubinovitch, B; Samra, Z; Shula, H; Siegman-Igra, Y; Weinberger, M | 1 |
| Beceiro, A; Bou, G; Canle, D; Cartelle, M; Cisneros, JM; del Mar Tomas, M; Llinares, P; Molina, F; Pertega, S; Villanueva, R | 1 |
| Cecchini, L; Chinello, P; Esposito, S; Franchi, C; Masala, M; Nicastri, E; Petrosillo, N; Proietti, MF; Venditti, M | 1 |
| Akcay, MN; Aktas, F; Altoparlak, U; Celebi, D; Ozkurt, Z | 1 |
| Hirschauer, C; Levy, M; Marchandin, H; Naas, T; Nordmann, P | 1 |
| Blasco, MD; Brisse, S; Coman, G; Filip, R; Héritier, C; Marqué, S; Naas, T; Nordmann, P; Poirel, L | 1 |
| Amyes, S; Brown, S | 1 |
| Bell, JM; Franklin, C; Peleg, AY; Spelman, DW; Walters, LJ | 1 |
| Lee, CC; Ling, JM; Ling, TKW; Ying, CM | 1 |
| Bertini, A; Carattoli, A; Giordano, A; Mancini, C; Varesi, P; Villa, L | 1 |
| Borgmann, S; Heeg, P; Kötter, I; Mayer, F; Riessen, R; Weyrich, P | 1 |
| Koulenti, D; Rello, J | 1 |
| Nordmann, P; Poirel, L | 1 |
| Rice, LB | 1 |
| Ariza, J; Domínguez, MA; Gudiol, F; Montero, A; Peña, C; Pujol, M; Saballs, M; Tubau, F | 1 |
| Lolans, K; Munoz-Price, LS; Quinn, JP; Rice, TW | 1 |
| Bauraing, C; Bogaerts, P; Glupczynski, Y; Naas, T; Nordmann, P; Piérard, D; Soetens, O; Wybo, I | 1 |
| Ikonomidis, A; Markogiannakis, A; Pournaras, S; Spanakis, N; Tsakris, A | 1 |
| Foustoukou, M; Héritier, C; Lebessi, E; Nordmann, P; Patsoura, A; Poirel, L | 1 |
| Coelho, JM; Glover, J; Kaufmann, ME; Livermore, DM; Palepou, MF; Patel, BC; Pike, R; Pitt, TL; Turton, JF; Warner, M; Woodford, N | 1 |
| Furtado, GH; Machado, AM; Martins, ST; Medeiros, EA; Wey, SB | 1 |
| Dijkshoorn, L; Iredell, J; Partridge, SR; Thomas, L; Valenzuela, JK; van der Reijden, T | 1 |
| Naas, T; Nordmann, P; Poirel, L | 1 |
| Craig, JC; Iredell, JR; Playford, EG | 1 |
| Hsu, LY; Koh, TH; Sng, LH; Wang, GC; Zhao, Y | 1 |
| Chang, CY; Chang, YL; Hsu, CK; Hsueh, PR; Kuo, LC; Lai, CC; Liao, CH | 1 |
| Falagas, ME; Manta, KG; Siempos, II; Vardakas, KZ | 1 |
| Luczak, M; Marchel, H; Towner, KJ; Wroblewska, MM | 1 |
| Correa, A; Guzman, AM; Kattan, JN; Livermore, D; Lolans, K; Quinn, JP; Villegas, MV; Woodford, N | 1 |
| Bagattini, M; Casillo, R; Crivaro, V; Cuccurullo, S; Di Popolo, A; Galdieri, N; Mattei, A; Ragone, E; Triassi, M; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Barth, AL; Silbert, S; Silva, FM; Soares, FC; Superti, SV; Zavascki, AP | 1 |
| Cassone, A; Di Sora, F; Dionisi, AM; Gallo, S; Longo, B; Luzzi, I; Monaco, M; Montella, F; Pantosti, A; Placanica, P; Rezza, G; Tarasi, A; Volpe, I | 1 |
| Bertini, A; Carattoli, A; Carfagna, P; Dionisi, AM; Giordano, A; Luzzi, I; Mancini, C; Varesi, P; Venditti, M; Villa, L | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Cheong, HJ; Hwang, IS; Jeong, HW; Kee, SY; Kim, WJ; Seo, YB; Song, JY | 1 |
| Allali, S; Kernbaum, S; Naas, T; Nordmann, P | 1 |
| Sinha, M; Srinivasa, H | 1 |
| Adams, JM; Doi, Y; Paterson, DL; Yamane, K | 1 |
| Chen, M; Guo, P; Sun, H; Wang, H; Xu, Y; Yang, Q; Zhu, Y | 1 |
| Durante-Mangoni, E; Fortunato, R; Tripodi, MF; Utili, R; Zarrilli, R | 1 |
| Falagas, ME; Koletsi, PK; Kopterides, P; Michalopoulos, A | 1 |
| Chin, BS; Choi, HK; Choi, JY; Choi, SH; Han, SH; Jeoung, SJ; Kim, CK; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Lee, HS; Lee, K; Song, YG; Yong, D; Yum, JH | 1 |
| Bedenic, B; Goic-Barisic, I; Kalenic, S; Katic, S; Punda-Polic, V; Tonkic, M | 1 |
| Blommaert, L; De Beer, T; De Regt, J; Lacor, P; Lauwers, S; Piérard, D; Soetens, O; Wybo, I | 1 |
| Iredell, J; Lü, X; Partridge, SR; Valenzuela, JK; Zong, Z | 1 |
| Levi, K; Towner, KJ; Vlassiadi, M | 1 |
| Malczynski, M; Parker, M; Qi, C; Scheetz, MH | 1 |
| Carattoli, A; Fadda, G; Gona, F; Mezzatesta, ML; Nicoletti, G; Nicolosi, D; Nicolosi, VM; Stefani, S; Trovato, G | 1 |
| Gianneli, D; Loli, A; Miriagou, V; Tzelepi, E; Tzouvelekis, LS | 1 |
| Arango, AI; Bravo, P; Gonzalez, EB; Mantilla, JR; Nuñez, JC; Pulido, IY; Reguero, MT; Saavedra, SY; Valenzuela, EM | 1 |
| Kim, JM; Kim, JW; Kim, YS; Ko, CS; Koo, SH; Kwon, KC; Park, JW; Shin, KS; Shin, SY; Song, JH; Sung, JY | 1 |
| Chang, K; Chen, YH; Chiang, WG; Huang, LY; Hwang, IJ; Lian, ST; Lin, CL; Lin, SF; Lu, PL; Siu, LK | 1 |
| Costa, SF; Grinbaum, RS; Levin, AS; Oliveira, MS; Prado, GV | 1 |
| Budak, F; Dundar, D; Eroglu, C; Gacar, G; Kasap, M; Kolayli, F; Meric, M; Vahaboglu, H | 1 |
| Arribas, JL; Asensio, A; Calbo-Torrecillas, F; Cantón, R; Herruzo, R; Sáenz, MC; Vaqué, J | 1 |
| Luczak, M; Marchel, H; Sawicka-Grzelak, A; Sivan, A; Wroblewska, MM | 1 |
| Chen, TL; Cho, WL; Fung, CP; Shaio, MF; Wu, RC | 1 |
| Maragakis, LL; Perl, TM | 1 |
| Brisse, S; Diancourt, L; Dijkshoorn, L; Krízová, L; Maixnerová, M; Nemec, A; van den Broek, P; van der Reijden, TJ | 1 |
| Alba, V; Blasco, MD; Espinal, P; Marti, S; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
| Alba, V; Blasco, MD; Espinal, P; Fernández-Cuenca, F; Marti, S; Pascual, A; Ruiz, M; Sánchez-Céspedes, J; Vila, J | 1 |
| Alarcón, T; López-Brea, M; López-Hernández, S | 1 |
| Da Silva, GJ; Leitão, GJ; Peixe, L | 1 |
| Joly-Guillou, ML | 1 |
| Corbella, X; Corral, L; Fernandez-Viladrich, P; Mateu, A; Tubau, F | 1 |
| Lal, H; Landman, D; Manikal, VM; Oydna, E; Quale, J; Saurina, G | 1 |
| Bou, G; Cerveró, G; Domínguez, MA; Martínez-Beltrán, J; Quereda, C | 1 |
| Argerich, MJ; Ariza, J; Ayats, J; Corbella, X; Domínguez, MA; Garrigosa, F; Gudiol, F; Montero, A; Pujol, M | 1 |
| Afzal-Shah, M; Livermore, DM; Woodford, N | 1 |
| Forward, KR; Gales, AC; Jones, RN; Liñares, J; Sader, HS; Verhoef, J | 1 |
| Bion, J; Das, I; Elliott, T; Hill, D; Lambert, P; Noy, M | 1 |
| Gatward, T; Henwood, CJ; James, D; Livermore, DM; Spence, RP; Stockdale, MW; Towner, KJ; Warner, M; Woodford, N | 1 |
| Livermore, DM | 1 |
| Adedeji, A; Brooks, S; Flores, C; Landman, D; Mayorga, D; Quale, JM; Ravishankar, J; Vangala, K | 1 |
58 review(s) available for carbapenems and Acinetobacter Infections
| Article | Year |
|---|---|
Multidrug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
Can Drug Repurposing be Effective Against Carbapenem-Resistant Acinetobacter baumannii?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2021 |
The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literatu
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Candida auris; Candidiasis; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Infection Control; Male; Middle Aged; Pandemics; Retrospective Studies; SARS-CoV-2; Switzerland | 2022 |
Contamination of healthcare environment by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Delivery of Health Care; Humans; Microbial Sensitivity Tests | 2022 |
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Deciphering the virulence factors, regulation, and immune response to
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Immunity; Virulence Factors | 2023 |
Hospital Reservoirs of Multidrug Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
Sulbactam-durlobactam: A novel β-lactam-β-lactamase inhibitor combination targeting carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Colistin; Humans; Lactams; United States | 2023 |
Navigating Available Treatment Options for Carbapenem-Resistant Acinetobacter baumannii-calcoaceticus Complex Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Sulbactam | 2023 |
Novel approaches to overcome Colistin resistance in Acinetobacter baumannii: Exploring quorum quenching as a potential solution.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Quorum Sensing | 2023 |
Systematic Review and Meta-analysis of Carbapenem Resistance of Acinetobacter baumannii in Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Iran; Prevalence | 2020 |
Emergence, molecular mechanisms and global spread of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Databases, Genetic; DNA Transposable Elements; DNA, Bacterial; Genome, Bacterial; Humans | 2019 |
Acinetobacter spp in a Third World Country with Socio-economic and Immigrants Challenges.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Developing Countries; Drug Resistance, Bacterial; Emigrants and Immigrants; Humans; Lebanon; Socioeconomic Factors | 2019 |
Clinical efficacy and safety of polymyxins based versus non-polymyxins based therapies in the infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review and meta-analysis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Length of Stay; Odds Ratio; Polymyxins; Treatment Outcome | 2020 |
Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; beta-Lactam Resistance; Carbapenems; DNA-Binding Proteins; Drug Resistance, Bacterial; Histatins; Humans; Intercellular Signaling Peptides and Proteins; Microbial Sensitivity Tests; Peptides, Cyclic; Pore Forming Cytotoxic Proteins; Wasp Venoms | 2020 |
Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Klebsiella Infections; Klebsiella pneumoniae; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline | 2020 |
Carbapenem resistance in Acinetobacter baumannii, and their importance in hospital-acquired infections: a scientific review.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests | 2021 |
Treatment of patients with serious infections due to carbapenem-resistant Acinetobacter baumannii: How viable are the current options?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Treatment Outcome | 2021 |
Rifabutin for infusion (BV100) for the treatment of severe carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Infusions, Intravenous; Rifabutin | 2021 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in Greece: an extended review (2000-2015).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Sequence Analysis, DNA | 2017 |
Antibiotic resistance of pathogenic Acinetobacter species and emerging combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adjuvants, Pharmaceutic; Anti-Bacterial Agents; Biofilms; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests | 2017 |
New Treatment Options against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Antibodies, Monoclonal; Carbapenems; Drug Discovery; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Phage Therapy | 2019 |
The use of polymyxins to treat carbapenem resistant infections in neonates and children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Child; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Humans; Infant, Newborn; Polymyxin B; Polymyxins | 2019 |
Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Prevalence; Risk Factors; Saudi Arabia | 2019 |
Prevalence and Mechanisms of Carbapenem Resistance in
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Gene Expression; Humans; Iran; Microbial Sensitivity Tests; Plasmids; Prevalence | 2020 |
Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Observational Studies as Topic; Pneumonia, Bacterial; Randomized Controlled Trials as Topic; Treatment Outcome | 2019 |
Predictors of mortality in patients infected with carbapenem-resistant Acinetobacter baumannii: A systematic review and meta-analysis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Clinical Decision Rules; Female; Humans; Male; Pneumonia, Bacterial; Risk Factors | 2019 |
Status of carbapenem-resistant Acinetobacter baumannii harboring carbapenemase: First systematic review and meta-analysis from Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans | 2019 |
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and management.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disease Management; Disease Outbreaks; Epidemiological Monitoring; Humans; Minocycline; Tigecycline | 2013 |
Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Management; Epidemiological Monitoring; Humans; Polymyxins; Porins | 2013 |
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression; Gene Transfer, Horizontal; Humans; Minocycline; Mutation; Tigecycline | 2013 |
The role of antimicrobial stewardship in curbing carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Drug Prescriptions; Drug Utilization; Enterobacteriaceae; Enterobacteriaceae Infections; Health Policy; Humans; Infection Control; Organizational Policy; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans | 2014 |
Treatment options for carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans | 2014 |
Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Humans; Incidence; Latin America; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulbactam; Tigecycline | 2015 |
Carbapenem-Resistant Non-Glucose-Fermenting Gram-Negative Bacilli: the Missing Piece to the Puzzle.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Transmission, Infectious; Gene Transfer, Horizontal; Humans; Infection Control; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Acinetobacter baumannii: biology and drug resistance - role of carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests | 2016 |
Minocycline and Tigecycline: What Is Their Role in the Treatment of Carbapenem-Resistant Gram-Negative Organisms?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; India; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2017 |
[Approach to directed therapy after knowledge of the isolate: carbapenemase-producing Enterobacteriaceae, multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2016 |
Carbapenem-Resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Asia, Southeastern; Asia, Western; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests; Prevalence | 2017 |
Systematic Review of Antimicrobial Resistance of Clinical Acinetobacter baumannii Isolates in Iran: An Update.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Iran; Meropenem; Microbial Sensitivity Tests; Minocycline; Polymyxin B; Rifampin; Thienamycins; Tigecycline | 2017 |
Acinetobacter baumannii skin and soft-tissue infection associated with war trauma.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Debridement; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Military Personnel; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Warfare; Wounds and Injuries; Wounds, Gunshot | 2008 |
Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Humans | 2009 |
Carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii: assessing their impact on organ transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Minocycline; Organ Transplantation; Risk Factors; Tigecycline | 2010 |
[Mechanisms of carbapenems resistance in acinetobacter and progress of treatment].
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Microbial Sensitivity Tests | 2010 |
Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Genes, MDR; Humans; Integrons; Microbial Sensitivity Tests; Permeability | 2011 |
Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Carrier State; Colistin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Europe; Gene Transfer, Horizontal; Humans | 2012 |
OXA-type carbapenemases in Acinetobacter baumannii in South America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; South America | 2012 |
Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Molecular Epidemiology; Oxytocin | 2012 |
The rise of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation; Humans; Immunocompromised Host | 2013 |
OXA (beta)-lactamases in Acinetobacter: the story so far.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Genes, Bacterial; Humans | 2006 |
Hospital-acquired pneumonia in the 21st century: a review of existing treatment options and their impact on patient care.
Topics: Acinetobacter Infections; Administration, Inhalation; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Cross Infection; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Methicillin Resistance; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Practice Guidelines as Topic; Pseudomonas Infections; Respiration, Artificial; Vancomycin | 2006 |
Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests | 2006 |
Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Biofilms; Carbapenems; Clinical Trials as Topic; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Immunocompromised Host; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Tigecycline | 2006 |
Carbapenems for the treatment of immunocompetent adult patients with nosocomial pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aminoglycosides; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Multiple; Drug Therapy, Combination; Fluoroquinolones; Humans; Immunocompetence; Intensive Care Units; Meropenem; Pneumonia, Bacterial; Pseudomonas Infections; Randomized Controlled Trials as Topic; Respiration, Artificial; Survival Rate; Thienamycins; Treatment Outcome | 2007 |
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Infection Control | 2008 |
The impact of carbapenemases on antimicrobial development and therapy.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Enzyme Inhibitors; Genes, Bacterial; Humans; Recombination, Genetic | 2002 |
11 trial(s) available for carbapenems and Acinetobacter Infections
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
Pathogen-Targeted Clinical Development to Address Unmet Medical Need: Design, Safety, and Efficacy of the ATTACK Trial.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sulbactam | 2023 |
The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Treatment Outcome | 2018 |
Meropenem/colistin versus meropenem/ampicillin-sulbactam in the treatment of carbapenem-resistant pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Female; Humans; Male; Meropenem; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Sulbactam | 2018 |
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Data Interpretation, Statistical; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome | 2019 |
A PROspective study on the Usage patterns of Doripenem in the Asia-Pacific region (PROUD study).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asia; Carbapenems; Doripenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intensive Care Units; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Treatment Outcome; Urinary Tract Infections; Young Adult | 2014 |
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome | 2014 |
Successful management of an outbreak due to carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Feces; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Meropenem; Prospective Studies; Thienamycins | 2015 |
Risk factors for occurrence and 30-day mortality for carbapenem-resistant Acinetobacter baumannii bacteremia in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Immunocompromised Host; Intensive Care Units; Male; Middle Aged; Odds Ratio; Renal Insufficiency; Retrospective Studies; Risk Factors; Survival Rate; Time Factors | 2012 |
Colistin vs. the combination of colistin and rifampicin for the treatment of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome | 2013 |
Rifampicin/imipenem combination in the treatment of carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Pilot Projects; Rifampin; Treatment Outcome | 2006 |
850 other study(ies) available for carbapenems and Acinetobacter Infections
| Article | Year |
|---|---|
The investigation of adrenal involvement in carbapenem resistant Acinetobacter baumannii sepsis: experimental mouse model
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adrenal Insufficiency; Animals; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Corticosterone; Female; Mice; Microbial Sensitivity Tests; Sepsis | 2021 |
Co-infection of ST2
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Coinfection; COVID-19; Humans; Iran; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pandemics; Tertiary Care Centers | 2021 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated from three major hospitals in Jordan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Hospitals; Humans; Jordan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2021 |
Molecular detection of blaOXA-23 gene and blaOXA-51 gene in carbapenem resistant strains of Acinetobacter baumannii in patients with ventilator associated pneumonia at tertiary care hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Humans; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Tertiary Care Centers | 2021 |
Deciphering Multidrug-Resistant Acinetobacter baumannii from a Pediatric Cancer Hospital in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cancer Care Facilities; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Hospitals, Pediatric; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Whole Genome Sequencing | 2021 |
Therapeutic Effects of Inhibitor of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Biofilms; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Humans; Mice, Inbred BALB C; Microbial Sensitivity Tests; Promoter Regions, Genetic; Small Molecule Libraries; Survival Analysis | 2021 |
Antiseptic 9-Meric Peptide with Potency against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents, Local; Biofilms; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Peptides | 2021 |
National trends in hospital, long-term care and outpatient
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Long-Term Care; Outpatients; United States | 2021 |
Impact of carbapenem-resistant Acinetobacter baumannii infections on acute pancreatitis patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pancreatitis; Retrospective Studies | 2022 |
Reduction in the acquisition rate of carbapenem-resistant Acinetobacter baumannii (CRAB) after room privatization in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Intensive Care Units; Privatization | 2022 |
[Risk factors of carbapenem resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Female; Humans; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Risk Factors | 2021 |
[Long course of polymyxin B for the treatment of brain abscess caused by carbapenem resistant Acinetobacter baumannii: a case report].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brain Abscess; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B | 2021 |
Burden of illness in carbapenem-resistant Acinetobacter baumannii infections in US hospitals between 2014 and 2019.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Cost of Illness; Cross Infection; Hospitals; Humans; Intensive Care Units; Retrospective Studies | 2022 |
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; COVID-19; Drug Resistance, Multiple, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Pandemics; Pneumonia, Ventilator-Associated; Tetracycline; Tigecycline; Zinc | 2022 |
Variants of Tn
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genome, Bacterial; Macrolides; Meropenem; Phylogeny; Sequence Alignment | 2022 |
Interbacterial Transfer of Carbapenem Resistance and Large Antibiotic Resistance Islands by Natural Transformation in Pathogenic Acinetobacter.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests | 2022 |
Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2022 |
Origin of the oxa235 carbapenem resistance gene found in transposon Tn6252.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests | 2022 |
Diversity of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa, Northern; Anti-Bacterial Agents; Bacterial Proteins; Bacteriophages; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Middle East; Molecular Epidemiology; Multilocus Sequence Typing; Whole Genome Sequencing | 2022 |
Azithromycin effect on multidrug resistant Acinetobacter baumannii biofilm production and composition.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Azithromycin; Biofilms; Carbapenems; Humans | 2021 |
Comparison of the outer membrane proteomes between clinical carbapenem-resistant and -susceptible Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Porins; Proteome | 2022 |
Antimicrobial Activity of a Repurposed Harmine-Derived Compound on Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Harmine; Humans; Microbial Sensitivity Tests | 2021 |
Spread of multidrug-resistant Acinetobacter baumannii isolates belonging to IC1 and IC5 major clones in Rondônia state.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteriophages; Biofilms; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Phage Therapy; Podoviridae | 2022 |
Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; COVID-19; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units | 2022 |
Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aerosols; Anti-Bacterial Agents; Bacteriophages; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prospective Studies | 2022 |
In a Pinch: Cefiderocol for CRAB Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
In vitro activity of nitroxoline against carbapenem-resistant Acinetobacter baumannii isolated from the urinary tract.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Escherichia coli; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Nitroquinolines; Sulfamethoxazole; Trimethoprim; Urinary Tract; Urinary Tract Infections | 2022 |
Rate and Risk Factors for Carbapenem Resistant Acinetobacter baumannii Clinical Infections in Colonized Patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Retrospective Studies; Risk Factors | 2022 |
High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2022 |
In vitro synergistic antimicrobial activity of a combination of meropenem, colistin, tigecycline, rifampin, and ceftolozane/tazobactam against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Combinations; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Rifampin; Tazobactam; Tigecycline | 2022 |
The Impact of Natural Transformation on the Acquisition of Antibiotic Resistance Determinants.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies | 2022 |
Genomic surveillance uncovers ongoing transmission of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies | 2023 |
In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Azabicyclo Compounds; Carbapenems; Drug Combinations; Humans; Microbial Sensitivity Tests; Sulbactam | 2022 |
Auranofin promotes antibacterial effect of doripenem against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Auranofin; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests | 2022 |
Origin, Phylogeny, and Transmission of the Epidemic Clone ST208 of Carbapenem-Resistant Acinetobacter baumannii on a Global Scale.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Humans; Microbial Sensitivity Tests; Phylogeny | 2022 |
The susceptibility pattern and distribution of blaOXA-23 genes of clinical isolate Acinetobacter baumannii in a tertiary hospital, Indonesia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Indonesia; Microbial Sensitivity Tests; Tertiary Care Centers | 2022 |
Comparing core-genome MLST with PFGE and MLST for cluster analysis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny | 2022 |
Investigating Biofilm Formation and Antibiofilm Activity Using Real Time Cell Analysis Method in Carbapenem Resistant Acinetobacter baumannii Strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Carbapenems; Humans; Microbial Sensitivity Tests | 2022 |
3-indoleacetonitrile attenuates biofilm formation and enhances sensitivity to imipenem in Acinetobacter baumannii.
Topics: Acetonitriles; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests | 2022 |
Description of a Rare Pyomelanin-Producing Carbapenem-Resistant Acinetobacter baumannii Strain Coharboring Chromosomal OXA-23 and NDM-1.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Chromosomes; Disinfectants; Humans; Melanins; Microbial Sensitivity Tests | 2022 |
A Novel Triple Combination To Combat Serious Infections with Carbapenem-Resistant Acinetobacter baumannii in a Mouse Pneumonia Model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Ascorbic Acid; Biological Factors; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Inflammation; Mice; Microbial Sensitivity Tests; Pneumonia; Transferrins | 2022 |
Risk factors for early mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteraemia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Microbial Sensitivity Tests; Risk Factors | 2022 |
Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; New Zealand; Phylogeny | 2022 |
Lipocalin-2 is an essential component of the innate immune response to Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacteremia; Carbapenems; COVID-19; Humans; Immunity, Innate; Iron; Lipocalin-2; Mice; Pandemics; Pneumonia, Bacterial; Siderophores | 2022 |
Extensively drug-resistant Acinetobacter baumannii co-producing VIM-2 and OXA-23 in intensive care units: Results of a one-day point prevalence in a Tunisian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prevalence | 2022 |
Genomic Analysis of Carbapenem-Resistant Acinetobacter baumannii Strains Recovered from Chilean Hospitals Reveals Lineages Specific to South America and Multiple Routes for Acquisition of Antibiotic Resistance Genes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Chile; Drug Resistance, Microbial; Genomics; Hospitals; Humans; Microbial Sensitivity Tests; Phylogeny | 2022 |
Preferential Selection of Low-Frequency, Lipopolysaccharide-Modified, Colistin-Resistant Mutants with a Combination of Antimicrobials in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Colistin; Disinfectants; Drug Resistance, Multiple, Bacterial; Humans; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests | 2022 |
Biofilm formation is not an independent risk factor for mortality in patients with
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Biofilms; Carbapenems; Heart Failure; Humans; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors | 2022 |
Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline | 2022 |
In vitro and in vivo efficacy of cefiderocol plus tigecycline, colistin, or meropenem against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Tigecycline | 2022 |
Whole-cell vaccine candidates induce a protective response against virulent
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Mice; Sulbactam | 2022 |
Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pneumonia; Retrospective Studies; Sulbactam; Tigecycline | 2022 |
Outpatient Clonal Propagation and Rapid Regional Establishment of an Emergent Carbapenem-Resistant Acinetobacter baumannnii Lineage Sequence Type 499Pas.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Outpatients | 2023 |
Insight into carbapenem resistance and virulence of Acinetobacter baumannii from a children's medical centre in eastern China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Retrospective Studies; Tetracyclines; Virulence | 2022 |
Rhamnetin, a Natural Flavonoid, Ameliorates Organ Damage in a Mouse Model of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carbapenems; Disease Models, Animal; Escherichia coli; Flavonoids; Mice; Microbial Sensitivity Tests; Sepsis | 2022 |
Risk Factors for 30-Day Mortality in Neonates With Carbapenem-resistant A. baumannii Sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Infant, Newborn; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Sepsis; Thrombocytopenia | 2022 |
Antimicrobial Susceptibility Testing Performed in RPMI 1640 Reveals Azithromycin Efficacy against Carbapenem-Resistant Acinetobacter baumannii and Predicts
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Azithromycin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Moths | 2023 |
The prevalence, presentation and outcome of colistin susceptible-only Acinetobacter Baumannii-associated pneumonia in intensive care unit: a multicenter observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Susceptibility; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Prevalence; Renal Dialysis; Retrospective Studies | 2023 |
Detection and homology analysis of carbapenem resistant Acinetobacter baumannii resistance gene.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans | 2022 |
Incidence, mortality, and risk factors associated with carbapenem-resistant Acinetobacter baumannii bacteremia within 30 days after liver transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Humans; Incidence; Liver Transplantation; Risk Factors | 2023 |
Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; COVID-19; Drug Combinations; Drug Synergism; Humans; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Europe; Humans | 2023 |
Evaluation of combination therapies with colistin in an experimental mouse pneumonia model induced by carbapenem-resistant Acinetobacter baumannii strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Imipenem; Mice; Microbial Sensitivity Tests; Sulbactam; Tigecycline | 2023 |
Carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Infection Control; Microbial Sensitivity Tests | 2023 |
Meropenem in combination with baicalein exhibits synergism against extensively drug resistant and pan-drug-resistant Acinetobacter baumannii clinical isolates in vitro.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests | 2023 |
Sulbactam-durlobactam: A Step Forward in Treating Carbapenem-Resistant Acinetobacter baumannii (CRAB) Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Sulbactam | 2023 |
Prevalence and Clinical Consequences of Colistin Heteroresistance and Evolution into Full Resistance in Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Prevalence | 2023 |
Oral doxycycline to carbapenem-resistant Acinetobacter baumannii infection as a polymyxin-sparing strategy: results from a retrospective cohort.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doxycycline; Humans; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies | 2023 |
Short versus long course of colistin treatment for carbapenem-resistant A. baumannii in critically ill patients: A propensity score matching study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Humans; Propensity Score; Retrospective Studies | 2023 |
Outcome of patients with carbapenem-resistant Acinetobacter baumannii infections treated with cefiderocol: A multicenter observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Female; Humans; Male; Prospective Studies; Retrospective Studies | 2023 |
Induced Heteroresistance in Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefiderocol; Humans; Iron; Microbial Sensitivity Tests | 2023 |
Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Topics: Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefiderocol; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Male; Retrospective Studies | 2023 |
The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Fosfomycin; Interleukin-6; Mesenchymal Stem Cells; Mice; Microbial Sensitivity Tests; Sepsis | 2023 |
Clinical impact of COVID-19 in patients with carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; COVID-19; Humans; Retrospective Studies | 2023 |
Prevalence of Acinetobacter baumannii and Candida auris in Patients Receiving Mechanical Ventilation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Candida auris; Candidiasis; Carbapenems; Cross-Sectional Studies; Drug Resistance, Microbial; Health Facilities; Humans; Maryland; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Respiration, Artificial | 2023 |
Colistin-induced structural and biochemical changes in carbapenem-resistant Acinetobacter baumannii isolated from the hospital environment.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests | 2023 |
Prevalence of carbapenem resistance in Acinetobacter baumannii and Pseudomonas aeruginosa in sub-Saharan Africa: A systematic review and meta-analysis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa South of the Sahara; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Meta-Analysis as Topic; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Systematic Reviews as Topic | 2023 |
Incidence of infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Cross Infection; Female; Hospitals, University; Humans; Incidence; Inpatients; Male; Middle Aged; Prevalence; Retrospective Studies; Risk Factors; Survival Analysis; Young Adult | 2019 |
Clonal relatedness and resistance characteristics of OXA-24 and -58 producing carbapenem-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Microbial Sensitivity Tests | 2019 |
Trends in resistant Enterobacteriaceae and Acinetobacter species in hospitalized patients in the United States: 2013-2017.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Microbial Sensitivity Tests; Retrospective Studies; United States | 2019 |
Diabetic status and the relationship of blood glucose to mortality in adults with carbapenem-resistant Acinetobacter baumannii complex bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Glucose; Carbapenems; Diabetes Complications; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Taiwan | 2019 |
Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Germany; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing | 2019 |
Molecular characterization of clinical and environmental carbapenem resistant Acinetobacter baumannii isolates in a hospital of the Eastern Region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Genes, Bacterial; Humans; Male; Phylogeny; Saudi Arabia | 2020 |
Rare purulent pericarditis caused by carbapenem-resistant Acinetobacter baumannii: A case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Kidney Injury; Aged; Carbapenems; Diagnosis, Differential; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Non-ST Elevated Myocardial Infarction; Pericardiocentesis; Pericarditis; Tomography, X-Ray Computed | 2019 |
Multiple sequence types responsible for healthcare-associated Acinetobacter baumannii dissemination in a single centre in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Cancer Care Facilities; Carbapenems; Drug Resistance, Multiple, Bacterial; Egypt; Female; Genes, Bacterial; Genotype; Health Personnel; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2019 |
Extensively drug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomics; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Multilocus Sequence Typing; Retrospective Studies; Whole Genome Sequencing | 2019 |
Antimicrobial Susceptibility and Molecular Characterization of Carbapenemase-Producing
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Enterobacter; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Serbia | 2020 |
Molecular characteristics of carbapenem-resistant Acinetobacter spp. from clinical infection samples and fecal survey samples in Southern China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Colistin; Communicable Diseases; Drug Resistance, Bacterial; Feces; Genetic Variation; Genotype; Humans; Integrons; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2019 |
Comparison of clinical and sewage isolates of Acinetobacter baumannii from two long-term care facilities in Zagreb; mechanisms and routes of spread.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Croatia; Genotype; Humans; Long-Term Care; Microbial Sensitivity Tests; Multilocus Sequence Typing; Sewage | 2020 |
Emergence of colistin and carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii (CCR-Acb) complex in a neurological intensive care unit followed by successful control of the outbreak.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aged; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests | 2020 |
Emergence of Carbapenem-Hydrolyzing Oxacillinases in Acinetobacter baumannii in Children from Croatia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Croatia; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Hydrolysis; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2019 |
Acinetobacter Infections.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Colistin; Humans; Treatment Outcome | 2020 |
In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline | 2019 |
Heteroresistance to colistin in oxacillinase-producing carbapenem-resistant Acinetobacter baumannii clinical isolates from Gorgan, Northern Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Humans; Iran | 2020 |
Identification of Acinetobacter baumannii and its carbapenem-resistant gene bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Biosensing Techniques; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Limit of Detection; Nucleic Acid Amplification Techniques | 2019 |
In vitro interactions of ambroxol hydrochloride or amlodipine in combination with antibacterial agents against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ambroxol; Amlodipine; Anti-Bacterial Agents; Carbapenems; Cefoperazone; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2020 |
Prevalence of carbapenem-hydrolyzing OXA-type β-lactamases among Acinetobacter baumannii in patients with severe urinary tract infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Hydrolysis; India; Microbial Sensitivity Tests; Plasmids; Prevalence; Severity of Illness Index; Urinary Tract Infections | 2019 |
Phenotypic and genotypic characterization of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Egypt; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Prevalence | 2019 |
Molecular Surveillance of Multidrug-Resistant Acinetobacter baumannii.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Humans; Microbial Sensitivity Tests | 2020 |
Insertion sequences and sequence types profile of clinical isolates of carbapenem-resistant A. baumannii collected across India over four year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Imipenem; India; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction | 2020 |
Faucet aerators as a reservoir for Carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drinking Water; Drug Resistance, Bacterial; Fomites; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Neurosurgery; Trachea; Water Supply | 2019 |
Origin of OXA-23 Variant OXA-239 from a Recently Emerged Lineage of Acinetobacter baumannii International Clone V.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Genomics; Honduras; Humans; Mexico; Microbial Sensitivity Tests | 2020 |
The clinical profile and outcomes of adult patients given intravenous colistin for multidrug-resistant gram negative infections in a Philippine tertiary hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Hospitalization; Humans; Male; Meropenem; Middle Aged; Organ Dysfunction Scores; Philippines; Respiratory Tract Infections; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Young Adult | 2020 |
Dissemination of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Clone Cells; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pakistan | 2020 |
β-lactamase genes in carbapenem resistance Acinetobacter baumannii isolates from a Turkish university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals, University; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Turkey | 2019 |
Donor-derived transmission through lung transplantation of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 carbapenemase during an ongoing healthcare facility outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Health Facilities; Humans; Lung Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Sputum; Tissue Donors | 2020 |
Molecular mechanisms of antibiotic co-resistance among carbapenem resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Pakistan; Tertiary Care Centers; Tigecycline | 2019 |
Using comparative genomics to understand molecular features of carbapenem-resistant Acinetobacter baumannii from South Korea causing invasive infections and their clinical implications.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Genomics; Humans; Male; Middle Aged; Multilocus Sequence Typing; Republic of Korea; Virulence Factors | 2020 |
Community-acquired in name only: A cluster of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Boston; Burn Units; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Tertiary Care Centers | 2020 |
Distinct Mechanisms of Dissemination of NDM-1 Metallo-β-Lactamase in
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; beta-Lactamases; Carbapenems; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids | 2020 |
Trends in microbial profile of burn patients following an event of dust explosion at a tertiary medical center.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Blast Injuries; Body Surface Area; Burns, Inhalation; Carbapenems; Drug Resistance, Multiple, Bacterial; Dust; Explosions; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Retrospective Studies; Staphylococcal Infections; Tertiary Care Centers; Time Factors; Young Adult | 2020 |
Intervention to reduce carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Microbial Sensitivity Tests | 2020 |
Genomic and Clinical Characterization of IMP-1-Producing Multidrug-Resistant
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Integrons; Microbial Sensitivity Tests; Sepsis; Tertiary Care Centers | 2020 |
Tigecycline susceptibility of multidrug-resistant Acinetobacter baumannii from intensive care units in the western Balkans.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Balkan Peninsula; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Intensive Care Units; Microbial Sensitivity Tests; Tigecycline | 2020 |
In vitro activity of colistin against multidrug-resistant Acinetobacter baumannii isolates harboring blaOXA-23-like and blaOXA-24-like genes: A multicenter based study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Prevalence; Young Adult | 2020 |
Multidrug-resistant Acinetobacter baumannii: differential adherence to HEp-2 and A-549 cells.
Topics: A549 Cells; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Adhesion; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Multiple, Bacterial; Epithelial Cells; Genetic Variation; Humans; Microbial Sensitivity Tests | 2020 |
Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii-Insight from in silico modelling and in vitro investigations.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Computer Simulation; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Estriol; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Targeted Therapy; Rec A Recombinases | 2020 |
Healthcare-associated carbapenem-resistant OXA-72-producing Acinetobacter baumannii of the clonal complex CC79 colonizing migratory and captive aquatic birds in a Brazilian Zoo.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Birds; Brazil; Carbapenems; Drug Resistance, Bacterial; Humans; Macrolides; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2020 |
Extensively Drug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cats; Drug Resistance, Multiple, Bacterial; Female; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pakistan; Urinary Tract Infections | 2020 |
Direct Detection and Discrimination of Carbapenemases of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacteriological Techniques; beta-Lactamases; Carbapenems; Genotype; Humans; Microbial Sensitivity Tests; Phenotype; Sensitivity and Specificity; Trachea | 2020 |
Distribution of Carbapenemases and Efflux Pump in Carbapenem-resistance
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes' by Nutman et al.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2020 |
Antimicrobial resistance patterns of Acinetobacter spp. of animal origin reveal high rate of multidrug resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Cats; Cattle; Dogs; Drug Resistance, Multiple, Bacterial; Horses; Microbial Sensitivity Tests | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant gram-negative infections: in vitro synergism is not associated with better clinical outcomes'-Author's reply.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2020 |
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Associated with Nosocomial Infection in the Pelotas, RS, Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests | 2020 |
The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Kidney; Kidney Diseases; Male; Meropenem; Middle Aged; Retrospective Studies; Thailand | 2020 |
Pathogenic spectrum of blood stream infections and resistance pattern in Gram-negative bacteria from Aljouf region of Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross-Sectional Studies; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2020 |
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Sulbactam | 2020 |
Development of a LAMP method for detection of carbapenem-resistant Acinetobacter baumannii during a hospital outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals; Humans; Mexico; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Nucleic Acid Amplification Techniques; Predictive Value of Tests; Sensitivity and Specificity | 2020 |
Control of a hospital-wide outbreak of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross Infection; Disease Outbreaks; Hospitals; Humans; Infection Control | 2020 |
The epidemiology of carbapenem-non-susceptible Acinetobacter species in Europe: analysis of EARS-Net data from 2013 to 2017.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Europe; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2020 |
Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; China; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Respiratory Tract Infections; Risk Factors | 2020 |
Detecting carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests | 2020 |
Implementation and evaluation of methods for the optimal detection of carbapenem-resistant and colistin-resistant Pseudomonas aeruginosa and Acinetobacter baumannii from stools.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Culture Media; Drug Resistance, Multiple, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity | 2020 |
Drug resistance of healthcare-associated pathogenic bacteria and carbapenem-resistant Acinetobacter baumannii homology in the general intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; China; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Retrospective Studies | 2020 |
Genomic features of a carbapenem-resistant OXA-219-positive Acinetobacter baumannii of international ST15 (CC15) from a patient with community-onset urinary tract infection in Chilean Patagonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Chile; Genomics; Humans; Multilocus Sequence Typing; Urinary Tract Infections | 2020 |
A Diverse Panel of Clinical Acinetobacter baumannii for Research and Development.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Research | 2020 |
Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxins; Sulbactam | 2020 |
Antimicrobial action of 1,10-phenanthroline-based compounds on carbapenemase-producing Acinetobacter baumannii clinical strains: efficacy against planktonic- and biofilm-growing cells.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Copper; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Phenanthrolines; Silver | 2020 |
Ventilator-associated pneumonia (VAP) caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19: Two problems, one solution?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Coinfection; Colistin; COVID-19; Drug Resistance, Bacterial; Humans; Models, Theoretical; Pneumonia, Ventilator-Associated | 2020 |
Re: 'Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes' by Nutman et al.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Humans; Meropenem | 2021 |
Extensively drug-resistant Acinetobacter baumannii carrying bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Humans; Intensive Care Units; Spain; Tertiary Care Centers | 2021 |
Risk factor for intestinal carriage of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Humans; Intensive Care Units; Pancreatitis; Retrospective Studies; Risk Factors | 2020 |
Characterization of carbapenem-resistant hypervirulent Acinetobacter baumannii strains isolated from hospitalized patients in the mid-south region of China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Child; China; Disease Models, Animal; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Middle Aged; Moths; Phylogeny; Virulence; Young Adult | 2020 |
PmrB mutations including a novel 10-amino acid repeat sequence insertion associated with low-level colistin resistance in carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Colistin; Drug Resistance, Bacterial; Genome, Bacterial; Genomics; Microbial Sensitivity Tests; Mutagenesis, Insertional; Transcription Factors | 2020 |
High prevalence of carbapenem-resistant Acinetobacter baumannii associated respiratory tract infections in Pakistani hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Hospitals; Humans; Microbial Sensitivity Tests; Pakistan; Prevalence; Respiratory Tract Infections | 2020 |
Genetic Diversity of OXA-like Genes in Multidrug-Resistant Acinetobacter baumannii Strains from ICUs.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Genetic Variation; Humans; Intensive Care Units; Microbial Sensitivity Tests; Turkey | 2020 |
The success of particular Acinetobacter baumannii clones: accumulating resistance and virulence inside a sugary shield.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Portugal; Sugars; Virulence | 2021 |
Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Jordan; Microbial Sensitivity Tests; Retrospective Studies | 2021 |
Epidemiological situation, laboratory capacity and preparedness for carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Bacterial; Europe; Humans; Laboratories | 2020 |
Investigation of an XDR-
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Lebanon; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Tertiary Care Centers | 2020 |
Infection control response to an outbreak of OXA-23 carbapenemase-producing carbapenem-resistant Acinetobacter baumannii in a skilled nursing facility in Utah.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Humans; Infection Control; Microbial Sensitivity Tests; Skilled Nursing Facilities; Utah | 2021 |
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii Blood Culture Isolates from Three Hospitals in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenems; Drug Resistance, Bacterial; Genetic Variation; Hospitals, University; Humans; Multilocus Sequence Typing; Turkey | 2021 |
Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; COVID-19; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; New Jersey; Patient Admission | 2020 |
Detection of OXA-23, GES-11 and NDM-1 among carbapenem-resistant Acinetobacter baumannii in Dubai: A preliminary study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Humans | 2021 |
Silent mutations in ribosomal protein genes are associated with high-risk clones of carbapenem-resistant Acinetobacter baumannii prevalent in Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ribosomal Proteins; Silent Mutation; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Whole Genome Sequencing | 2021 |
Performance of VITEK 2, E-test, Kirby-Bauer disk diffusion, and modified Kirby-Bauer disk diffusion compared to reference broth microdilution for testing tigecycline susceptibility of carbapenem-resistant K. pneumoniae and A. baumannii in a multicenter st
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; China; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tigecycline | 2021 |
The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment Contamination; Female; Genetic Carrier Screening; Humans; Inpatients; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed | 2021 |
Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Physiological; Anti-Bacterial Agents; Carbapenems; Catheters; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Phenotype; Piperacillin; Sputum; Tennessee; Urine; Wounds and Injuries | 2021 |
Associated factors of Acinetobacter baumannii complex in hospitalized patients: A case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Case-Control Studies; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Risk Factors; Young Adult | 2021 |
What is the optimal antibiotic treatment strategy for carbapenem-resistant Acinetobacter baumannii (CRAB)? A multicentre study in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Republic of Korea; Retrospective Studies | 2021 |
Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Aspirin; Carbapenems; COVID-19; COVID-19 Drug Treatment; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Middle Aged; Opportunistic Infections; Piperacillin, Tazobactam Drug Combination; Pneumonia; Retrospective Studies; SARS-CoV-2; Steroids; Survival Analysis; Treatment Outcome | 2021 |
Molecular characterization and antibiotic resistance of Acinetobacter baumannii in cerebrospinal fluid and blood.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood; Carbapenems; Cerebrospinal Fluid; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests | 2021 |
The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014-2018): an analysis of data from the national Antimicrobial Resistance Surveillance system.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Germany; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2021 |
Clinical Experience of Personalized Phage Therapy Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Lung; Male; Microbial Sensitivity Tests; Phage Therapy; Pneumonia; Pulmonary Disease, Chronic Obstructive | 2021 |
Molecular Epidemiology and Clone Transmission of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Clone Cells; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny | 2021 |
Adaptations of carbapenem resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Physiological; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Environmental Microbiology; Female; Genes, Bacterial; Humans; Imipenem; Integrons; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors; Virulence | 2021 |
Predominance of international clone 2 multidrug-resistant Acinetobacter baumannii clinical isolates in Thailand: a nationwide study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Clone Cells; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Thailand | 2021 |
Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Greece; Humans; Israel; Italy; Logistic Models; Male; Meropenem; Middle Aged; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Identification of potential therapeutic antimicrobial peptides against Acinetobacter baumannii in a mouse model of pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Chemistry, Pharmaceutical; Disease Models, Animal; Drug Design; Drug Resistance, Multiple, Bacterial; Hemolysis; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Pneumonia; Pore Forming Cytotoxic Proteins; Stem Cells | 2021 |
Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Humans; Italy; Male; Middle Aged; Multivariate Analysis; Rectum; Retrospective Studies; Risk Factors; Tertiary Care Centers; Young Adult | 2021 |
A comprehensive approach to ending an outbreak of rare bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hospitals, Community; Humans; Kansas; Microbial Sensitivity Tests | 2021 |
A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Biofilms; Carbapenems; Chlorocebus aethiops; Drug Resistance, Bacterial; Drug Stability; Drug Synergism; Female; Humans; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peptides; Pneumonia, Bacterial; Spider Venoms; Vero Cells | 2021 |
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Mice; Microbial Sensitivity Tests; Treatment Failure | 2022 |
Surveillance cultures following a regional outbreak of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests | 2022 |
Clonal change of carbapenem-resistant Acinetobacter baumannii isolates in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Republic of Korea | 2021 |
Wall painting following terminal cleaning with a chlorine solution as part of an intervention to control an outbreak of carbapenem-resistant Acinetobacter baumannii in a neurosurgical intensive care unit in Israel.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Chlorine; Cross Infection; Disease Outbreaks; Humans; Intensive Care Units; Israel | 2021 |
Diversity of Sequence Types and Impact of Fitness Cost among Carbapenem-Resistant Acinetobacter baumannii Isolates from Tripoli, Libya.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Libya; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2021 |
Identification and characterization of the type II toxin-antitoxin systems in the carbapenem-resistant Acinetobacterbaumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Microbial Sensitivity Tests; Toxin-Antitoxin Systems | 2021 |
Molecular characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates from Egyptian patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Humans; Microbial Sensitivity Tests | 2021 |
Does enhanced environmental cleaning reduce carbapenem-resistant Acinetobacter baumannii colonization in the intensive care unit?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Intensive Care Units | 2021 |
Rapid typing of carbapenem-resistant
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Polymerase Chain Reaction; Taiwan | 2021 |
Epidemiological and genomic characteristics of Acinetobacter baumannii from different infection sites using comparative genomics.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Communicable Diseases; Drug Resistance, Multiple, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny | 2021 |
Acinetobacter baumannii strains isolated from cerebrospinal fluid (CSF) and bloodstream analysed by cgMLST: the dominance of clonal complex CC92 in CSF infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
A four-year follow-up survey of antimicrobial resistance among Acinetobacter baumannii complex from inpatients in Southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Follow-Up Studies; Humans; Inpatients; Microbial Sensitivity Tests | 2021 |
Decreasing incidence of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Incidence; Pneumonia, Bacterial; Quinolones; Retrospective Studies; Vancomycin | 2022 |
A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Antimicrobial Stewardship; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hand Hygiene; Hand Sanitizers; Hospitals, University; Humans; Infection Control; Intensive Care Units; Italy; Tertiary Care Centers; Whole Genome Sequencing | 2021 |
Case Commentary: Uncertainty in Evaluating Treatment Outcomes in Carbapenem-Resistant Acinetobacter baumannii Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Humans; Microbial Sensitivity Tests; Treatment Outcome; Uncertainty | 2021 |
WCK 4234, a novel diazabicyclooctane potentiating carbapenems against Enterobacteriaceae, Pseudomonas and Acinetobacter with class A, C and D β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Cyclooctanes; Drug Discovery; Drug Resistance, Multiple, Bacterial; Drug Synergism; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2017 |
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxin B; Thienamycins | 2017 |
GES-14-Producing Acinetobacter baumannii Isolates in a Neonatal Intensive Care Unit in Tunisia Are Associated with a Typical Middle East Clone and a Transferable Plasmid.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Intensive Care Units, Neonatal; Plasmids; Sequence Analysis, DNA; Tunisia | 2017 |
Repeated local emergence of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Bacterial; Evolution, Molecular; Genes, Bacterial; Genetic Variation; Genome, Bacterial; Humans; Phylogeny; Pneumonia, Ventilator-Associated; Recombination, Genetic; Vietnam; Whole Genome Sequencing | 2016 |
Epidemiological, Physiological, and Molecular Characteristics of a Brazilian Collection of Carbapenem-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Biofilms; Brazil; Carbapenems; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Gene Expression; Genes, MDR; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Oxidative Stress; Porins; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
Emergence of carbapenemase-producing Acinetobacter ursingii in The Netherlands.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Netherlands; Sequence Analysis, DNA | 2017 |
Problems with the Oxford Multilocus Sequence Typing Scheme for Acinetobacter baumannii: Do Sequence Type 92 (ST92) and ST109 Exist?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Humans; Multilocus Sequence Typing | 2017 |
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Female; Genes, Bacterial; Humans; Lebanon; Male; Microbial Sensitivity Tests | 2017 |
Carbapenem resistant Acinetobacter spp restricted the Therapeutic alternatives.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Pakistan | 2017 |
Evaluation of two automated systems for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Automation; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Greece; Humans; Microbial Sensitivity Tests; Tertiary Care Centers | 2017 |
A cold hard menace: A contaminated ice machine as a potential source for transmission of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Reservoirs; Equipment Contamination; Humans; Ice; Refrigeration | 2017 |
Transdermally administered proline-arginine-rich host defense peptides show systemic efficacy in a lethal mouse bacteremia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Cutaneous; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Arginine; Bacteremia; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Ear; Humans; Mice; Proline; Skin; Survival Analysis | 2017 |
ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Dogs; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Mice; Models, Molecular; Penicillin-Binding Proteins; Rats; Sulbactam | 2017 |
Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Comorbidity; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome | 2017 |
Bloodstream infections caused by Acinetobacter species with reduced susceptibility to tigecycline: clinical features and risk factors.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Disease Susceptibility; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Male; Middle Aged; Minocycline; Risk Factors; Tigecycline | 2017 |
Should we treat patients with only one set of positive blood cultures for extensively drug-resistant Acinetobacter baumannii the same as multiple sets?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Leukopenia; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Severity of Illness Index; Survival Analysis; Thrombocytopenia | 2017 |
Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Actinidia; Alkaloids; Amyloidogenic Proteins; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Carbapenems; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Flavonoids; Microbial Sensitivity Tests; Phytochemicals; Plant Extracts; Polysaccharides, Bacterial; Secondary Metabolism; Syzygium | 2017 |
Isolation and Whole-genome Sequence Analysis of the Imipenem Heteroresistant Acinetobacter baumannii Clinical Isolate HRAB-85.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genome, Bacterial; Genomic Islands; Humans; Imipenem; Multilocus Sequence Typing; Whole Genome Sequencing | 2017 |
Emergence of carbapenem-resistant Acinetobacter baumannii ST787 in clinical isolates from blood in a tertiary teaching hospital in Northern Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction; Taiwan; Tertiary Care Centers | 2017 |
The role of conserved surface hydrophobic residues in the carbapenemase activity of the class D β-lactamases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Crystallography, X-Ray; Humans; Hydrophobic and Hydrophilic Interactions; Molecular Docking Simulation; Protein Conformation | 2017 |
Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in a Tertiary Care Hospital in Egypt: Clonal Spread of blaOXA-23.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Cross Infection; Drug Resistance, Multiple, Bacterial; Egypt; Female; Gene Expression; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Tertiary Care Centers | 2018 |
Virulence profiles and innate immune responses against highly lethal, multidrug-resistant nosocomial isolates of Acinetobacter baumannii from a tertiary care hospital in Mexico.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Immunity, Innate; Mexico; Microbial Sensitivity Tests; Tertiary Care Centers; Tumor Necrosis Factor-alpha; Virulence | 2017 |
The difference in medical costs between carbapenem-resistant Acinetobacter baumannii and non-resistant groups: a case study from a hospital in Zhejiang province, China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Female; Hospital Costs; Hospitals; Humans; Male; Middle Aged; Retrospective Studies | 2017 |
Acquisition and clearance of multidrug resistant Acinetobacter baumannii on healthy young adults concurrently burned in a dust explosion in Taiwan: the implication for antimicrobial stewardship.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Burns; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Dust; Explosions; Female; Humans; Intensive Care Units; Male; Retrospective Studies; Taiwan; Young Adult | 2017 |
High prevalence of OXA-type carbapenemases among Acinetobacter baumannii strains in a teaching hospital of Tehran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Humans; Iran; Microbial Sensitivity Tests; Prevalence | 2017 |
Infection control interventions affected by resource shortages: impact on the incidence of bacteremias caused by carbapenem-resistant pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Germany; Humans; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers | 2018 |
Tn2008-driven carbapenem resistance in Acinetobacter baumannii isolates from a period of increased incidence of infections in a Southwest Virginia hospital (USA).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Humans; Incidence; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Tertiary Care Centers; Virginia | 2018 |
Detection of OXA-58-Producing Acinetobacter seifertii Recovered from a Black-Necked Swan at a Zoo Lake.
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anseriformes; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Lakes; Microbial Sensitivity Tests | 2017 |
Carbapenemases among Acinetobacter species isolated from NICU of a tertairy care hospital in Karachi.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests | 2017 |
A large plasmid, pD46-4, carrying a complex resistance region in an extensively antibiotic-resistant ST25 Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Australia; Carbapenems; Conjugation, Genetic; Drug Resistance, Bacterial; Genes, Bacterial; Multigene Family; Plasmids | 2017 |
Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
Topics: Academic Medical Centers; Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Centers for Disease Control and Prevention, U.S.; Drug Resistance, Microbial; Humans; Imipenem; Maryland; Meropenem; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; ROC Curve; Sensitivity and Specificity; Thienamycins; United States | 2017 |
The combined use of tigecycline with high-dose colistin might not be associated with higher survival in critically ill patients with bacteraemia due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Cohort Studies; Colistin; Critical Illness; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Propensity Score; Survival Analysis; Tigecycline; Treatment Outcome | 2018 |
Emergence of ISAba1 harboring carbapenem-resistant Acinetobacter baumannii isolates in Pakistan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Antigens, Bacterial; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Humans; Pakistan; Tertiary Care Centers | 2017 |
[Efficacy of extended-infusion of carbapenem plus sulbactam for ventilator-associated pneumonia caused by extensive drug-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam | 2017 |
Uncommon carbapenemase-encoding plasmids in the clinically emergent Acinetobacter pittii.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Plasmids; Portugal; Sequence Analysis, DNA | 2018 |
The blaOXA-23-associated transposons in the genome of Acinetobacter spp. represent an epidemiological situation of the species encountering carbapenems.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Republic of Korea | 2017 |
Clonal spread of carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Disease Transmission, Infectious; Female; Humans; Infant, Newborn; Infection Control; Intensive Care Units, Neonatal; Male; Molecular Typing | 2018 |
Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; beta-Lactam Resistance; Carbapenems; Coinfection; Critical Illness; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Severity of Illness Index; Taiwan; Treatment Failure; Treatment Outcome | 2018 |
Acinetobacter
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cats; Dogs; Drug Resistance, Bacterial; Horses; Pets; Plasmids; Rabbits | 2018 |
Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals; Humans; Integrons; Interspersed Repetitive Sequences; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phenotype; Philadelphia; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic | 2017 |
Management of carbapenem-resistant Acinetobacter baumannii epidemic in an intensive care unit using multifaceted intervention strategy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Republic of Korea; Retrospective Studies | 2018 |
Distribution and Molecular Characterization of Acinetobacter baumannii International Clone II Lineage in Japan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology | 2018 |
Outcomes of adjunctive therapy with intrathecal or intraventricular administration of colistin for post-neurosurgical meningitis and ventriculitis due to carbapenem-resistant acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Anti-Bacterial Agents; Blood-Brain Barrier; Carbapenems; Cerebral Ventriculitis; Colistin; Female; Humans; Injections, Intraventricular; Injections, Spinal; Male; Meningitis, Bacterial; Middle Aged; Retrospective Studies; Surgical Wound Infection | 2018 |
Triton X-100 and Increased Volume of Test Bacteria in the Carbapenem Inactivation Method Enhanced the Detection of Carbapenemase-Producing Acinetobacter baumannii Complex Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Octoxynol; Sensitivity and Specificity | 2018 |
Extensively drug-resistant ArmA-producing Acinetobacter baumannii in an Italian intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests | 2018 |
Endemic carbapenem-nonsusceptible
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Female; Health Personnel; Humans; Indonesia; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Prevalence; Prospective Studies; Referral and Consultation; Retrospective Studies | 2018 |
Comparative Evaluation of Broth Microdilution with Polystyrene and Glass-Coated Plates, Agar Dilution, E-Test, Vitek, and Disk Diffusion for Susceptibility Testing of Colistin and Polymyxin B on Carbapenem-Resistant Clinical Isolates of Acinetobacter baum
Topics: Acinetobacter baumannii; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B; Polystyrenes; Reproducibility of Results | 2018 |
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand | 2018 |
Extensively drug-resistant Acinetobacter baumannii bacteraemia in a multidisciplinary intensive care unit during a 6-year period: Risk factors for fulminant sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Kidney Failure, Chronic; Male; Middle Aged; Retrospective Studies; Risk Factors; Sepsis | 2018 |
High Prevalence of Extensively Drug-resistant Acinetobacter baumannii at a Children Hospital in Bolivia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Biofilms; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Prevalence | 2018 |
Transmission and survival of carbapenem-resistant Acinetobacter baumannii outside hospital setting.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Croatia; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Seawater; Wastewater; Water Microbiology | 2017 |
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012-2015.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; History, 21st Century; Humans; Incidence; Infant; Infant, Newborn; Male; Middle Aged; Population Surveillance; United States; Young Adult | 2018 |
Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Communicable Diseases, Emerging; Cross Infection; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Genotype; Hospitals, Teaching; Humans; Intensive Care Units; Iran; Minocycline; Molecular Typing; Tigecycline | 2018 |
Dual infections of two carbapenemase-producing
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Blood Culture; Carbapenems; Child; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genotype; Humans; Iran; Microbial Sensitivity Tests; Phenotype; Whole Genome Sequencing | 2018 |
Acinetobacter baumannii Resistance Trends in Children in the United States, 1999-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cephalosporins; Child; Child, Preschool; Cross Infection; Databases, Factual; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Logistic Models; Male; Microbial Sensitivity Tests; Prevalence; Regression Analysis; United States | 2019 |
Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Databases, Factual; Drug Resistance, Bacterial; Humans; Prevalence; Switzerland | 2018 |
EMERGENCE OF CO-CARBAPENEMASE GENES, BLA(OXA23), BLA(VIM) AND BLA(NDM) IN CARBAPENEMRESISTANT ACINETOBACTER BAUMANNII CLINICAL ISOLATES.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Humans; Microbial Sensitivity Tests | 2016 |
Occurrence of IMP-1 in non-baumannii Acinetobacter clinical isolates from Brazil.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Humans; Integrons | 2018 |
Research and analysis of 74 bloodstream infection cases of Acinetobacter baumannii and drug resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2018 |
Environmental colonization and onward clonal transmission of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Hygiene; Intensive Care Units; Intubation; Male; Mass Screening; Microbial Sensitivity Tests | 2018 |
ISAba1 Regulated OXA-23 Carbapenem Resistance in Acinetobacter baumannii Strains in Durban, South Africa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Child; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; South Africa | 2018 |
Identifying Risk Factors for Healthcare-Associated Infections Caused by Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Egypt; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Odds Ratio; Prospective Studies; Risk Factors | 2018 |
Emergence of carbapenem-resistant Acinetobacter nosocomialis strain ST410 harbouring plasmid-borne bla
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Plasmids; Retrospective Studies; Taiwan | 2018 |
Carbapenem-resistant Acinetobacter baumannii Bacteremia in Liver Transplant Recipients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Incidence; Liver Transplantation; Living Donors; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Postoperative Complications; Risk Factors | 2018 |
Trends and factors associated with antimicrobial resistance of Acinetobacter spp. invasive isolates in Europe: A country-level analysis.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Climate; Drug Resistance, Multiple, Bacterial; Europe; Europe, Eastern; Fluoroquinolones; Gross Domestic Product; Humans; Logistic Models; Microbial Sensitivity Tests; Risk Factors | 2018 |
Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; RNA, Ribosomal, 16S; Uruguay | 2018 |
[In prosse].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans | 2017 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii international clones II and III in Lima, Peru.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Communicable Diseases, Emerging; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Peru | 2018 |
Fluorescence-Based Detection of Natural Transformation in Drug-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; DNA-Binding Proteins; Drug Resistance, Multiple, Bacterial; Flow Cytometry; Gene Transfer, Horizontal; Green Fluorescent Proteins; Microbial Sensitivity Tests; Microscopy, Fluorescence; Transformation, Bacterial | 2018 |
A formidable foe: carbapenem-resistant Acinetobacter baumannii and emerging nonantibiotic therapies.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests | 2018 |
A multiplex loop-mediated isothermal amplification assay for rapid screening of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA-Binding Proteins; Drug Resistance, Bacterial; Humans; Nucleic Acid Amplification Techniques; Rec A Recombinases; Sensitivity and Specificity | 2018 |
Genomic characterization of extensively drug-resistant Acinetobacter baumannii strain, KAB03 belonging to ST451 from Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Colistin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Phylogeny; Polymorphism, Single Nucleotide; Republic of Korea | 2018 |
Implementing an infection control and prevention program decreases the incidence of healthcare-associated infections and antibiotic resistance in a Russian neuro-ICU.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Incidence; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Russia; Young Adult | 2018 |
Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Genomics; Hospitalization; Humans; Microbial Sensitivity Tests; Mutation; Phylogeny; Polymorphism, Single Nucleotide; Tertiary Care Centers; United States; Whole Genome Sequencing | 2018 |
Does the intrinsic oxaAb (blaOXA-51-like) gene of Acinetobacter baumannii confer resistance to carbapenems when activated by ISAba1?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Australia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA Transposable Elements; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Transcriptional Activation | 2018 |
Emergence of carbapenem-resistant Acinetobacter pittii carrying the bla
Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Plasmids; Pneumonia, Ventilator-Associated; Recombination, Genetic; Sequence Analysis, DNA | 2019 |
Collaboration for containment: Detection of OXA-23-like carbapenamase-producing Acinetobacter baumannii in Colorado.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colorado; Humans; Microbial Sensitivity Tests | 2018 |
Resistance pattern and distribution of carbapenemase and antiseptic resistance genes among multidrug-resistant Acinetobacter baumannii isolated from intensive care unit patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2018 |
Co-occurrence of carbapenemase encoding genes in Acinetobacter baumannii, a dream or reality?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests | 2018 |
Five novel carbapenem-hydrolysing OXA-type β-lactamase groups are intrinsic in Acinetobacter spp.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Computational Biology; Drug Resistance, Bacterial; Escherichia coli; Gene Knockout Techniques; Hydrolysis; Imipenem; Microbial Sensitivity Tests; Phylogeny | 2018 |
High prevalence and clonal dissemination of OXA-72-producing Acinetobacter baumannii in a Chinese hospital: a cross sectional study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Young Adult | 2018 |
Mechanisms of carbapenem resistance in Acinetobacter pittii and Acinetobacter nosocomialis isolates from Thailand.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Thailand | 2018 |
Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Epidemiological Monitoring; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2019 |
Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Catheter-Related Infections; Cross Infection; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiration, Artificial; Retrospective Studies; Risk Factors | 2019 |
Detection and prevalence of carbapenem-resistant Gram-negative bacteria among European laboratories in the COMBACTE network: a COMBACTE LAB-Net survey.
Topics: Acinetobacter; Acinetobacter Infections; Bacteriological Techniques; beta-Lactam Resistance; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Europe; Humans; Prevalence; Procedures and Techniques Utilization; Surveys and Questionnaires | 2019 |
Carbapenem resistance in Acinetobacter baumannii is associated with enhanced survival on hospital fabrics.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents, Local; beta-Lactam Resistance; Biofilms; Carbapenems; Environmental Microbiology; Hospitals; Humans; Microbial Viability; Spain | 2019 |
Comparative Analysis of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2019 |
Natural prognosis of carbapenem-resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: A retrospective multicenter study in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Male; Middle Aged; Prognosis; Republic of Korea; Retrospective Studies | 2018 |
Carbapenem-resistant Acinetobacter baumannii: Current status of the problem in four Bulgarian university hospitals (2014-2016).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Carbapenems; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2019 |
In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Lepidoptera; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
An Emerging Clone (ST457) of Acinetobacter baumannii Clonal Complex 92 With Enhanced Virulence and Increasing Endemicity in South China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Animals; Bacterial Typing Techniques; Carbapenems; China; Endemic Diseases; Evolution, Molecular; Female; Genomics; Healthcare-Associated Pneumonia; Humans; Larva; Male; Middle Aged; Moths; Multilocus Sequence Typing; Prevalence; Virulence; Virulence Factors; Whole Genome Sequencing | 2018 |
A Case-Control Study: Clinical Characteristics of Nosocomial Bloodstream Infections Versus Non-bloodstream Infections of Acinetobacter spp.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospital Mortality; Hospitals, Teaching; Humans; Male; Medical Records; Middle Aged; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Treatment Outcome; Young Adult | 2018 |
Molecular epidemiology and genetic characterisation of carbapenem-resistant Acinetobacter baumannii isolates from Guangdong Province, South China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2019 |
Clonal relationship and the association of the ST218 strain harboring bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Multivariate Analysis; Risk Factors; Taiwan; Virulence; Virulence Factors | 2019 |
An intervention to control an ICU outbreak of carbapenem-resistant Acinetobacter baumannii: long-term impact for the ICU and hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; APACHE; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Female; Humans; Infection Control; Intensive Care Units; Israel; Male; Middle Aged | 2018 |
One-year molecular surveillance of carbapenem-susceptible
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Cross Infection; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Genotyping Techniques; Germany; Humans; Infection Control; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Tertiary Care Centers; Whole Genome Sequencing; Young Adult | 2018 |
Molecular epidemiology of multidrug-resistant Acinetobacter baumannii infection in two hospitals in Central Brazil: the role of ST730 and ST162 in clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genetic Variation; Hospitals; Humans; Infant; Male; Middle Aged; Molecular Epidemiology; Norepinephrine; Respiratory Tract Infections; Young Adult | 2019 |
Epidemiological investigation of an Acinetobacter baumannii outbreak using core genome multilocus sequence typing.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Disease Outbreaks; Humans; Intensive Care Units; Italy; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction; Whole Genome Sequencing | 2019 |
Trimethoprim-sulfamethoxazole vs. colistin or ampicillin-sulbactam for the treatment of carbapenem-resistant Acinetobacter baumannii: A retrospective matched cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Sulbactam; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Genotype; Hospitals; Humans; India; Intensive Care Units; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Typing; Phenotype; Prevalence; Prospective Studies; Respiratory Tract Infections; Species Specificity; Virulence | 2019 |
Molecular Epidemiology of Endemic Carbapenem-Resistant Gram-Negative Bacteria in an Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Gene Expression; Greece; Humans; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Pseudomonas aeruginosa; Pseudomonas Infections | 2019 |
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Africa; Aminoglycosides; Anti-Bacterial Agents; Asia; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Genotype; Humans; Microbial Sensitivity Tests; Nebramycin; South America; Whole Genome Sequencing | 2019 |
Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Animal Husbandry; Animals; Anti-Bacterial Agents; Carbapenems; Croatia; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Farms; Fertilizers; Fluoroquinolones; Humans; Manure; Microbial Sensitivity Tests; Multilocus Sequence Typing; Penicillins; Phylogeny; Polymyxins; Swine | 2019 |
Evaluation of the OXA-23 K-SeT® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase-producing Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Biological Specimen Banks; Carbapenems; Humans; Immunoassay; Microbial Sensitivity Tests; Retrospective Studies | 2019 |
Carbapenem-resistant Acinetobacter baumannii isolates carrying bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; Female; Humans; Iran; Male; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2019 |
Effect of rifampicin-colistin combination against XDR Acinetobacter baumannii harbouring bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Egypt; Hospitals, University; Humans; Microbial Sensitivity Tests; Rifampin | 2019 |
Ventilator-Associated Pneumonia due to Drug-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cohort Studies; Drug Resistance, Multiple, Bacterial; Erythrocyte Transfusion; Female; Hospital Mortality; Hospitals, University; Humans; Intensive Care Units; Length of Stay; Lithuania; Logistic Models; Male; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; ROC Curve; Sex Factors | 2019 |
Phenotypic and molecular characterisations of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Genomic Islands; Humans; Integrons; Madagascar; Microbial Sensitivity Tests; Phenotype; Plasmids; Virulence Factors | 2019 |
In-Vitro Evaluation of Different Antimicrobial Combinations with and without Colistin Against Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Vancomycin | 2019 |
Identification of the novel class D β-lactamase OXA-679 involved in carbapenem resistance in Acinetobacter calcoaceticus.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Amino Acid Sequence; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Larva; Microbial Sensitivity Tests; Models, Molecular; Moths; Protein Conformation; Whole Genome Sequencing | 2019 |
Antimicrobial photodynamic therapy against clinical isolates of carbapenem-susceptible and carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colony-Forming Units Assay; Drug Resistance, Microbial; Humans; Methylene Blue; Microbial Sensitivity Tests; Microbial Viability; Photochemotherapy; Photosensitizing Agents | 2019 |
ISAba1/bla
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Iran; Molecular Epidemiology | 2019 |
Risk factors for acquisition and mortality of multidrug-resistant Acinetobacter baumannii bacteremia: A retrospective study from a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Catheter-Related Infections; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Male; Middle Aged; Mortality; Pneumonia; Retrospective Studies; Risk Factors | 2019 |
Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Bacteriophages; Carbapenems; Disease Models, Animal; Drug Resistance, Bacterial; Female; Larva; Mice; Mice, Inbred C57BL; Moths; Phage Therapy; Pneumonia, Bacterial; Republic of Korea | 2019 |
Adjunctive therapy of intravenous colistin to intravenous tigecycline for adult patients with non-bacteremic post-surgical intra-abdominal infection due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Administration, Intravenous; Adult; Carbapenems; Colistin; Drug Resistance, Microbial; Female; Humans; Intraabdominal Infections; Male; Middle Aged; Postoperative Complications; Renal Insufficiency; Retrospective Studies; Tigecycline | 2019 |
In vitro activity of eravacycline in combination with colistin against carbapenem-resistant A. baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Tetracyclines | 2019 |
Evolutionary dynamics of carbapenem-resistant Acinetobacter baumannii circulating in Chilean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Cross Infection; Evolution, Molecular; Hospitals, Pediatric; Humans; Phylogeny | 2019 |
Clinical characteristics and outcomes of community and hospital-acquired Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Animals; Anti-Bacterial Agents; Bacteremia; Carbapenems; Community-Acquired Infections; Disease Models, Animal; Female; Hospitals; Humans; Kaplan-Meier Estimate; Larva; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Retrospective Studies; Risk Factors; Virulence | 2019 |
Rapid and economical detection of eight carbapenem-resistance genes in Enterobacteriaceae, Pseudomonas spp, and Acinetobacter spp directly from positive blood cultures using an internally controlled multiplex-PCR assay.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; India; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Prospective Studies; Pseudomonas; Pseudomonas Infections | 2019 |
Molecular Detection of Carbapenem Resistance in Acinetobacter Baumannii Isolated From Patients in Khorramabad City, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Cross-Sectional Studies; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Iran; Microbial Sensitivity Tests; Sulbactam | 2020 |
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in ICU of the eastern Heilongjiang Province, China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Enterobacteriaceae; Female; Gene Transfer, Horizontal; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged | 2019 |
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; beta-Lactam Resistance; Carbapenems; Comorbidity; Cross Infection; Disease Management; Drug Resistance, Multiple, Bacterial; Female; Humans; Italy; Kaplan-Meier Estimate; Male; Middle Aged; Patient Outcome Assessment; Proportional Hazards Models; Prospective Studies; Tertiary Care Centers | 2019 |
Emergence of Carbapenem-Resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Hong Kong; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Retrospective Studies | 2019 |
Molecular characterization of carbapenem-resistant Escherichia coli and Acinetobacter baumannii in the Lao People's Democratic Republic.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Humans; Laos; Male; Middle Aged; Public Health Surveillance | 2019 |
Antimicrobial Susceptibility and Molecular Characterization of Clinical Strains of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Young Adult | 2019 |
Molecular characterization & epidemiology of carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Genotype; Humans; India; Microbial Sensitivity Tests; Molecular Epidemiology; Multiplex Polymerase Chain Reaction | 2019 |
Challenges in diagnosing community-acquired carbapenem-susceptible Acinetobacter baumannii enterogenic sepsis: A case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Community-Acquired Infections; Humans; Intestinal Diseases; Male; Microbial Sensitivity Tests; Sepsis | 2019 |
Ventilator associated pneumonia due to carbapenem resistant microorganisms in children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; Infant; Intensive Care Units, Pediatric; Length of Stay; Male; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors | 2019 |
Rapid screening and early precautions for carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Early Diagnosis; Female; Humans; Incidence; Infection Control; Intensive Care Units; Japan; Male; Middle Aged; Molecular Diagnostic Techniques; Non-Randomized Controlled Trials as Topic; Nucleic Acid Amplification Techniques; Watchful Waiting | 2019 |
Resistome and a Novel
Topics: Acinetobacter; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Male; Mexico; Microbial Sensitivity Tests; Plasmids; Whole Genome Sequencing | 2019 |
Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Antimicrobial Cationic Peptides; Carbapenems; Cell Membrane; Disease Models, Animal; Drug Design; Drug Resistance, Multiple, Bacterial; HeLa Cells; Humans; Kinetics; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritoneum; Protein Structure, Secondary; Tigecycline; Time Factors | 2019 |
Dual Role of
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Lepidoptera; Microbial Sensitivity Tests; Minocycline; Tigecycline; Virulence | 2019 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates reveals the emergence of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Evolution, Molecular; Humans; India; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Prevalence; Tertiary Care Centers | 2019 |
Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Diagnostic Tests, Routine; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Indicators and Reagents; Microbial Sensitivity Tests; Oxazines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Xanthenes | 2019 |
Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Carrier State; Drug Resistance, Bacterial; Female; Humans; Israel; Kaplan-Meier Estimate; Male; Middle Aged; Patient Readmission | 2019 |
The origin of Acinetobacter baumannii TYTH-1: a comparative genomics study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Genome, Bacterial; Genomics; Humans; Microbial Sensitivity Tests; Phylogeny; Retrospective Studies; Sequence Analysis, DNA; Taiwan | 2013 |
OXA-235, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cephalosporins; Chromosomes, Bacterial; Cloning, Molecular; DNA Transposable Elements; Escherichia coli; Humans; Isoenzymes; Molecular Sequence Data; Mutation; Plasmids; Recombinant Proteins; Sequence Alignment; Sequence Analysis, DNA; Sequence Homology, Amino Acid | 2013 |
Complete sequence of the bla(NDM-1)-carrying plasmid pNDM-AB from Acinetobacter baumannii of food animal origin.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Gene Order; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Swine; Swine Diseases; Synteny | 2013 |
Clonal spread of carbapenem resistant Acinetobacter baumannii ST92 in a Chinese Hospital during a 6-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Cluster Analysis; Cross Infection; DNA Fingerprinting; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2013 |
High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Diabetes Complications; Diabetes Mellitus; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Prevalence; Saudi Arabia | 2013 |
Risk factors and mortality of patients with nosocomial carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Cross Infection; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Retrospective Studies; Risk Factors | 2013 |
In vitro activity of doripenem alone and in multi-agent combinations against extensively drug-resistant Acinetobacter baumannii and Klebsiella pneumoniae.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Rifampin | 2013 |
Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Retrospective Studies; Young Adult | 2013 |
Empirical antimicrobial therapy for critically ill patients with Acinetobacter baumannii bacteremia: combination is better.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Male | 2013 |
Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; China; Cross Infection; Female; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing | 2013 |
In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Intensive Care Units; Microbial Sensitivity Tests; Minocycline; Tertiary Healthcare; Tigecycline | 2013 |
Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Cohort Studies; Colombia; Cross Infection; Female; Health Care Costs; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome | 2014 |
Multidrug-resistant Acinetobacter baumannii clone, France.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Cross Infection; Egypt; France; Humans; Tunisia | 2013 |
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Minocycline; Models, Theoretical; Sulbactam; Tigecycline | 2013 |
Molecular epidemiology, antimicrobial susceptibility and carbapenemase resistance determinants among Acinetobacter baumannii clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Public Health Surveillance; Taiwan | 2014 |
Study of the carbapenem resistance mechanisms in clinical isolates of Acinetobacter baumannii: comparison of burn and non-burn strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Burns; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
First report of carbapenem-resistant Acinetobacter nosocomialis isolates harboring ISAba1-blaOXA-23 genes in Latin America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Humans | 2013 |
The clinical characteristics, carbapenem resistance, and outcome of Acinetobacter bacteremia according to genospecies.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Genotype; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Risk Factors; Treatment Outcome | 2014 |
The minimal inhibitory concentration for sulbactam was not associated with the outcome of infections caused by carbapenem-resistant Acinetobacter sp. treated with ampicillin/sulbactam.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Sulbactam; Treatment Outcome; Young Adult | 2013 |
Aerosolization of Acinetobacter baumannii in a trauma ICU*.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Air Microbiology; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Intensive Care Units; Multilocus Sequence Typing; Patients' Rooms; Trauma Centers; Ventilation | 2013 |
Assessment of the combination of doripenem plus a fluoroquinolone against non-susceptible Acinetobacter baumannii isolates from nosocomial pneumonia patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Carbapenems; Ciprofloxacin; Doripenem; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Synergism; Drug Therapy, Combination; Female; Levofloxacin; Mice; Ofloxacin; Pneumonia, Ventilator-Associated; Random Allocation; Survival Analysis | 2013 |
Successful treatment of skin and soft tissue infection due to carbapenem-resistant Acinetobacter baumannii by ampicillin-sulbactam and meropenem combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Ampicillin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Female; Humans; Meropenem; Microbial Sensitivity Tests; Skin Diseases, Bacterial; Soft Tissue Infections; Sulbactam; Thienamycins; Treatment Outcome | 2013 |
Comparison between bacteremia caused by carbapenem resistant Acinetobacter baumannii and Acinetobacter nosocomialis.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Female; Humans; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Retrospective Studies; Risk Factors; Statistics, Nonparametric | 2013 |
In vitro activity of sitafloxacin against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asia, Southeastern; beta-Lactam Resistance; Carbapenems; Cross Infection; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Pneumonia, Bacterial | 2013 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Republic of Korea | 2013 |
[Clonal relatedness of bla(OXA-58)--carrying Acinetobacter baumannii clinical isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Cloning, Molecular; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests | 2013 |
Outbreak of NDM-1-producing Acinetobacter baumannii in France, January to May 2013.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Carrier State; Contact Tracing; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Travel | 2013 |
Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance islands.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; DNA Transposable Elements; Epidemiological Monitoring; Gene Expression; Humans; Phylogeny; Prevalence | 2013 |
Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Microbial Sensitivity Tests; Phylogeny; Porins; Quinolones; Tetracyclines | 2013 |
MLST analysis of multiple antimicrobial resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Japan; Multilocus Sequence Typing; Pathology, Molecular; Polymerase Chain Reaction | 2013 |
Description of the metallo-β-lactamase GIM-1 in Acinetobacter pittii.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Germany; Humans; Integrins; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids | 2014 |
Isolation of genetically indistinguishable carbapenem-resistant and -susceptible Acinetobacter baumannii isolates from a single patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Plasmids; Sputum | 2013 |
Eighteen years of experience with Acinetobacter baumannii in a tertiary care hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Blood; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Florida; Humans; Intensive Care Units; Longitudinal Studies; Microbial Sensitivity Tests; Respiratory System; Retrospective Studies; RNA, Ribosomal, 16S; Tertiary Care Centers; Wounds and Injuries | 2013 |
Wide distribution of CC92 carbapenem-resistant and OXA-23-producing Acinetobacter baumannii in multiple provinces of China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cluster Analysis; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Prevalence | 2013 |
Carbapenem resistance in Acinetobacter baumannii: where is it heading?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Hospitals, University; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Prognosis; Risk Factors; Thienamycins; Turkey | 2013 |
Colonization pressure as a risk factor for colonization by multiresistant Acinetobacter spp and carbapenem-resistant Pseudomonas aeruginosa in an intensive care unit.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacterial Load; beta-Lactam Resistance; Brazil; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Time Factors; Young Adult | 2013 |
Evolution of carbapenem resistance in Acinetobacter baumannii: an 18-year longitudinal study from a medical center in northern Taiwan.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Humans; Longitudinal Studies; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Prevalence; Taiwan | 2015 |
Emergence of carbapenem-resistant Acinetobacter baumannii in hospitals in Pakistan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Cross Infection; Female; Hospitals; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Pakistan; Young Adult | 2014 |
Epidemiology of bloodstream infections caused by Acinetobacter baumannii and impact of drug resistance to both carbapenems and ampicillin-sulbactam on clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Michigan; Middle Aged; Retrospective Studies; Sulbactam | 2013 |
Associations between carbapenem use, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Incidence; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand | 2013 |
Emergence of Acinetobacter baumannii international clone II in Brazil: reflection of a global expansion.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Brazil; Carbapenems; Humans; Multilocus Sequence Typing | 2013 |
Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; China; Cluster Analysis; Cross-Sectional Studies; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Hospitals; Humans; Molecular Epidemiology; Multilocus Sequence Typing | 2013 |
Characterizing in vivo pharmacodynamics of carbapenems against Acinetobacter baumannii in a murine thigh infection model to support breakpoint determinations.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Mice; Microbial Sensitivity Tests; Thigh | 2014 |
Carbapenem-resistant Acinetobacter baumannii from Brazil: role of carO alleles expression and blaOXA-23 gene.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Molecular Typing; Phenotype; Polymerase Chain Reaction; Porins; Sequence Analysis, DNA | 2013 |
Carbapenem resistance and acquired class D beta-lactamases in Acinetobacter baumannii from Croatia 2009-2010.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Croatia; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology | 2014 |
[Distribution of blaOXA genes in Acinetobacter baumannii strains: a multicenter study].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Reagent Kits, Diagnostic; Real-Time Polymerase Chain Reaction; Turkey | 2013 |
Phenotypic characterization and colistin susceptibilities of carbapenem-resistant of Pseudomonas aeruginosa and Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
In vitro responses of Acinetobacter baumannii to two- and three-drug combinations following exposure to colistin and doripenem.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Administration Schedule; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Sulbactam | 2014 |
In vitro synergistic activity of colistin with tigecycline or β-lactam antibiotic/β-lactamase inhibitor combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Carbapenems; Cefoperazone; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Tigecycline | 2013 |
First report of OXA-23-mediated carbapenem resistance in sequence type 2 multidrug-resistant Acinetobacter baumannii associated with urinary tract infection in a cat.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cat Diseases; Cats; Drug Resistance, Multiple, Bacterial; Gene Expression; Urinary Tract Infections | 2014 |
Nosocomial outbreak of a multiresistant Acinetobacter baumannii expressing OXA-23 carbapenemase in Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Spain; Survival Analysis; Tigecycline | 2014 |
A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Central Venous Catheters; Cephalosporins; Coinfection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Respiratory Tract Infections; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Clinical efficacy and safety of the combination of colistin plus vancomycin for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2013 |
Prevalence of carbapenem-hydrolyzing class D β-lactamase genes in Acinetobacter spp. isolates in China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; DNA, Bacterial; Humans; Hydrolysis; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence | 2014 |
Effects of Carbapenem consumption on the prevalence of Acinetobacter infection in intensive care unit patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Prescriptions; Drug Resistance, Multiple, Bacterial; Drug Utilization; Female; Humans; Infection Control; Intensive Care Units; Male; Middle Aged; Organizational Policy; Prevalence; Retrospective Studies; Young Adult | 2014 |
Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Bacterial Load; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Imipenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Sepsis; Sulbactam; Tigecycline; Time Factors | 2013 |
Characterization of carbapenem-resistant Acinetobacter baumannii clinical isolates in a tertiary care hospital in Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Saudi Arabia; Tertiary Care Centers; Young Adult | 2014 |
Comparison of colistin-carbapenem, colistin-sulbactam, and colistin plus other antibacterial agents for the treatment of extremely drug-resistant Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Bacteremia; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Risk Factors; Sulbactam; Treatment Outcome | 2014 |
First report of blaNDM-1-producing Acinetobacter baumannii isolated in Lebanon from civilians wounded during the Syrian war.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ethnic Violence; Female; Gene Expression; Humans; Infant; Lebanon; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Wounds, Penetrating; Young Adult | 2014 |
Distribution of carbapenem resistance determinants among epidemic and non-epidemic types of Acinetobacter species in Japan.
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Gene Expression Regulation, Bacterial; Gene Expression Regulation, Enzymologic; Humans; Japan; Multilocus Sequence Typing; Species Specificity | 2014 |
Environmental exposure to carbapenem-resistant Acinetobacter baumannii as a risk factor for patient acquisition of A. baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Environmental Exposure; Female; Florida; Humans; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Factors | 2014 |
Molecular characterization of carbapenem-insensitive Acinetobacter baumannii in Egypt.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Egypt; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids | 2014 |
Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Carbapenems; Cohort Studies; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Retrospective Studies; Sulbactam; Tigecycline; Treatment Outcome; Young Adult | 2014 |
Comparative in vitro activity of sitafloxacin against bacteremic isolates of carbapenem resistant Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; DNA, Intergenic; DNA, Ribosomal; Fluoroquinolones; Humans; Microbial Sensitivity Tests; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2015 |
Spread of a carbapenem- and colistin-resistant Acinetobacter baumannii ST2 clonal strain causing outbreaks in two Sicilian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Polymerase Chain Reaction; Sicily | 2014 |
Correlation between antibiotic consumption and carbapenem-resistant Acinetobacter baumannii causing health care-associated infections at a hospital from 2005 to 2010.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Drug Utilization; Fluoroquinolones; Hospitals; Humans; Incidence; Taiwan | 2015 |
Bloodstream infection with carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Acinetobacter baumannii: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Shock, Septic | 2014 |
Microbiological and molecular detection of VIM-1 metallo beta lactamase-producing Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Saudi Arabia; Young Adult | 2014 |
Control of a two-decade endemic situation with carbapenem-resistant Acinetobacter baumannii: electronic dissemination of a bundle of interventions.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Electronics, Medical; Hospitals, Teaching; Humans; Infection Control; Information Dissemination; Patient Care Bundles | 2014 |
[In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cefoperazone; Cross Infection; Drug Combinations; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Sulbactam; Thienamycins | 2014 |
Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anal Canal; Anti-Bacterial Agents; Carbapenems; Carrier State; Cross Infection; Decontamination; Disease Outbreaks; Disinfectants; Disinfection; Drug Resistance, Microbial; Equipment and Supplies, Hospital; Equipment Contamination; France; Hospitals, General; Humans; Hydrogen Peroxide; Intensive Care Units; Male; Patient Isolation; Patients' Rooms; Personnel, Hospital; Pharynx; Sphygmomanometers; Universal Precautions | 2014 |
Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Agar; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Culture Media; Humans; Sensitivity and Specificity | 2014 |
Characterization of carbapenem-resistant Acinetobacter baumannii in Brazil (2008-2011): countrywide spread of OXA-23-producing clones (CC15 and CC79).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alleles; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Geography, Medical; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Multiplex Polymerase Chain Reaction | 2014 |
OXA-207, a novel OXA-24 variant with reduced catalytic efficiency against carbapenems in Acinetobacter pittii from Spain.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Sequence; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Binding Sites; Carbapenems; Cloning, Molecular; Drug Resistance, Bacterial; Gene Expression; Humans; Integrases; Isoenzymes; Microbial Sensitivity Tests; Molecular Sequence Data; Oxacillin; Recombination, Genetic; Sequence Alignment; Spain | 2014 |
A conjugative plasmid carrying the carbapenem resistance gene blaOXA-23 in AbaR4 in an extensively resistant GC1 Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; DNA Transposable Elements; Gene Order; Humans; Molecular Sequence Data; Plasmids | 2014 |
Effects of Group 1 versus Group 2 carbapenems on the susceptibility of Acinetobacter baumannii to carbapenems: a before and after intervention study of carbapenem-use stewardship.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests | 2014 |
Control of simultaneous outbreaks of carbapenemase-producing enterobacteriaceae and extensively drug-resistant Acinetobacter baumannii infection in an intensive care unit using interventions promoted in the Centers for Disease Control and Prevention 2012
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Centers for Disease Control and Prevention, U.S.; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Infection Control; Intensive Care Units; Outcome Assessment, Health Care; United States; Virginia | 2014 |
A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Female; Genotype; Humans; Israel; Male; Middle Aged; Molecular Typing; Risk Factors; Sequence Analysis, DNA; Survival Analysis | 2014 |
Mathematical model to quantify the effects of risk factors on carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Humans; Models, Statistical; Prevalence; Reproducibility of Results; Risk Factors | 2014 |
[Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Cefepime; Cephalosporins; Drug Resistance; Humans; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Pharmaceutical Preparations; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam; Thienamycins | 2014 |
Emergence of carbapenem-resistant Acinetobacter baumannii as the major cause of ventilator-associated pneumonia in intensive care unit patients at an infectious disease hospital in southern Vietnam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Child; Child, Preschool; DNA, Bacterial; Female; Genotype; Hospitals; Humans; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Prevalence; Retrospective Studies; Vietnam; Young Adult | 2014 |
Clonal diversity of Acinetobacter baumannii from diabetic patients in Saudi Arabian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Diabetes Mellitus; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genetic Variation; Genotype; Humans; Male; Saudi Arabia | 2014 |
Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Humans; India; Infant, Newborn; Intensive Care, Neonatal; Male; Risk Factors; Survival Analysis | 2014 |
Invasive infection caused by carbapenem-resistant Acinetobacter soli, Japan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Fatal Outcome; Humans; Japan; Male; Microbial Sensitivity Tests; Middle Aged | 2014 |
Common clinical substitutions enhance the carbapenemase activity of OXA-51-like class D β-lactamases from Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Catalytic Domain; Cross Infection; Humans; Protein Folding | 2014 |
Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hand Hygiene; Hospitals, University; Humans; Incidence; Infection Control; Intensive Care Units; Republic of Korea | 2014 |
Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cohort Studies; Colistin; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Incidence; Male; Middle Aged; Spain | 2014 |
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins | 2015 |
Evaluation of meropenem regimens suppressing emergence of resistance in Acinetobacter baumannii with human simulated exposure in an in vitro intravenous-infusion hollow-fiber infection model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2014 |
Evaluation of a loop-mediated isothermal amplification-based methodology to detect carbapenemase carriage in Acinetobacter clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Nucleic Acid Amplification Techniques | 2014 |
Carbapenem resistance in a human clinical isolate identified to be closely related to Acinetobacter indicus.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; Humans; Male; Molecular Sequence Data; Phylogeny; Plasmids; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Effect of carbapenem consumption patterns on the molecular epidemiology and carbapenem resistance of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Drug Utilization; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Hungary; Integrons; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Prevalence | 2014 |
A pseudo-outbreak due to Acinetobacter species (GIM-1) contamination of the pneumatic transport system of a Large University Hospital.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Disease Outbreaks; Equipment Contamination; Germany; Hospital Communication Systems; Hospitals, University; Humans; Infant, Newborn; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Young Adult | 2014 |
Pseudo-outbreak of Oxa-23-mediated carbapenem-resistant Acinetobacter baumannii in urinary tract infections caused by an automated urine analyzer.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Equipment Contamination; Humans; Urinalysis; Urinary Tract Infections | 2014 |
Surveillance cultures growing carbapenem-Resistant Acinetobacter baumannii predict the development of clinical infections: a retrospective cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Cohort Studies; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Tertiary Care Centers | 2015 |
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp. bacteremia: a cohort study.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Respiration, Artificial; Retrospective Studies; Risk Factors; Severity of Illness Index | 2014 |
Structure of ADC-68, a novel carbapenem-hydrolyzing class C extended-spectrum β-lactamase isolated from Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; beta-Lactams; Carbapenems; Cephalosporins; Crystallography, X-Ray; Humans; Models, Molecular; Molecular Sequence Data; Protein Conformation | 2014 |
Molecular characterization of carbapenemase and cephalosporinase genes among clinical isolates of Acinetobacter baumannii in a tertiary medical centre in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporinase; Cephalosporins; Child; Child, Preschool; DNA-Directed RNA Polymerases; DNA, Bacterial; DNA, Ribosomal; Female; Humans; Infant; Infant, Newborn; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tertiary Care Centers; Young Adult | 2015 |
Description of the OXA-23 β-lactamase gene located within Tn2007 in a clinical isolate of Acinetobacter baumannii from Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Humans; Imipenem; Male; Microbial Sensitivity Tests; Spain | 2015 |
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cohort Studies; Critical Illness; Cross Infection; Decision Support Techniques; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intensive Care Units; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Renal Dialysis; Risk Factors; Surgical Procedures, Operative; Systemic Inflammatory Response Syndrome; Urinary Tract Infections | 2014 |
Carbapenem and amikacin resistance on a large conjugative Acinetobacter baumannii plasmid.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Australia; Carbapenems; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Gene Order; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2015 |
Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biological Transport; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Hydrazones; Imipenem; Meropenem; Mexico; Microbial Sensitivity Tests; Thienamycins | 2014 |
Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Analysis of Variance; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Risk Factors | 2015 |
The comparison of genotyping, antibiogram, and antimicrobial resistance genes between carbapenem-susceptible and -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Female; Gene Expression; Genotype; Humans; Infant; Integrons; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Plasmids | 2014 |
Clinical outcomes of children with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Prognosis; Retrospective Studies; Thailand; Treatment Outcome | 2014 |
Molecular epidemiology of carbapenem non-susceptible Acinetobacter baumannii in France.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; France; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2014 |
Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Lebanon; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2014 |
A nightmare for haematology clinics: extensively drug-resistant (XDR) Acinetobacter baumannnii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Hematology; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Sulbactam; Survival Rate; Treatment Outcome; Turkey | 2014 |
Detection of the frequency of PER-1 type extended-spectrum β-lactamase-producing Acinetobacter baumannii clinical isolates in Turkey: a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Prevalence; Real-Time Polymerase Chain Reaction; Seroepidemiologic Studies; Turkey | 2014 |
Four carbapenem-resistant gram-negative species carrying distinct carbapenemases in a single patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Enterobacter aerogenes; Enterobacteriaceae Infections; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2015 |
Risk factors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; APACHE; Bacteremia; Carbapenems; Colistin; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Minocycline; Respiratory Tract Infections; Retrospective Studies; Risk Factors; Tigecycline | 2016 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child, Preschool; Cluster Analysis; Female; Genotype; Hospitals; Humans; Infant; Male; Middle East; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2015 |
Molecular characterization of carbapenemase production among gram-negative bacteria in saudi arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child, Preschool; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Humans; Incidence; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Plasmids; Polymerase Chain Reaction; Pseudomonas aeruginosa; Pseudomonas Infections; Saudi Arabia | 2015 |
Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Clone Cells; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Gene Expression Regulation, Bacterial; Homes for the Aged; Humans; Male; Microbial Sensitivity Tests; Nursing Homes; Phylogeny; Plasmids; Sequence Analysis, DNA | 2015 |
Genetic Characterization of ST195 and ST365 Carbapenem-Resistant Acinetobacter baumannii Harboring blaOXA-23 in Guangzhou, China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Bacterial; Genes, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2015 |
Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electronic Health Records; Electrophoresis, Gel, Pulsed-Field; Ethanolamines; Female; Humans; Lipid A; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Sulbactam | 2015 |
Editorial commentary: Polymyxin-resistant Acinetobacter baumannii: urgent action needed.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male | 2015 |
A novel New Delhi metallo-β-lactamase variant, NDM-14, isolated in a Chinese Hospital possesses increased enzymatic activity against carbapenems.
Topics: Acinetobacter; Acinetobacter Infections; Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Humans; Imipenem; Intensive Care Units; Kinetics; Meropenem; Molecular Sequence Data; Plasmids; Thienamycins | 2015 |
Novel approach to optimize synergistic carbapenem-aminoglycoside combinations against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colony Count, Microbial; Computer Simulation; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Monte Carlo Method | 2015 |
Dual-tubed multiplex-PCR for molecular characterization of carbapenemases isolated among Acinetobacter spp. and Pseudomonas spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; India; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Pseudomonas; Pseudomonas Infections | 2015 |
Prevalence of digestive tract colonization of carbapenem-resistant Acinetobacter baumannii in hospitals in Saudi Arabia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Gastrointestinal Tract; Genetic Variation; Hospitals; Humans; Intensive Care Units; Molecular Typing; Prevalence; Rectum; Saudi Arabia | 2015 |
Fulminant endocarditis and disseminated infection caused by carbapenem-resistant Acinetobacter baumannii in a renal-pancreas transplant recipient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Diabetes Mellitus, Type 1; Drug Resistance, Bacterial; Endocarditis, Bacterial; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Pancreas Transplantation; Postoperative Complications | 2015 |
Increasing carbapenem-resistant Gram-negative bacilli and decreasing metallo-β-lactamase producers over eight years from Korea.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Incidence; Microbial Sensitivity Tests; Population Surveillance; Pseudomonas; Republic of Korea | 2015 |
Molecular epidemiology of carbapenem non-susceptible Acinetobacter nosocomialis in a medical center in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactam Resistance; Carbapenems; Conjugation, Genetic; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Taiwan | 2015 |
Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Male; Mice; Mice, Inbred BALB C; Minocycline; Sepsis; Sulbactam; Tigecycline | 2015 |
Sulbactam treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Ampicillin; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Time Factors | 2015 |
High endemic rates of OXA-23-producing carbapenem-resistant Acinetobacter baumannii isolates caused by the persistence of major clones in hospitals in a Brazilian city 5 years after an outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Endemic Diseases; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Tertiary Care Centers; Time Factors | 2015 |
Simultaneous Identification of Multiple β-Lactamases in Acinetobacter baumannii in Relation to Carbapenem and Ceftazidime Resistance, Using Liquid Chromatography-Tandem Mass Spectrometry.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Ceftazidime; Chromatography, Liquid; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Peptide Mapping; Proteomics; Tandem Mass Spectrometry | 2015 |
Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia: A Multicenter Prospective Observational Study.
Topics: Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Intensive Care Units; Kaplan-Meier Estimate; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Organ Dysfunction Scores; Prospective Studies; Taiwan; Tigecycline | 2015 |
Investigation of a possible outbreak of carbapenem-resistant Acinetobacter baumannii in Odense, Denmark using PFGE, MLST and whole-genome-based SNPs.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Denmark; Disease Outbreaks; Genetic Variation; Genotype; Hospitals, University; Humans; Molecular Epidemiology; Molecular Typing; Polymorphism, Single Nucleotide | 2015 |
Reduction in the prevalence of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa in New York City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Hospitals; Humans; Infection Control; New York City; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Piscidin is highly active against carbapenem-resistant Acinetobacter baumannii and NDM-1-producing Klebsiella pneumonia in a systemic Septicaemia infection mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Behavior, Animal; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Fish Proteins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Microbial Sensitivity Tests; Protein Isoforms; Recombinant Proteins; Sepsis; Survival Analysis; Tilapia | 2015 |
[Clinical characteristics and molecular epidemiology of carbapenem- resistant Acinetobacter baumannii infections at Shenzhen People's Hospital during an 8-year period].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction | 2015 |
Combination Therapy for Extreme Drug-Resistant Acinetobacter baumannii: Ready for Prime Time?
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Pneumonia, Ventilator-Associated; Renal Insufficiency; Retrospective Studies; Sulbactam; Treatment Outcome | 2015 |
Comparative Evaluation of Colistin Susceptibility Testing Methods among Carbapenem-Nonsusceptible Klebsiella pneumoniae and Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 2015 |
Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Intensive Care Units; Male; Middle Aged; Multiple Organ Failure; Organ Dysfunction Scores; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Thailand | 2015 |
Long-term effectiveness of infection and antibiotic control programs on the transmission of carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex in central Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Cross Infection; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Taiwan; Time Factors; Treatment Outcome; Young Adult | 2015 |
High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Retrospective Studies; Treatment Outcome | 2015 |
Diversity of Acinetobacter baumannii strains isolated in humans, companion animals, and the environment in Reunion Island: an exploratory study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Animals; Carbapenems; Cats; Child; Child, Preschool; Dogs; Drug Resistance, Bacterial; Female; Genetic Variation; Humans; Male; Middle Aged; Pets; Reunion; Young Adult | 2015 |
[A study of outer membrane protein and molecular epidemiology of carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Membrane Proteins; Polymerase Chain Reaction | 2015 |
Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin and tigecycline resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Containment of Biohazards; Cross Infection; Drug Resistance, Multiple, Bacterial; Gentamicins; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Tertiary Care Centers; Tigecycline | 2015 |
[Investigation of oxacillinase genes in nosocomial multidrug-resistant Acinetobacter baumannii isolates by multiplex PCR and evaluation of their clonal relationship with Rep-PCR].
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction | 2015 |
Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Israel; Male; Microbial Sensitivity Tests; Middle Aged; Odds Ratio; Retrospective Studies; Risk Factors; Socioeconomic Factors; Young Adult | 2015 |
Clinical Specimen-Direct LAMP: A Useful Tool for the Surveillance of blaOXA-23-Positive Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Nucleic Acid Amplification Techniques; Thailand | 2015 |
Effect of daily chlorhexidine bathing on acquisition of carbapenem-resistant Acinetobacter baumannii (CRAB) in the medical intensive care unit with CRAB endemicity.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Baths; beta-Lactam Resistance; Carbapenems; Chlorhexidine; Cross Infection; Disinfectants; Disinfection; Female; Humans; Intensive Care Units; Interrupted Time Series Analysis; Male; Microbial Sensitivity Tests; Middle Aged; Non-Randomized Controlled Trials as Topic; Prevalence; Retrospective Studies; Young Adult | 2015 |
OXA-type Carbapenemases and Susceptibility of Colistin and Tigecycline Among Carbapenem-Resistant Acinetobacter Baumannii Isolates from Patients with Bacteremia in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Female; Genotype; Hospitals, University; Humans; Inpatients; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Multiplex Polymerase Chain Reaction; Tigecycline; Turkey | 2015 |
Stable polymyxin B susceptibility among carbapenem-resistant Acinetobacter baumannii: for how long?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Polymyxin B | 2017 |
Genetic basis of antimicrobial resistance and clonal dynamics of carbapenem-resistant Acinetobacter baumannii sequence type 191 in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acyltransferases; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Mutation; Phenotype; Republic of Korea | 2015 |
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Sulbactam; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2016 |
Do Results of Surveillance Cultures Impact the Choice of Empirical Antibiotics Among Patients with Carbapenem-Resistant Acinetobacter baumannii Infections?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Florida; Hospitals, Teaching; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance; Young Adult | 2015 |
Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Biofilms; Carbapenems; Croatia; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Intensive Care Units; Microbial Sensitivity Tests; Monte Carlo Method; Respiratory System; Respiratory Tract Infections; Sulbactam; Urine; Wounds and Injuries | 2015 |
"Excess Mortality" and Colistin-Tigecycline for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia.
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
First report of carbapenem-resistant Acinetobacter soli isolates coharboring blaNDM-1 and blaOXA-58 genes from China.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Genotype; Humans; Male | 2015 |
The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins; Vancomycin; Young Adult | 2015 |
Extending the reservoir of bla IMP-5: the emerging pathogen Acinetobacter bereziniae.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Plasmids | 2015 |
In Vitro Efficacy of Doripenem against Pseudomonas aeruginosa and Acinetobacter baumannii by E-Test.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross-Sectional Studies; Doripenem; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2015 |
Appropriate Tigecycline Use for Extensively Drug-Resistant Infections: The Standard Dose May Not Be Enough!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Mortality and Extensively Drug Resistance: Drugs or Methods? That Is the Question!
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Humans; Male; Minocycline | 2015 |
Rapid dissemination of colistin and carbapenem resistant Acinetobacter baumannii in Central Greece: mechanisms of resistance, molecular identification and epidemiological data.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing | 2015 |
Carbapenem-resistant Acinetobacter baumannii acquired before liver transplantation: Impact on recipient outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Liver Failure; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Reoperation; Risk Factors; Time Factors; Treatment Outcome; Young Adult | 2016 |
Loop-mediated isothermal amplification: Rapid and sensitive detection of the antibiotic resistance gene ISAba1-blaOXA-51-like in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Nucleic Acid Amplification Techniques; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Molecular Sequence Data; Polymerase Chain Reaction | 2016 |
In Vitro Interactions of Antibiotic Combinations of Colistin, Tigecycline, and Doripenem Against Extensively Drug-Resistant and Multidrug-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Tigecycline | 2016 |
Comparative in vitro activity of minocycline and selected antibiotics against carbapenem-resistant Acinetobacter baumannii from Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Humans; Microbial Sensitivity Tests; Minocycline; Thailand | 2016 |
Outbreak of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: a multi-level strategic management approach.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Female; Humans; Infection Control; Intensive Care Units; Male; Middle Aged | 2016 |
First Description of Two Sequence Type 2 Acinetobacter baumannii Isolates Carrying OXA-23 Carbapenemase in Pagellus acarne Fished from the Mediterranean Sea near Bejaia, Algeria.
Topics: Acetyltransferases; Acinetobacter baumannii; Acinetobacter Infections; Algeria; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Fish Diseases; Fish Proteins; Gastrointestinal Tract; Gene Expression; Genotype; Gills; Mediterranean Sea; Perciformes; Phylogeny | 2016 |
ISAba1/blaOXA-23: A serious obstacle to controlling the spread and treatment of Acinetobacter baumannii strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Genetic Variation; Genotype; Hospitals; Humans; Microbial Sensitivity Tests | 2016 |
Novel Aminoglycoside Resistance Transposons and Transposon-Derived Circular Forms Detected in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Ceftazidime; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2016 |
Population Structure Analysis of Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates from Brazil Reveals Predominance of Clonal Complexes 1, 15, and 79.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Genotype; Hospitals; Humans; Isoenzymes; Multilocus Sequence Typing; Plasmids; Public Health Surveillance | 2016 |
A Multicenter Study in Mexico Finds Acinetobacter baumannii Clinical Isolates Belonging to Clonal Complexes 636B (113B) and 92B Harboring OXA-72, OXA-239, and OXA-469.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Mexico; Microbial Sensitivity Tests; Public Health Surveillance | 2016 |
Old Clinical Isolates of Acinetobacter seifertii in Brazil Producing OXA-58.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Microbial Sensitivity Tests; Public Health Surveillance; Time Factors | 2016 |
Controlling endemic multidrug-resistant Acinetobacter baumannii in Intensive Care Units using antimicrobial stewardship and infection control.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Chi-Square Distribution; Cross Infection; Disinfection; Drug Resistance, Multiple, Bacterial; Endemic Diseases; Hand Disinfection; Humans; Incidence; Infection Control; Microbial Sensitivity Tests; Odds Ratio; Patient Isolation; Program Evaluation; Republic of Korea; Risk Factors; Tertiary Care Centers; Time Factors; Treatment Outcome | 2016 |
Clinical and Epidemiological Significance of Carbapenem Resistance in Acinetobacter baumannii Infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Kaplan-Meier Estimate; Microbial Sensitivity Tests; Multivariate Analysis; Retrospective Studies; RNA, Ribosomal, 16S | 2016 |
The evolving threat of carbapenem-resistant infections after liver transplantation: The case of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Humans; Liver Transplantation | 2016 |
Epidemic Dissemination of a Carbapenem-Resistant Acinetobacter baumannii Clone Carrying armA Two Years After Its First Isolation in an Italian Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Disease Outbreaks; Gene Expression Regulation, Bacterial; Hospitals, University; Humans; Integrons; Italy; Methyltransferases; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Plasmids; Polymerase Chain Reaction; Retrospective Studies; Sequence Analysis, DNA | 2016 |
In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tetracyclines; Tigecycline | 2016 |
Carbapenem-Resistant Acinetobacter baumannii: Concomitant Contamination of Air and Environmental Surfaces.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Air Microbiology; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Environmental Exposure; Humans; Intensive Care Units; Patients' Rooms; Rectum; Respiratory System | 2016 |
Head-to-Head Comparison of Two Multi-Locus Sequence Typing (MLST) Schemes for Characterization of Acinetobacter baumannii Outbreak and Sporadic Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2016 |
Antibiotic Resistance Profiles and Genetic Similarities Within a New Generation of Carbapenem-Resistant Acinetobacter calcoaceticus-A. baumannii Complex Resistotypes in Bosnia and Herzegovina.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Bosnia and Herzegovina; Carbapenems; Clone Cells; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Phylogeny; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Molecular Investigation of Carbapenem-Resistant Acinetobacter spp. from Hospitals in North Rhine-Westphalia, Germany.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clone Cells; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Germany; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Plasmids; Public Health Surveillance; Travel | 2017 |
Emergence of Carbapenem-Resistant Acinetobacter baumannii in Nursing Homes With High Background Rates of MRSA Colonization.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Female; Hong Kong; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Nursing Homes | 2016 |
Prediction of Putative Resistance Islands in a Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 Clinical Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Genomic Islands; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Evaluating the Impact of Antibiotic Exposures as Time-Dependent Variables on the Acquisition of Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Age Factors; Anti-Bacterial Agents; APACHE; Carbapenems; Comorbidity; Drug Resistance, Bacterial; Female; Florida; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sex Factors; Time Factors | 2016 |
Comparative in vitro activity of carbapenems against clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Doripenem; Humans; Imipenem; Iran; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2016 |
Detection of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Minocycline; Phylogeny; Plasmids; Polymerase Chain Reaction; Prevalence; Public Health Surveillance; Saudi Arabia; Tigecycline | 2017 |
Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2016 |
Persistence of Multidrug-Resistant Acinetobacter baumannii Isolates Harboring blaOXA-23 and bap for 5 Years.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Biofilms; Carbapenems; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentian Violet; Humans; Multiplex Polymerase Chain Reaction; Republic of Korea; Sequence Analysis, DNA; Time Factors | 2016 |
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cephalosporins; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Pneumonia, Ventilator-Associated; Pulmonary Surfactants; Risk Factors; Treatment Outcome | 2016 |
Abscess of Native Kidney Caused by Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Renal Transplantation: A Case Report.
Topics: Abscess; Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Infective Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Immunocompromised Host; Kidney Transplantation; Male | 2016 |
Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Disk Diffusion Antimicrobial Tests; Electrophoresis, Gel, Pulsed-Field; Female; French Guiana; Hospitals; Humans; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Retrospective Studies; Young Adult | 2016 |
Surveillance of antibiotic susceptibility in a Swedish Burn Center 1994-2012.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Burn Units; Burns; Carbapenems; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Klebsiella; Klebsiella Infections; Linear Models; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Staphylococcal Infections; Sweden; Urinary Tract Infections; Wound Infection; Young Adult | 2016 |
Clonal spread of blaOXA-72-carrying Acinetobacter baumannii sequence type 512 in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Humans; Multilocus Sequence Typing; Plasmids; Taiwan | 2016 |
Spread of carbapenem-resistant international clones of Acinetobacter baumannii in Turkey and Azerbaijan: a collaborative study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Azerbaijan; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Multiplex Polymerase Chain Reaction; Turkey | 2016 |
In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Fusidic Acid; Humans; Microbial Sensitivity Tests | 2016 |
Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amidohydrolases; Amikacin; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Imipenem; Microbial Sensitivity Tests; Minocycline; Rifampin; Tigecycline; Vancomycin | 2016 |
First Detection of VIM-4-Producing Pseudomonas aeruginosa and OXA-48-Producing Klebsiella pneumoniae in Northeastern (Annaba, Skikda) Algeria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa | 2017 |
Rapid Blue-Carba test: reduction in the detection time of carbapenemases performed from a 4-hour bacterial lawn.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, University; Humans; Inactivation, Metabolic; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections; Sensitivity and Specificity; Time Factors | 2017 |
Rapid species identification and epidemiological analysis of carbapenem-resistant Acinetobacter spp. by a PCR-based open reading frame typing method.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; DNA-Directed RNA Polymerases; Genotype; Humans; Molecular Typing; Open Reading Frames; Polymerase Chain Reaction; Sequence Analysis, DNA; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Time Factors | 2016 |
Antimicrobial resistance profiles and genetic elements involved in carbapenem resistance in Acinetobacter baumannii isolates from a referral hospital in Southern Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Iran; Microbial Sensitivity Tests | 2016 |
Clonal Transmission of Gram-Negative Bacteria with Carbapenemases NDM-1, VIM-1, and OXA-23/72 in a Bulgarian Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Bulgaria; Carbapenems; Escherichia coli; Gram-Negative Bacteria; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Pseudomonas aeruginosa | 2017 |
In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Prospective Studies; Republic of Korea; Rifampin; Tertiary Care Centers | 2016 |
Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Minocycline; Pneumonia, Bacterial; Retrospective Studies; Sulbactam; Taiwan; Tigecycline; Treatment Outcome | 2016 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in South America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genotype; Hospitals; Humans; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; South America | 2016 |
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacteriuria; beta-Lactamases; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sulbactam; Trachea; Wound Infection | 2016 |
In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole Alone and in Combination with Colistin against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Trimethoprim, Sulfamethoxazole Drug Combination | 2016 |
Is airborne transmission of Acinetobacter baumannii possible: A prospective molecular epidemiologic study in a tertiary care hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Air Microbiology; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Disease Transmission, Infectious; Humans; Intensive Care Units; Microbial Viability; Molecular Epidemiology; Molecular Typing; Prospective Studies; Tertiary Care Centers | 2016 |
Effects of silver nanoparticles in combination with antibiotics on the resistant bacteria Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Humans; Male; Metal Nanoparticles; Mice, Inbred C57BL; Microbial Sensitivity Tests; Peritonitis; Rifampin; Silver | 2016 |
Differences in Biofilm Mass, Expression of Biofilm-Associated Genes, and Resistance to Desiccation between Epidemic and Sporadic Clones of Carbapenem-Resistant Acinetobacter baumannii Sequence Type 191.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Biofilms; Carbapenems; Cross Infection; Desiccation; Epidemics; Genes, Bacterial; Humans; Republic of Korea | 2016 |
Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Iran; Microbial Sensitivity Tests; Minocycline; Sulbactam; Tigecycline; Tobramycin | 2016 |
Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Doxycycline; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
Carbapenem Breakpoints for Acinetobacter baumannii Group: Supporting Clinical Outcome Data from Patients with Bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacteremia; Carbapenems; Female; Humans; Middle Aged; Retrospective Studies; Treatment Outcome | 2016 |
Wide spread of OXA-23-producing carbapenem-resistant Acinetobacter baumannii belonging to clonal complex II in different hospitals in Lebanon.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Lebanon; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2016 |
Synergistic killing by meropenem and colistin combination of carbapenem-resistant Acinetobacter baumannii isolates from Chinese patients in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Asian People; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Humans; Meropenem; Microbial Sensitivity Tests; Microbial Viability; Models, Biological; Thienamycins | 2016 |
Emergence of New Delhi metallo-beta-lactamase 1 and other carbapenemase-producing Acinetobacter calcoaceticus-baumannii complex among patients in hospitals in Ha Noi, Viet Nam.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adolescent; Adult; Aged; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Female; Genotype; Hospitals; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Typing; Plasmids; Prospective Studies; Vietnam; Young Adult | 2017 |
Investigation of Extensively Drug-Resistant blaOXA-23-Producing Acinetobacter baumannii Spread in a Greek Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Greece; Hospitals; Humans; Intensive Care Units; Male; Membrane Transport Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Mutation; Retrospective Studies; Survival Analysis; Tigecycline; Transcription Factors | 2017 |
Does Thymoglobulin Induction Increase Susceptibility to Carbapenem-Resistant Acinetobacter baumannii Sepsis-related Death in Expanded Criteria Donors?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Antilymphocyte Serum; Brazil; Carbapenems; Delayed Graft Function; Disease Susceptibility; Donor Selection; Drug Resistance, Bacterial; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Odds Ratio; Pancreas Transplantation; Postoperative Complications; Retrospective Studies; Risk Factors; Sepsis; Tissue Donors | 2016 |
First report of an NDM-1 metallo-β-lactamase-producing Acinetobacter baumannii clinical isolate in Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Greece; Humans; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2016 |
Molecular characterisation of extensively drug-resistant Acinetobacter baumannii: First report of a new sequence type in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Italy | 2016 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA | 2017 |
Occurrence of Diverse AbGRI1-Type Genomic Islands in Acinetobacter baumannii Global Clone 2 Isolates from South Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genomic Islands; Genotype; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Republic of Korea | 2017 |
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Biofilms; Carbapenems; Cross Infection; Disk Diffusion Antimicrobial Tests; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genotype; Hemolysis; Humans; Lebanon; Microbial Sensitivity Tests; Peptide Hydrolases; Phenotype; Polymerase Chain Reaction; Siderophores; Virulence; Virulence Factors | 2016 |
Evaluation of a modified cleaning procedure in the prevention of carbapenem-resistant Acinetobacter baumannii clonal spread in a burn intensive care unit using a high-sensitivity luminometer.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Burn Units; Carbapenems; Cross Infection; Disease Transmission, Infectious; Disinfectants; Disinfection; Environmental Microbiology; Guideline Adherence; Hospitals, Teaching; Housekeeping, Hospital; Humans; Intensive Care Units; Italy; Luminescent Measurements; Quality Control | 2017 |
Control of carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit of a teaching hospital in Southern Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genotype; Humans; Infection Control; Intensive Care Units; Italy; Male; Middle Aged; Molecular Typing; Pneumonia, Ventilator-Associated; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2016 |
Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aerosols; Bacteriophages; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Incidence; Infection Control; Intensive Care Units; Prospective Studies | 2016 |
In vitro activity of antimicrobial agents against multidrug- and extensively drug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins | 2017 |
Molecular epidemiology of bla
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Follow-Up Studies; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2017 |
Growing OXA-23 type strains among carbapenem-resistant
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2016 |
Occurrence of bla
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gene Expression Regulation, Bacterial; Gene Transfer, Horizontal; Humans; India; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Pseudomonas aeruginosa; Pseudomonas Infections; Tertiary Care Centers; Transcription, Genetic | 2017 |
Antibacterial activity of epigallocatechin-3-gallate (EGCG) and its synergism with β-lactam antibiotics sensitizing carbapenem-associated multidrug resistant clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Catechin; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts | 2017 |
Genomic sequencing of a strain of Acinetobacter baumannii and potential mechanisms to antibiotics resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Base Sequence; beta-Lactamases; Carbapenems; DNA Repair; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gene Expression; Genome, Bacterial; Humans; INDEL Mutation; Microbial Sensitivity Tests; Middle Aged; Phylogeny; Polymorphism, Single Nucleotide; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2017 |
Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Longitudinal Studies; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Phenotype; Prevalence; Tandem Repeat Sequences; Vietnam; Young Adult | 2017 |
Carbapenem-resistance and pathogenicity of bovine Acinetobacter indicus-like isolates.
Topics: Acinetobacter; Acinetobacter Infections; Animals; beta-Lactam Resistance; Carbapenems; Cattle; Microbial Sensitivity Tests; Phylogeny; Virulence | 2017 |
Carbapenem-resistant Acinetobacter pittii strain harboring bla
Topics: Acinetobacter; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Female; Hospitalization; Humans; Middle Aged; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2017 |
Active surveillance for carbapenem-resistant Acinetobacter baumannii in a medical intensive care unit: Can it predict and reduce subsequent infections and the use of colistin?
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Patient Isolation; Population Surveillance; Predictive Value of Tests; Prospective Studies | 2017 |
First Report of the Carbapenemase Gene
Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Humans; Male; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2017 |
Comparison of the efficacies of three empirically-selected antibiotics for treating Acinetobacter baumannii pulmonary infection: experience from a teaching hospital in China
.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cefoperazone; China; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Male; Middle Aged; Minocycline; Respiratory Tract Infections; Retrospective Studies; Sputum; Sulbactam; Tigecycline; Time Factors; Treatment Outcome | 2017 |
Characterization of Acinetobacter baumannii carrying bla(OXA-23), bla(PER-1) and armA in a Korean hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Korea; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Sequence Analysis, DNA | 2008 |
Clonal spread of carbapenem-resistant OXA-23-positive Acinetobacter baumannii in a Bulgarian university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Bulgaria; Carbapenems; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genes, Bacterial; Genotype; Hospitals, University; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction | 2008 |
Colistin and rifampicin combination in the treatment of ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Rifampin; Treatment Outcome | 2008 |
Observations on carbapenem resistance by minimum inhibitory concentration in nosocomial isolates of Acinetobacter species: an experience at a tertiary care hospital in North India.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Colony Count, Microbial; Cross Infection; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; India; Microbial Sensitivity Tests; Treatment Outcome | 2008 |
Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Child; China; Cross Infection; Disease Outbreaks; Genes, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Membrane Transport Proteins; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2008 |
Investigation and management of an outbreak of multidrug-carbapenem-resistant Acinetobacter baumannii in Cambridge, UK.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Infection Control; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; United Kingdom | 2008 |
Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Belgium; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Genes, Bacterial; Humans | 2008 |
[Transmission and molecular characteristics of carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Humans | 2008 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in New Caledonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Conjugation, Genetic; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Isoelectric Focusing; Molecular Epidemiology; New Caledonia; Polymerase Chain Reaction | 2008 |
Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppression Therapy; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neutropenia; Pneumonia, Bacterial; Rifampin; Treatment Outcome | 2009 |
Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Conjugation, Genetic; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Middle Aged; Plasmids; United Arab Emirates | 2008 |
In vitro activity of doripenem against Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Doripenem; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2009 |
Increasing carbapenem resistance due to the clonal dissemination of oxacillinase (OXA-23 and OXA-58)-producing Acinetobacter baumannii: report from the Turkish SENTRY Program sites.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Sentinel Surveillance; Turkey | 2008 |
Dissemination of OXA-23-producing and carbapenem-resistant Acinetobacter baumannii in a University Hospital in Tunisia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Tunisia | 2008 |
Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Ireland; Male; Middle Aged; Molecular Epidemiology; Prevalence | 2009 |
Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Blotting, Southern; Carbapenems; Cluster Analysis; DNA Fingerprinting; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Genotype; Hospitals; Humans; Polymerase Chain Reaction; Taiwan | 2009 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Hospitals; Humans; Intensive Care Units; Mediterranean Region; Molecular Epidemiology | 2009 |
Diversity of plasmid-mediated carbapenem-hydrolysing oxacillinases among carbapenem-resistant Acinetobacter baumannii isolates from Kingdom of Bahrain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bahrain; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Plasmids | 2009 |
Investigation of carbapenem-resistant Acinetobacter baumannii isolates in a district hospital in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genotype; Hospitals, District; Humans; Plasmids; Taiwan | 2009 |
Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Plasmids; Thailand | 2009 |
Colonization of a medical center in Southern Taiwan by epidemic strains of carbapenem- and multidrug-resistant Acinetobacter baumannii and the genetic organization of their integrons.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Humans; Integrons; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; Taiwan | 2009 |
Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Ireland; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2009 |
Role of tigecycline in the control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Environmental Microbiology; Humans; Incidence; Intensive Care Units; Microbial Sensitivity Tests; Middle Aged; Minocycline; Molecular Epidemiology; Tigecycline; Young Adult | 2009 |
Endemic carbapenem-resistant Acinetobacter baumannii in a Brazilian intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Brazil; Carbapenems; Cross Infection; Endemic Diseases; Environmental Microbiology; Humans; Intensive Care Units | 2009 |
Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Time Factors | 2009 |
Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Canada; Carbapenems; Cluster Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Young Adult | 2009 |
Outbreak of carbapenem-resistant Acinetobacter baumannii carrying the carbapenemase OXA-23 in a German university medical centre.
Topics: Academic Medical Centers; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Germany; Humans; Infection Control; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Young Adult | 2009 |
Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Female; Mice; Mice, Inbred BALB C; Pneumonia, Bacterial; Time Factors; Trachea | 2009 |
Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Korea; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA | 2009 |
Characterization of Acinetobacter baumannii genotypes recovered from patients with repeated colonization or infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Carrier State; Cluster Analysis; DNA Fingerprinting; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Molecular Epidemiology | 2009 |
Occurrence of OXA-107 and ISAba1 in carbapenem-resistant isolates of Acinetobacter baumannii from Croatia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cluster Analysis; Croatia; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infant; Infant, Newborn; Intensive Care Units; Male; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Young Adult | 2009 |
Disruption of adeB gene has a greater effect on resistance to meropenems than adeA gene in Acinetobacter spp. isolated from University Malaya Medical Centre.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Malaysia; Membrane Transport Proteins; Meropenem; Models, Genetic; Mutation; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins | 2009 |
Swab cultures across three different body sites among carriers of carbapenem-resistant P. aeruginosa and Acinetobacter species: a poor surveillance strategy.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cross Infection; Humans; Mass Screening; Pseudomonas aeruginosa; Pseudomonas Infections | 2010 |
Carbapenem-resistant Acinetobacter baumannii infections after organ transplantation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Organ Transplantation | 2010 |
Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2009 |
[Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients].
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Turkey | 2009 |
Heteroresistance to meropenem in carbapenem-susceptible Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Greece; Humans; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2009 |
Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cefotaxime; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals; Humans; Imipenem; Iran; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins | 2009 |
Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii in a newly established Greek hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Electrophoresis, Gel, Pulsed-Field; Female; Greece; Humans; Infant; Infant, Newborn; Male; Middle Aged; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; Young Adult | 2009 |
In vitro activity of various combinations of antimicrobials against carbapenem-resistant Acinetobacter species in Singapore.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Microbial Viability; Singapore; Time Factors | 2009 |
Mutant prevention concentration of tigecycline for carbapenem-susceptible and -resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Mutation; Tigecycline | 2010 |
Differences in carbapenem resistance genes among Acinetobacterbaumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Codon, Nonsense; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Taiwan | 2010 |
Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Child; Child, Preschool; DNA Fingerprinting; DNA, Bacterial; Female; Gene Transfer, Horizontal; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Young Adult | 2010 |
Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cities; Cluster Analysis; DNA Fingerprinting; Genotype; Hospitals; Humans; Polymerase Chain Reaction; Sequence Analysis, DNA | 2010 |
Empiric combination antibiotic therapy is associated with improved outcome against sepsis due to Gram-negative bacteria: a retrospective analysis.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Cohort Studies; Drug Therapy, Combination; Escherichia coli Infections; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Sepsis; Shock, Septic | 2010 |
Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Australia; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disinfectants; Housekeeping, Hospital; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Peroxides; Sulfuric Acids | 2010 |
Molecular characterization of acinetobacter isolates collected in intensive care units of six hospitals in Florence, Italy, during a 3-year surveillance program: a population structure analysis.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cluster Analysis; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Genotype; Humans; Infant, Newborn; Intensive Care Units; Italy; Molecular Epidemiology; Polymorphism, Genetic; Young Adult | 2010 |
Prevalence of antibiotics resistance and OXA carbapenemases genes in multidrug-resistant Acinetobacter baumannii isolates in central Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Prevalence; Taiwan | 2010 |
Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aminoglycosides; beta-Lactamases; Carbapenems; Cephalosporins; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Taiwan | 2010 |
Multi-drug resistant Pseudomonas aeruginosa and Acinetobacter baumannii infections among hospitalized patients: risk factors and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2009 |
Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Cross Infection; Drug Resistance, Bacterial; Female; Greece; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Regression Analysis; Risk Factors | 2010 |
Clonal spread of carbapenem resistant Acinetobacter baumannii in the patients and their environment at BMA Medical College and Vajira Hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Patients' Rooms; Prospective Studies; Thailand; Young Adult | 2009 |
Antibacterial activity of carbapenem-based combinations againts multidrug-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Analysis of Variance; Anti-Bacterial Agents; Area Under Curve; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Humans; Imipenem; In Vitro Techniques; Meropenem; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Sulbactam; Thienamycins | 2010 |
In vitro double and triple bactericidal activities of doripenem, polymyxin B, and rifampin against multidrug-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Klebsiella pneumoniae, and Escherichia coli.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin | 2010 |
Multidrug resistant Acinetobacter baumannii: risk factors for appearance of imipenem resistant strains on patients formerly with susceptible strains.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Treatment Outcome | 2010 |
Outbreak of resistant Acinetobacter baumannii- measures and proposal for prevention and control.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Risk Factors; Severity of Illness Index | 2009 |
Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Young Adult | 2010 |
CHROMagar Acinetobacter is not selective for carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Culture Media; Humans; Sensitivity and Specificity | 2010 |
Characterisation of carbapenem-resistant Acinetobacter baumannii outbreak strains producing OXA-58 in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Child; Disease Outbreaks; Drug Resistance, Bacterial; Female; Genes, Bacterial; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Turkey | 2010 |
Risk factors for 30-day mortality in patients with carbapenem-resistant Acinetobacter baumannii during an outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Female; Humans; Intensive Care Units; Male; Risk Factors; Shock, Septic | 2011 |
Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Child; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Female; Genes, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Molecular Sequence Data; Ohio; Sequence Analysis, DNA; Young Adult | 2010 |
In vitro activities of tigecycline alone and in combination with colistin sulfate or sulbactam against carbapenem-susceptible and -resistant Acinetobacter baumannii strains isolated from Intensive Care Units.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Bacterial; Drug Synergism; Humans; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Minocycline; Sulbactam; Thienamycins; Tigecycline | 2010 |
[Carbapenem and multidrug-resistant Acinetobacter baumannii colonisation/infection: epidemiology and factors associated with infection].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Prospective Studies; Young Adult | 2010 |
Synergistic activities between carbapenems and other antimicrobial agents against Acinetobacter baumannii including multidrug-resistant and extensively drug-resistant isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Infective Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests | 2010 |
In vitro activity of tigecycline and other tetracyclines against carbapenem-resistant Acinetobacter species: report from a tertiary care centre in Karachi, Pakistan.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Minocycline; Pakistan; Tetracyclines; Tigecycline | 2010 |
[Variability in the sensitivity to tigecycline against Acinetobacter baumannii in different culture media].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Culture Media; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reproducibility of Results; Tigecycline | 2010 |
[A case of hospital-acquired pneumonia caused by intermediately susceptible carbapenem Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Carbapenems; Cross Infection; Humans; Male; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones | 2010 |
Risk factors for carbapenem-resistant Acinetobacter baumannii infections at a tertiary care hospital in New Caledonia, South Pacific.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross Infection; Female; Hospitals; Humans; Male; Middle Aged; New Caledonia; Risk Factors; Treatment Outcome | 2010 |
Intramuscularly administered peptide A3-APO is effective against carbapenem-resistant Acinetobacter baumannii in mouse models of systemic infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Disease Models, Animal; Drug Resistance, Bacterial; Female; Mice; Peptides | 2011 |
High prevalence of bla(OXA)-23 in oligoclonal carbapenem-resistant Acinetobacter baumannii from Siriraj Hospital, Mahidol University, Bangkok, Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Genetic Markers; Humans; Plasmids; Thailand | 2010 |
Outbreak of carbapenem-resistant Acinetobacter baumannii among non-burn patients in a burn intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; Burn Units; Carbapenems; Disease Outbreaks; Female; Humans; Intensive Care Units; Male; Middle Aged; Risk Factors | 2010 |
Carbapenemase-producing Acinetobacter baumannii, Algeria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Intensive Care Units; Microbial Sensitivity Tests | 2010 |
Rifampin resistance in carbapenem-resistant Acinetobacter baumannii in Siriraj Hospital, Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Rifampin; Thailand | 2009 |
A multicenter study of risk factors and outcome of hospitalized patients with infections due to carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheterization, Central Venous; Child; Child, Preschool; Cross Infection; Drug Resistance, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged; Risk Factors; Taiwan; Treatment Outcome; Young Adult | 2010 |
Sequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 years.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cluster Analysis; DNA Fingerprinting; Humans; Molecular Epidemiology; Portugal; Sequence Analysis, DNA | 2010 |
Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Female; Humans; Male; Membrane Transport Proteins; Middle Aged; Minocycline; Molecular Sequence Data; Mutagenesis, Insertional; Reverse Transcriptase Polymerase Chain Reaction; Tigecycline | 2010 |
Acinetobacter baumannii 2002-2008: increase of carbapenem-associated multiclass resistance in the United States.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Databases, Factual; Drug Resistance, Multiple, Bacterial; Hospitalization; Humans; Internet; Logistic Models; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Risk Factors; United States | 2010 |
Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Bacteremia; Blood; Carbapenems; Cross Infection; Culture Media; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Intensive Care Units; Length of Stay; Male; Microbial Sensitivity Tests; Middle Aged | 2010 |
Gut colonization by multidrug-resistant and carbapenem-resistant Acinetobacter baumannii in neonates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Blood; Carbapenems; Culture Media; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Gastrointestinal Tract; Humans; India; Intensive Care, Neonatal; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Sequence Analysis, DNA | 2010 |
[Comparative activity of doripenem, meropenem, and imipenem in recent clinical isolates obtained during the COMPACT-Spain epidemiological surveillance study].
Topics: Acinetobacter Infections; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Carbapenems; Doripenem; Enterobacteriaceae Infections; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas Infections; Spain; Thienamycins | 2010 |
Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia.
Topics: Acinetobacter Infections; Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Europe; Female; Humans; Intensive Care Units; Length of Stay; Male; Middle Aged; Piperacillin; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Quinolones; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2011 |
Carbapenem-resistant OXA-23-producing Acinetobacter baumannii isolates causing ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; Critical Care; Drug Resistance, Bacterial; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated | 2010 |
In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Fatal Outcome; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation, Missense; Reverse Transcriptase Polymerase Chain Reaction | 2010 |
Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; DNA-Directed RNA Polymerases; DNA, Bacterial; Genotype; Hospitals; Humans; Korea; Molecular Epidemiology; Multilocus Sequence Typing; Phylogeny; Polymerase Chain Reaction | 2011 |
[Investigation of presence of class 1 integrons in clinical isolates of carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Integrons; Polymerase Chain Reaction | 2010 |
[In vitro tigecycline and carbapenem susceptibilities of clinical Acinetobacter baumannii isolates].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
An outbreak of carbapenem-resistant Acinetobacter baumannii infection in a neonatal intensive care unit: investigation and control.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Contact Tracing; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals, Teaching; Humans; Infant; Infant, Newborn; Intensive Care Units, Neonatal; Medical Audit; Michigan | 2011 |
ISAba825, a functional insertion sequence modulating genomic plasticity and bla(OXA-58) expression in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Gene Expression Regulation, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Global spread of New Delhi metallo-β-lactamase 1.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Germany; Humans | 2010 |
Detection of CTX-M-15-producing and carbapenem-resistant Acinetobacter baumannii strains from urine from an Indian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; India; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Urinary Tract Infections; Urine | 2010 |
Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Animals; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Models, Animal; Female; Genes, Bacterial; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Republic of Korea; Rifampin; Risk Factors | 2011 |
Presence of OXA-23-producing isolates of Acinetobacter baumannii in wastewater from hospitals in southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Medical Waste; Microbial Sensitivity Tests; Polymerase Chain Reaction; Water Pollutants | 2011 |
Should polymyxin be used empirically to treat infections in patients under high risk for carbapenem-resistant Acinetobacter?
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Brazil; Carbapenems; Child; Cross Infection; Female; Humans; Male; Middle Aged; Polymyxins; Survival Analysis; Young Adult | 2011 |
High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Female; Hospitals, Teaching; Humans; Imipenem; Iran; Male; Meropenem; Middle Aged; Polymerase Chain Reaction; Prevalence; Thienamycins; Young Adult | 2011 |
Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Prevalence; Thailand | 2009 |
Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Croatia; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Molecular Typing; Sequence Analysis, DNA | 2011 |
High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Organ Transplantation; Transplantation; Treatment Outcome | 2011 |
Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Integrases; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Pakistan; Private Sector; Public Sector; Young Adult | 2011 |
Gastrointestinal selective capacity of doripenem, meropenem, and imipenem for carbapenem-resistant gram-negative bacilli in treated patients with pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Bacterial; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Rectum; Stenotrophomonas maltophilia; Thienamycins | 2011 |
Intrahospital dissemination of carbapenem-resistant Acinetobacter baumannii and analysis of the infected patients' prognosis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cerebrovascular Disorders; Cross Infection; Drug Resistance, Microbial; Female; Humans; Intensive Care Units; Male; Middle Aged; Prognosis; Pulmonary Disease, Chronic Obstructive; Risk Factors | 2011 |
Community-acquired carbapenem-resistant Acinetobacter baumannii urinary tract infection just after marriage in a renal transplant recipient.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; beta-Lactam Resistance; Carbapenems; Community-Acquired Infections; Female; Humans; Kidney Transplantation; Marriage; Microbial Sensitivity Tests; Postoperative Complications; Urinary Tract Infections | 2011 |
Evaluation of an automated system for the detection of carbapenem resistant Acinetobacter baumannii and assessment of metallo-β-lactamase production using two different phenotyping methods.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Microbial Sensitivity Tests | 2011 |
Carbapenem-resistant Acinetobacter baumannii: diversity of resistant mechanisms and risk factors for infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Chi-Square Distribution; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Republic of Korea; Risk Factors; Statistics, Nonparametric; Thienamycins | 2012 |
Widespread carbapenem resistant Acinetobacter baumannii clones in Italian hospitals revealed by a multicenter study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Genotype; Hospitals; Humans; Italy; Multilocus Sequence Typing; Phylogeny; Sequence Analysis, DNA | 2011 |
Comparative in vitro antimicrobial susceptibilities and synergistic activities of antimicrobial combinations against carbapenem-resistant Acinetobacter species: Acinetobacter baumannii versus Acinetobacter genospecies 3 and 13TU.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Genotype; Hospitals, University; Humans; Microbial Sensitivity Tests; Microbial Viability; Taiwan; Time Factors | 2011 |
Clinical and molecular microbiological characteristics of carbapenem-resistant Acinetobacter baumannii strains in an NICU.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; China; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Incidence; Infant, Newborn; Intensive Care Units, Neonatal; Male; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction | 2011 |
Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Germany; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2011 |
Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Disease Outbreaks; Female; Hospitals; Humans; Italy; Male; Middle Aged; Multilocus Sequence Typing; Young Adult | 2011 |
Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacteremia; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Incidence; Logistic Models; Male; Middle Aged; Retrospective Studies; Risk Factors; Thailand; Treatment Outcome; Young Adult | 2011 |
Evolution of antimicrobial resistance of Acinetobacter baumannii in a university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Brazil; Carbapenems; Hospitals, University; Humans | 2011 |
Epidemiological characterization and distribution of carbapenem-resistant Acinetobacter baumannii clinical isolates in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cluster Analysis; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Infant; Italy; Male; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Young Adult | 2012 |
Acinetobacter calcoaceticus-Acinetobacter baumannii complex species in clinical specimens in Singapore.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Hospitals; Humans; Molecular Typing; Prevalence; Singapore | 2012 |
Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Thailand; Treatment Outcome; Young Adult | 2011 |
Bloodstream infections with OXA-23-producing Acinetobacter baumannii isolates in a university-affiliated hospital in Brazil: epidemiology and clinical outcomes.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2011 |
Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and P. aeruginosa in Korea: KONSAR study 2009.
Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea | 2011 |
Outcomes in patients infected with carbapenem-resistant Acinetobacter baumannii and treated with tigecycline alone or in combination therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Therapy, Combination; Drug Utilization; Female; Hospitals; Humans; Male; Middle Aged; Minocycline; Retrospective Studies; Tigecycline; Treatment Outcome; Turkey; Young Adult | 2011 |
Clonal spread of carbapenem-resistant OXA-72-positive Acinetobacter baumannii in a Croatian university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Croatia; Cross Infection; Drug Resistance, Bacterial; Genotyping Techniques; Hospitals, University; Humans; Microbial Sensitivity Tests | 2011 |
Carbapenem susceptibility testing errors using three automated systems, disk diffusion, Etest, and broth microdilution and carbapenem resistance genes in isolates of Acinetobacter baumannii-calcoaceticus complex.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Doripenem; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2011 |
Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Intensive Care Units; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Species Specificity | 2011 |
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxins; Retrospective Studies; Treatment Outcome | 2011 |
A diversity of OXA-carbapenemases and class 1 integrons among carbapenem-resistant Acinetobacter baumannii clinical isolates from Sweden belonging to different international clonal lineages.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Genetic Variation; Greece; Humans; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Poland; Polymerase Chain Reaction; Sequence Analysis, DNA; Sweden | 2011 |
Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Genotype; Hospitals; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Species Specificity; Thienamycins | 2012 |
Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Integrons; Japan; Microbial Sensitivity Tests; Multilocus Sequence Typing; RNA, Ribosomal, 16S; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2011 |
Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Multiplex Polymerase Chain Reaction; Taiwan | 2011 |
AbaR4 replaces AbaR3 in a carbapenem-resistant Acinetobacter baumannii isolate belonging to global clone 1 from an Australian hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Australia; Bacterial Proteins; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Carbapenems; Carrier Proteins; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genomic Islands; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Multilocus Sequence Typing; Sequence Alignment; Sequence Analysis, DNA | 2011 |
Emergence and clonal dissemination of carbapenem-hydrolysing OXA-58-producing Acinetobacter baumannii isolates in Bolivia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Bolivia; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Imipenem; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Young Adult | 2012 |
Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Romania | 2011 |
Molecular epidemiology of carbapenem-nonsusceptible Acinetobacter baumannii in the United States.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cluster Analysis; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Humans; Molecular Epidemiology; Molecular Typing; United States | 2011 |
Evolution of multidrug-resistant Acinetobacter baumannii clonal lineages: a 10 year study in Greece (2000-09).
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cluster Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Greece; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2011 |
Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Carbapenems; Cell Line; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Porins; Virulence | 2011 |
Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillin-Binding Proteins; Point Mutation; Sequence Analysis, DNA; Spain | 2011 |
Production of a plasmid-encoded OXA-72 β-lactamase associated with resistance to carbapenems in a clinical isolate Acinetobacter junii.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Plasmids | 2012 |
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; Carbapenems; Cross Infection; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Real-Time Polymerase Chain Reaction; Republic of Korea | 2012 |
Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Humans; Imipenem; Microbial Sensitivity Tests; Mutation; Nuclear Proteins; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic | 2012 |
Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; Carbapenems; Humans; Specimen Handling | 2012 |
Emergence of carbapenem-resistant non-baumannii species of Acinetobacter harboring a blaOXA-51-like gene that is intrinsic to A. baumannii.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA; Taiwan; Young Adult | 2012 |
[Analysis of clinical characteristics and antimicrobial resistance of carbapenem-resistant Acinetobacter baumannii infections in children].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Anti-Infective Agents; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Pneumonia, Bacterial; Retrospective Studies | 2011 |
Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Acute Disease; Animals; Anti-Bacterial Agents; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Cytokines; Disease Models, Animal; Drug Combinations; Drug Resistance, Bacterial; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Pneumonia, Bacterial; Stem Cells; Thienamycins | 2012 |
Multidrug and carbapenem-resistant Acinetobacter baumannii infections: Factors associated with mortality.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Young Adult | 2012 |
Identification of the naturally occurring genes encoding carbapenem-hydrolysing oxacillinases from Acinetobacter haemolyticus, Acinetobacter johnsonii, and Acinetobacter calcoaceticus.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Phylogeny; Polymerase Chain Reaction; Sequence Alignment | 2012 |
Tn125-related acquisition of blaNDM-like genes in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Switzerland | 2012 |
Severe infection in a lung transplant recipient caused by donor-transmitted carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacteremia; beta-Lactam Resistance; Carbapenems; Fatal Outcome; Female; Humans; Lung Transplantation; Middle Aged; Time Factors; Tissue Donors | 2012 |
NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA, Bacterial; Female; Genotype; Humans; Middle Aged; Molecular Sequence Data; Molecular Typing; Neoplasms; Sequence Analysis, DNA; United Arab Emirates; Urine | 2012 |
Mortality attributable to carbapenem-resistant nosocomial Acinetobacter baumannii infections in a Turkish university hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Penicillins; Proportional Hazards Models; Retrospective Studies; Risk Factors; Turkey | 2012 |
Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Humans; Infant; Microbial Sensitivity Tests; Prevalence; Respiratory Tract Infections; Retrospective Studies; Syria; Urinary Tract Infections; Young Adult | 2012 |
"Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Carrier State; Cohort Studies; Coinfection; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Molecular Epidemiology; Molecular Typing; Pseudomonas aeruginosa; Pseudomonas Infections | 2012 |
Molecular characterization of carbapenem-non-susceptible Acinetobacter spp. in Japan: predominance of multidrug-resistant Acinetobacter baumannii clonal complex 92 and IMP-type metallo-β-lactamase-producing non-baumannii Acinetobacter species.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction | 2012 |
Three distinct clones of carbapenem-resistant Acinetobacter baumannii with high diversity of carbapenemases isolated from patients in two hospitals in Kuwait.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Teaching; Humans; Kuwait; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2012 |
Tn6167, an antibiotic resistance island in an Australian carbapenem-resistant Acinetobacter baumannii GC2, ST92 isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Australia; beta-Lactam Resistance; Carbapenems; Cluster Analysis; DNA Transposable Elements; DNA, Bacterial; Gene Order; Genes, Bacterial; Genomic Islands; Humans; Molecular Sequence Data; Multilocus Sequence Typing; Sequence Analysis, DNA | 2012 |
Prevalence of OXA-type β-lactamases among Acinetobacter baumannii isolates from Northwest of Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; DNA Transposable Elements; Female; Genes, Bacterial; Humans; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Plasmids; Polymerase Chain Reaction | 2012 |
First carbapenem-resistant isolates of Acinetobacter soli in Japan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Japan; Microbial Sensitivity Tests; Sequence Analysis, DNA | 2012 |
Rapid detection of carbapenem resistance in Acinetobacter baumannii using matrix-assisted laser desorption ionization-time of flight mass spectrometry.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Diagnostic Techniques and Procedures; Drug Resistance, Bacterial; Humans; Point-of-Care Systems; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2012 |
Retrospective evaluation of colistin versus tigecycline for the treatment of Acinetobacter baumannii and/or carbapenem-resistant Enterobacteriaceae infections.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Cohort Studies; Colistin; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Michigan; Middle Aged; Minocycline; Retrospective Studies; Severity of Illness Index; Survival Analysis; Tigecycline; Treatment Outcome | 2012 |
Prevalence and analysis of microbiological factors associated with phenotypic heterogeneous resistance to carbapenems in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Phenotype; Prevalence; Spain | 2012 |
Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; Genotype; Humans; Japan; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing | 2012 |
High prevalence of OXA-143 and alteration of outer membrane proteins in carbapenem-resistant Acinetobacter spp. isolates in Brazil.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cluster Analysis; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Electrophoresis, Polyacrylamide Gel; Genotype; Humans; Microbial Sensitivity Tests; Molecular Typing; Molecular Weight; Polymerase Chain Reaction; Prevalence | 2012 |
Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Integrons; Iran; Microbial Sensitivity Tests; Molecular Epidemiology; Multiplex Polymerase Chain Reaction; Polymerase Chain Reaction; Sequence Analysis, DNA | 2012 |
Bacteremia caused by Acinetobacter junii at a medical center in Taiwan, 2000-2010.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Catheter-Related Infections; Central Venous Catheters; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Female; Hospital Mortality; Humans; Incidence; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; RNA, Ribosomal, 16S; Sequence Analysis, RNA; Taiwan; Tertiary Care Centers; Tigecycline | 2012 |
Risk factors for mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: impact of appropriate antimicrobial therapy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Age Factors; Aged; Anti-Bacterial Agents; APACHE; Carbapenems; Diabetes Complications; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Odds Ratio; Pneumonia; Prognosis; Retrospective Studies; Risk Factors; Shock, Septic; Survival Rate | 2012 |
Risk factors and clinical outcomes of patients with carbapenem-resistant Acinetobacter baumannii bacteremia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Survival Analysis; Taiwan; Treatment Outcome | 2012 |
Carbapenem-hydrolyzing oxacillinase in high resistant strains of Acinetobacter baumannii isolated from India.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Hydrolysis; India; Microbial Sensitivity Tests; Molecular Sequence Data | 2012 |
Carbapenemase-producing Acinetobacter baumannii in two university hospitals in Algeria.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Algeria; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals, University; Humans; Polymerase Chain Reaction | 2012 |
Increase of carbapenem-resistant Acinetobacter baumannii infection in acute care hospitals in Taiwan: association with hospital antimicrobial usage.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; Databases, Factual; Drug Resistance, Bacterial; Hospitals; Humans; Incidence; Prevalence; Taiwan | 2012 |
[Molecular epidemiological characteristics of clinically isolated carbapenem-resistant Acinetobacter baumannii in Changsha].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Molecular Epidemiology; Piperacillin; Polymerase Chain Reaction | 2012 |
Variations of AbaR4-type resistance islands in Acinetobacter baumannii isolates from South Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Republic of Korea | 2012 |
AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Republic of Korea; Thailand | 2012 |
Persistence of carbapenem-resistant Acinetobacter baumannii strains in an Italian intensive care unit during a forty-six month study period.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitalization; Humans; Intensive Care Units; Italy; Male; Middle Aged | 2012 |
Carbapenem-susceptible Acinetobacter baumannii carrying the ISAba1 upstream blaOXA-51-like gene in Porto Alegre, southern Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Humans; Integrases; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology | 2013 |
Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Disinfectants; Disinfection; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrogen Peroxide; Intensive Care Units; Male; Microbial Sensitivity Tests; Molecular Typing; Volatilization | 2012 |
Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Down-Regulation; Drug Resistance, Bacterial; Proteomics; Tandem Mass Spectrometry; Up-Regulation | 2012 |
Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Coinfection; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Minocycline; Pseudomonas aeruginosa; Pseudomonas Infections; Republic of Korea; Retrospective Studies; Survival Rate; Tigecycline | 2012 |
[Risk factors for acquired multidrug-resistant Acinetobacter baumannii colonization in respiratory intensive care unit].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Male; Middle Aged; Respiration, Artificial; Respiratory Care Units; Retrospective Studies; Risk Factors; Young Adult | 2012 |
Epidemiological and clinical features associated with colonisation/infection by Acinetobacter baumannii with phenotypic heterogeneous resistance to carbapenems.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Risk Factors | 2012 |
Epidemiology and clonality of carbapenem-resistant Acinetobacter baumannii from an intensive care unit in Palermo, Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Carbapenems; Clone Cells; Demography; Drug Resistance, Multiple, Bacterial; Female; Humans; Intensive Care Units; Italy; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction; Time Factors; Young Adult | 2012 |
Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Drug Resistance, Multiple, Bacterial; Equipment and Supplies, Hospital; Humans; Intensive Care Units; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Clonal Evolution; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Genetic Variation; Genotype; Humans; Male; Molecular Epidemiology; Molecular Sequence Data; Molecular Typing; Portugal; Sequence Analysis, DNA | 2012 |
Risk factors for carbapenem non-susceptibility and mortality in Acinetobacter baumannii bacteremia in children.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Bacteremia; Carbapenems; Child; Child, Preschool; Drug Resistance, Bacterial; Female; Humans; In Vitro Techniques; Infant; Infant, Newborn; Logistic Models; Microbial Sensitivity Tests; Retrospective Studies; Survival Rate; Thailand | 2012 |
Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Carbapenems; Drug Resistance, Bacterial; Humans; Lethal Dose 50; Lung; Male; Mice; Peritoneum; Peritonitis; Pneumonia; Structure-Activity Relationship | 2012 |
Acinetobacter baumannii as a cause of sepsis.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Sepsis | 2012 |
Comparative evaluation of tigecycline susceptibility testing methods for expanded-spectrum cephalosporin- and carbapenem-resistant gram-negative pathogens.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2012 |
Fast assessment of resistance to carbapenems and ciprofloxacin of clinical strains of Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests | 2012 |
Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Analysis of Variance; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Chi-Square Distribution; Female; Humans; Infant, Newborn; Intensive Care Units, Neonatal; Male; Odds Ratio; Risk Factors; Statistics, Nonparametric; Thailand; Treatment Outcome | 2013 |
ESBL- and MBL-mediated resistance in Acinetobacter baumannii: a global threat to burn patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Burn Units; Burns; Carbapenems; Ceftazidime; Child; Child, Preschool; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Infant; Iran; Male; Microbial Sensitivity Tests; Middle Aged; Phenotype; Prevalence; Young Adult | 2012 |
Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cloning, Molecular; Cluster Analysis; Disease Outbreaks; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Gene Expression Profiling; Genetic Vectors; Genotype; Humans; Microbial Sensitivity Tests; Molecular Typing; Poland; Polymerase Chain Reaction; Sequence Analysis, DNA; Transformation, Bacterial | 2013 |
Investigation of Acinetobacter baumannii resistance to carbapenems in Marseille hospitals, south of France: a transition from an epidemic to an endemic situation.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; France; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymerase Chain Reaction | 2013 |
Genome sequence of Acinetobacter baumannii AC12, a polymyxin-resistant strain isolated from Terengganu, Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Genome, Bacterial; Malaysia; Molecular Sequence Data; Polymyxins; Sequence Analysis, DNA | 2012 |
First report of an OXA-23 carbapenemase-producing Acinetobacter baumannii clinical isolate related to Tn2006 in Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; DNA Transposable Elements; Electrophoresis, Gel, Pulsed-Field; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Spain | 2013 |
Emergence of the OXA-23 carbapenemase-encoding gene in multidrug-resistant Acinetobacter baumannii clinical isolates from the Principal Hospital of Dakar, Senegal.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Female; Hospitals; Humans; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Senegal; Young Adult | 2013 |
Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii isolates in Kuwait.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Kuwait; Plasmids | 2013 |
Risk factors and outcomes in patients with carbapenem-resistant Acinetobacter infection.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Analysis of Variance; Anti-Bacterial Agents; Carbapenems; Critical Care; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Lung Diseases; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; Risk Factors; Treatment Outcome | 2013 |
Identification of a novel insertion sequence element associated with carbapenem resistance and the development of fluoroquinolone resistance in Acinetobacter radioresistens.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; DNA Transposable Elements; DNA, Bacterial; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2013 |
Nosocomial spread of carbapenem-resistant Acinetobacter baumannii (types ST75 and ST137) carrying blaOXA-23-like gene with an upstream ISAba1 in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Alleles; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Cross Infection; Gene Expression; Humans; Multilocus Sequence Typing | 2013 |
Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Carrier State; Cohort Studies; Cross Infection; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Humans; Infection Control; Male; Mass Screening; Middle Aged; Organs at Risk; Prevalence; Prospective Studies | 2013 |
Molecular and epidemiological characterization of carbapenem-resistant Acinetobacter baumannii in non-tertiary Korean hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Polymerase Chain Reaction; Prevalence; Republic of Korea | 2013 |
Dissemination of a carbapenem-resistant Acinetobacter baumannii strain belonging to international clone II/sequence type 2 and harboring a novel AbaR4-like resistance island in Latvia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; DNA Transposable Elements; Genes, MDR; Genomic Islands; Integrons; Latvia; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data | 2013 |
Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Biological Transport, Active; Carbapenems; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Humans; Leukocyte L1 Antigen Complex; Lung; Manganese; Mice; Mice, Knockout; Neutrophil Infiltration; Neutrophils; Pneumonia, Bacterial; Zinc | 2012 |
The influence of carbapenem resistance on mortality in solid organ transplant recipients with Acinetobacter baumannii infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Immunocompromised Host; Kidney Transplantation; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Survival Analysis; Transplantation; Treatment Outcome | 2012 |
Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Child; Child, Hospitalized; Child, Preschool; Cross Infection; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Pseudomonas; Pseudomonas Infections; Survival Analysis | 2013 |
Diverse carbapenem-resistance mechanisms in 16S rRNA methylase-producing Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Hospitals, University; Humans; Japan; Methyltransferases; Microbial Sensitivity Tests; Multilocus Sequence Typing | 2013 |
Imported and intensive care unit-born Acinetobacter baumannii clonal complexes: one-year prospective cohort study in intensive care patients.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; Brazil; Carbapenems; Cohort Studies; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Intensive Care Units; Multilocus Sequence Typing; Polymerase Chain Reaction; Prospective Studies; Random Amplified Polymorphic DNA Technique | 2013 |
Detection of tripoli metallo-β-lactamase 2 (TMB-2), a variant of blaTMB-1, in clinical isolates of Acinetobacter spp. in Japan.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Japan; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2013 |
Longitudinal surveillance for meningitis by Acinetobacter in a large urban setting in Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brazil; Carbapenems; Child; Child, Preschool; Colistin; Drug Resistance, Multiple, Bacterial; Epidemiological Monitoring; Female; Humans; Male; Meningitis, Bacterial; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Urban Population; Young Adult | 2013 |
The resistance mechanisms of b-lactam antimicrobials in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Humans | 2002 |
Endemic carbapenem resistance associated with OXA-40 carbapenemase among Acinetobacter baumannii isolates from a hospital in northern Spain.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Endemic Diseases; Hospital Bed Capacity, 100 to 299; Hospitals, Urban; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA; Spain | 2002 |
Population structure and antibiotic resistance of Acinetobacter DNA group 2 and 13TU isolates from hospitals in the UK.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cluster Analysis; Colistin; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Random Amplified Polymorphic DNA Technique; United Kingdom | 2002 |
Environmental contamination during a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Disease Outbreaks; Disease Reservoirs; Environmental Microbiology; Environmental Monitoring; Epidemiological Monitoring; Equipment Contamination; Humans; Infection Control; Intensive Care Units; Microbial Sensitivity Tests; Turkey | 2002 |
Identification of an epidemic carbapenem-resistant Acinetobacter baumannii strain at hospitals in Buenos Aires City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Argentina; Carbapenems; Drug Resistance, Microbial; Female; Hospitals; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Sensitivity and Specificity; Urban Population | 2003 |
Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Infection Control; London; Phenotype | 2003 |
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; beta-Lactamases; Brazil; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Middle Aged | 2003 |
The activity of meropenem and comparators against Acinetobacter strains isolated from European hospitals, 1997-2000.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Europe; Humans; Meropenem; Thienamycins | 2003 |
Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Biological Transport; Carbapenems; Carrier Proteins; Disease Outbreaks; DNA Fingerprinting; Drug Resistance; Drug Resistance, Bacterial; Drug Resistance, Multiple; Hexosyltransferases; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Muramoylpentapeptide Carboxypeptidase; New York City; Penicillin-Binding Proteins; Peptidyl Transferases | 2003 |
Spread of low-level carbapenem-resistant Acinetobacter baumannii clones in a tertiary care Greek hospital.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Drug Resistance, Bacterial; Greece; Hospitals; Microbial Sensitivity Tests; Reverse Transcriptase Polymerase Chain Reaction | 2003 |
Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Humans; Italy; Microbial Sensitivity Tests | 2004 |
Typing and characterization of carbapenem-resistant Acinetobacter calcoaceticus-baumannii complex in a Chinese hospital.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; China; Clavulanic Acid; Cloxacillin; Cross Infection; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enzyme Inhibitors; Genes, Bacterial; Genotype; Imipenem; Isoelectric Focusing; Isoelectric Point; Microbial Sensitivity Tests; Molecular Epidemiology; Sequence Analysis, DNA | 2004 |
[Carbapenem resistance and Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Multicenter Studies as Topic; Spain | 2004 |
[Carbapenemase detection in Acinetobacter baumannii clones resistant to imipenem].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Multicenter Studies as Topic; Spain; Thienamycins | 2004 |
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Humans; Latin America; Microbial Sensitivity Tests; Population Surveillance; Ribotyping | 2004 |
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Rifampin; Tobramycin | 2004 |
A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; France; Hospitals, University; Humans; Imipenem; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA | 2005 |
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Imipenem; Latin America; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas fluorescens; Pseudomonas Infections; Ribotyping; Sentinel Surveillance | 2005 |
Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amino Acid Sequence; Anti-Bacterial Agents; Argentina; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Imipenem; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction | 2005 |
Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997-2002.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Hospital Mortality; Humans; Incidence; Israel | 2005 |
Hospital outbreak caused by a carbapenem-resistant strain of Acinetobacter baumannii: patient prognosis and risk-factors for colonisation and infection.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Catheterization, Peripheral; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Humans; Hypotension; Imipenem; Logistic Models; Male; Risk Factors; Shock; Spain | 2005 |
Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Colistin; Critical Illness; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Rifampin; Treatment Outcome | 2005 |
Prevalence of metallo-beta-lactamase among Pseudomonas aeruginosa and Acinetobacter baumannii isolated from burn wounds and in vitro activities of antibiotic combinations against these isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Burn Units; Burns; Carbapenems; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Opportunistic Infections; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |
Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Disease Outbreaks; Female; Hospital Bed Capacity, 300 to 499; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Polynesia | 2005 |
Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Europe; Humans; Microbial Sensitivity Tests; Plasmids | 2005 |
OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia.
Topics: Acinetobacter; Acinetobacter Infections; Australia; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Hydrolysis; Imidazoles; Piperidines | 2006 |
Characterization of carbapenem-resistant Acinetobacter baumannii in Shanghai and Hong Kong.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; Carbapenems; China; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hong Kong; Humans | 2006 |
First report of the carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter baumannii isolates in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Blood; Carbapenems; Colony Count, Microbial; Disease Outbreaks; Drug Resistance, Bacterial; Hospitals, University; Hydrolysis; Imipenem; Italy; Microbial Sensitivity Tests; Pharynx; Urine; Wounds and Injuries | 2006 |
Fatal multidrug-resistant Acinetobacter baumannii sepsis in a patient with travel history and recent onset of systemic lupus erythematosus: a case report.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Female; Greece; Humans; Lupus Erythematosus, Systemic; Sepsis; Travel | 2006 |
Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Ceftazidime; Chicago; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Humans; Indiana; Isoelectric Focusing; Microbial Sensitivity Tests; Polymerase Chain Reaction | 2006 |
Outbreak of infection by carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-58 in Belgium.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Belgium; beta-Lactamases; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged | 2006 |
Carriage of OXA-58 but not of OXA-51 beta-lactamase gene correlates with carbapenem resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2006 |
Nosocomial spread of OXA-58-positive carbapenem-resistant Acinetobacter baumannii isolates in a paediatric hospital in Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance; Greece; Hospitals, Pediatric; Hospitals, Urban; Humans; Risk Factors | 2006 |
Occurrence of carbapenem-resistant Acinetobacter baumannii clones at multiple hospitals in London and Southeast England.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; England; Humans; Microbial Sensitivity Tests | 2006 |
Clinical culture surveillance of carbapenem-resistant Pseudomonas aeruginosa and Acinetobacter species in a teaching hospital in Sao Paulo, Brazil: a 7-year study.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Culture Media; Drug Resistance, Bacterial; Female; Hospitals, Teaching; Humans; Male; Population Surveillance; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Urine | 2006 |
Horizontal gene transfer in a polyclonal outbreak of carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Australia; Bacterial Proteins; Carbapenems; Disease Outbreaks; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Humans; Molecular Sequence Data; Sequence Analysis, DNA | 2007 |
Pyrosequencing for rapid identification of carbapenem-hydrolysing OXA-type beta-lactamases in Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; DNA Primers; DNA, Bacterial; Electrophoresis, Agar Gel; Humans; Polymerase Chain Reaction; Sequence Analysis, DNA | 2006 |
Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Australia; Carbapenems; Case-Control Studies; Cross Infection; Drug Resistance, Bacterial; Female; Hospitals, University; Humans; Infection Control; Intensive Care Units; Length of Stay; Male; Middle Aged; Retrospective Studies; Risk Factors | 2007 |
IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Hospitals, General; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; Singapore | 2007 |
Multidrug-resistant Acinetobacter baumannii bacteraemia: clinical features, antimicrobial therapy and outcome.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Treatment Outcome | 2007 |
Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Poland; Retrospective Studies | 2007 |
Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colombia; Hospitals; Humans; Microbial Sensitivity Tests; Polymerase Chain Reaction; Population Surveillance | 2007 |
Molecular epidemiology of a clonal outbreak of multidrug-resistant Acinetobacter baumannii in a university hospital in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; beta-Lactamases; Carbapenems; Community-Acquired Infections; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, University; Humans; Intensive Care Units; Italy; Male; Microbial Sensitivity Tests | 2007 |
Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Brazil; Carbapenems; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Molecular findings and antibiotic-resistance in an outbreak of Acinetobacter baumannii in an intensive care unit.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Carbapenems; Colistin; Cross Infection; Disease Outbreaks; Disinfection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Intensive Care Units; Male; Middle Aged; Patient Isolation; Rifampin; Rome; Sulbactam | 2007 |
Outbreak of Acinetobacter baumannii producing the carbapenem-hydrolyzing oxacillinase OXA-58 in Rome, Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteriological Techniques; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Genotype; Humans; Integrons; Intensive Care Units; Random Amplified Polymorphic DNA Technique; Rome | 2007 |
Acinetobacter baumannii meningitis in post-neurosurgical patients: clinical outcome and impact of carbapenem resistance.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Female; Humans; Male; Meningitis, Bacterial; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures | 2007 |
In vitro activities of carbapenem/sulbactam combination, colistin, colistin/rifampicin combination and tigecycline against carbapenem-resistant Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Colistin; Colony Count, Microbial; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Sulbactam; Tigecycline | 2007 |
Multidrug-resistant Acinetobacter baumannii, Russia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; France; Humans; Male; Microbial Sensitivity Tests; Patient Transfer; Russia | 2007 |
Mechanisms of resistance to carbapenems in meropenem- resistant Acinetobacter isolates from clinical samples.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Biological Transport, Active; Carbapenems; Child; Drug Resistance, Bacterial; Female; Humans; Infant; Infant, Newborn; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Thienamycins | 2007 |
Identification of 16S rRNA methylase-producing Acinetobacter baumannii clinical strains in North America.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Aminoglycosides; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Electrophoresis, Gel, Pulsed-Field; Humans; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; North America; RNA, Ribosomal, 16S; Sequence Analysis, DNA | 2007 |
Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals.
Topics: Acinetobacter; Acinetobacter Infections; Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Blotting, Southern; Carbapenems; China; Chloramphenicol; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Sequence Data; Rifampin; Sequence Analysis, DNA | 2007 |
Comparative activities of colistin, rifampicin, imipenem and sulbactam/ampicillin alone or in combination against epidemic multidrug-resistant Acinetobacter baumannii isolates producing OXA-58 carbapenemases.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Ampicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Italy; Microbial Sensitivity Tests; Rifampin; Sulbactam | 2007 |
Exposure to quinolones is associated with carbapenem resistance among colistin-susceptible Acinetobacter baumannii blood isolates.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Blood; Carbapenems; Cohort Studies; Colistin; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Penicillins; Quinolones; Retrospective Studies; Risk Factors | 2007 |
Risk factors and outcomes of bloodstream infections with metallo-beta-lactamase-producing Acinetobacter.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Carbapenems; Case-Control Studies; Cephalosporins; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Male; Middle Aged; Neutropenia; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2008 |
First report of molecular characterization of carbapenem-resistant Acinetobacter baumannii in different intensive care units in University Hospital Split, Croatia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Croatia; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, University; Humans; Intensive Care Units; Polymerase Chain Reaction | 2007 |
Outbreak of multidrug-resistant Acinetobacter baumannii in a Belgian university hospital after transfer of patients from Greece.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Belgium; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Female; Greece; Hospitals, University; Humans; Male; Middle Aged; Patient Isolation; Patient Transfer; Respiratory Tract Infections; Travel | 2007 |
An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China.
Topics: Acinetobacter baumannii; Acinetobacter Infections; beta-Lactamases; Carbapenems; China; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Integrons; Intensive Care Units; Interspersed Repetitive Sequences; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactam Resistance; Carbapenems; Cross Infection; Electrophoresis, Gel, Pulsed-Field; Europe; Genetic Variation; Geography; Humans; Imipenem; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique | 2008 |
Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2008 |
In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Italy; Microbial Sensitivity Tests; Minocycline; Polymerase Chain Reaction; Tigecycline | 2008 |
Outbreak of Acinetobacter baumannii with chromosomally encoded VIM-1 undetectable by imipenem-EDTA synergy tests.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Chromosomes, Bacterial; Cross Infection; Disease Outbreaks; DNA, Bacterial; Drug Resistance, Bacterial; Edetic Acid; Greece; Humans; Imipenem; Integrons; Isoelectric Focusing; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA | 2008 |
Characterisation of carbapenem-resistant Acinetobacter calcoaceticus--A. baumannii complex isolates in a third-level hospital in Bogotá, Colombia.
Topics: Acinetobacter baumannii; Acinetobacter calcoaceticus; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Colombia; Cross Infection; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Plasmids; Reverse Transcriptase Polymerase Chain Reaction | 2008 |
[Dissemination of IMP-1 and OXA type beta-lactamase in carbapenem-resistant Acinetobacter baumannii].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Polymerase Chain Reaction | 2008 |
How carbapenem-resistant Acinetobacter spp. established in a newly constructed hospital.
Topics: Acinetobacter; Acinetobacter baumannii; Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Child; Child, Preschool; Cross Infection; DNA, Bacterial; Hospitals; Humans; Integrons; Middle Aged; Taiwan | 2008 |
Ampicillin/sulbactam compared with polymyxins for the treatment of infections caused by carbapenem-resistant Acinetobacter spp.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Ampicillin; APACHE; beta-Lactam Resistance; Bronchoalveolar Lavage Fluid; Carbapenems; Child; Child, Preschool; Cross Infection; Female; Hospitals, Teaching; Humans; Infant; Logistic Models; Male; Middle Aged; Multivariate Analysis; Polymyxins; Prognosis; Renal Insufficiency; Retrospective Studies; Risk Factors; Shock, Septic; Sulbactam; Time Factors; Treatment Outcome | 2008 |
Emergence and spread of carbapenem-resistant Acinetobacter baumannii in a tertiary care hospital in Turkey.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Intensive Care Units; Turkey | 2008 |
[Prevalence of infection by carbapenem-resistant Acinetobacter baumannii in Spain (1999-2005)].
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Aged, 80 and over; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Male; Middle Aged; Prevalence | 2008 |
Biofilm production by clinical strains of Acinetobacter baumannii isolated from patients hospitalized in two tertiary care hospitals.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Biofilms; Carbapenems; Cross Infection; DNA, Bacterial; Humans; Microbial Sensitivity Tests; Random Amplified Polymorphic DNA Technique; Retrospective Studies | 2008 |
Acquisition of a plasmid-borne blaOXA-58 gene with an upstream IS1008 insertion conferring a high level of carbapenem resistance to Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; DNA Primers; DNA Transposable Elements; DNA, Bacterial; Genes, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Promoter Regions, Genetic; Transformation, Genetic | 2008 |
Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cluster Analysis; Cross Infection; Czech Republic; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genotype; Hospitals; Humans; Intensive Care Units; Microbial Sensitivity Tests; Prospective Studies; Sequence Analysis, DNA | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase OXA-58 in an Acinetobacter phenon 6/ct13TU clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; beta-Lactamases; Carbapenems; DNA, Bacterial; Electrophoresis, Agar Gel; Gene Transfer, Horizontal; Genes, Bacterial; Humans; Nucleic Acid Hybridization; Plasmids; Sequence Analysis, DNA; Sequence Homology | 2008 |
Characterization of the carbapenem-hydrolyzing oxacillinase oxa-58 in an Acinetobacter genospecies 3 clinical isolate.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; beta-Lactamases; Carbapenems; Humans; Imipenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Sequence Analysis, DNA | 2008 |
Carbapenem resistance mediated by beta-lactamases in clinical isolates of Acinetobacter baumannii in Spain.
Topics: Acinetobacter; Acinetobacter Infections; Aged; Aged, 80 and over; beta-Lactam Resistance; Carbapenems; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Thienamycins | 1998 |
Emergence of carbapenem-hydrolyzing enzymes in Acinetobacter baumannii clinical isolates.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Humans; Hydrolysis; Microbial Sensitivity Tests | 1999 |
[Focus on Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple; Humans; Intensive Care Units | 1999 |
Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Anti-Bacterial Agents; Brain Diseases; Carbapenems; Central Nervous System Bacterial Infections; Cerebral Ventricles; Colistin; Drug Resistance, Microbial; Encephalitis; Female; Humans; Injections, Intraventricular; Male; Middle Aged; Treatment Outcome | 1999 |
Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: citywide prevalence, interinstitutional spread, and relation to antibiotic usage.
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Synergism; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Humans; New York City; Prevalence | 2000 |
Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Carbapenems; Child; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Humans; Hydrolysis; Imipenem; Meropenem; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thienamycins | 2000 |
Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Adult; Aged; Carbapenems; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Electrophoresis, Gel, Pulsed-Field; Female; Hospitals, Teaching; Humans; Infection Control; Intensive Care Units; Male; Middle Aged; Polymerase Chain Reaction; Risk Factors | 2000 |
Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii.
Topics: Acinetobacter; Acinetobacter Infections; Base Sequence; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; DNA, Bacterial; Drug Resistance, Microbial; Genes, Bacterial; Humans; In Situ Hybridization; Isoelectric Focusing; Kinetics; Microbial Sensitivity Tests; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Canada; Carbapenems; Child; Child, Preschool; Cross Infection; Drug Resistance, Multiple; Europe; Female; Gram-Negative Bacterial Infections; Humans; Infant; Infant, Newborn; Latin America; Male; Microbial Sensitivity Tests; Middle Aged; Seasons; Stenotrophomonas maltophilia; United States | 2001 |
Carbapenem-resistant Acinetobacter and role of curtains in an outbreak in intensive care units.
Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Middle Aged; United Kingdom | 2002 |
Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936).
Topics: Acinetobacter; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Minocycline; Tigecycline; United Kingdom | 2002 |
Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.
Topics: Acinetobacter; Acinetobacter Infections; Carbapenems; Disease Outbreaks; DNA Fingerprinting; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Incidence; Microbial Sensitivity Tests; New York; Pseudomonas aeruginosa; Pseudomonas Infections; Ribotyping | 2002 |